{"meta":{"query_hash":"3e9b50bef42a","filters":{"venue":"Cancer Immunology Immunotherapy"},"cohort_total":148,"direct_labels_cover":0,"predictions_cover":148,"exported":148,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3e9b50bef42a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Immunology+Immunotherapy"},"results":[{"id":"W1522355061","doi":"10.1007/s00262-002-0357-4","title":"Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Mastocytoma; Vinblastine; Cytotoxic T cell; Paclitaxel; Cancer research; CD3; Cytotoxicity; In vitro; Immunology; Biology; Tumor cells; Chemistry; Medicine; Chemotherapy; CD8; Immune system; Internal medicine; Biochemistry","score_opus":0.017310360743286776,"score_gpt":0.28743186376468083,"score_spread":0.27012150302139404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522355061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975095,0.00042944174,0.00047988375,0.000080764505,0.000040142673,0.000012037588,0.00017176621,0.000027254006,0.0012491773],"genre_scores_gemma":[0.99636406,0.0003419029,0.00040751457,0.000033554064,0.000010008126,0.000015420092,0.00033939118,0.000010763623,0.002477438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982005,0.000020926624,0.000013025436,0.000022466822,0.000027810209,0.000095790216],"domain_scores_gemma":[0.99993956,0.000017458862,0.000012788888,0.000012676458,0.0000040323307,0.000013499709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007138715,0.00020277206,0.00025422644,0.00016944241,0.0002250313,0.00032433536,0.00022565268,0.00028815307,0.0017727265],"category_scores_gemma":[0.00007310222,0.00018768948,0.00028770042,0.00019468334,0.0001611633,0.00017998886,0.00012067322,0.0005494784,0.00048257067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024004086,0.00003649501,0.000126271,0.000010562654,0.0000044784497,0.00008274502,0.000010524363,0.000033057073,0.9987507,0.00008798648,0.00006303896,0.00055409834],"study_design_scores_gemma":[0.000031455736,0.00025697073,0.0038939656,0.0000023536204,0.0000112934895,0.00021437912,0.000026292455,0.0003805932,0.99384016,0.000027956323,0.0013122454,0.000002424228],"about_ca_topic_score_codex":0.001059802,"about_ca_topic_score_gemma":0.0017471943,"teacher_disagreement_score":0.0017727265,"about_ca_system_score_codex":0.00036393234,"about_ca_system_score_gemma":0.00018799001,"threshold_uncertainty_score":0.005930364},"labels":[],"label_agreement":null},{"id":"W1964892365","doi":"10.1007/s002620000121","title":"Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex","year":2000,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"DNA; CpG site; DNA methylation; Biology; Mycobacterium phlei; Molecular biology; Cell biology; Mycobacterium; Biochemistry; Gene; Bacteria; Genetics; Gene expression","score_opus":0.0225285911055001,"score_gpt":0.28756314286416684,"score_spread":0.26503455175866675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964892365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764925,0.0005737954,0.0010757083,0.00007379566,0.000043763157,0.000013007683,0.000059101985,0.000029835797,0.00048176514],"genre_scores_gemma":[0.99805343,0.00016933781,0.0008913614,0.000030375048,0.000010770734,0.00001000499,0.00011733659,0.000009388552,0.00070788775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982446,0.000049226568,0.000016436052,0.000022976817,0.000030186562,0.000056769226],"domain_scores_gemma":[0.9996444,0.000119631244,0.000080274505,0.00003868141,0.000030151037,0.00008675854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021777001,0.000327643,0.00020337015,0.00018333826,0.000129855,0.0003832664,0.0001706445,0.0004041144,0.0014722638],"category_scores_gemma":[0.00035266328,0.0001545522,0.00019187371,0.00013342738,0.00037949308,0.00017409788,0.00020154112,0.00080739125,0.00035413474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000602906,0.00004476726,0.00009832586,0.000020264833,0.0000046489786,0.000028136894,0.000008570619,0.00007743215,0.99831057,0.00009884352,0.000013545082,0.0006919851],"study_design_scores_gemma":[0.00008409173,0.00040752933,0.00064748863,0.000005360968,0.000011915443,0.00005349755,0.000010402473,0.00058038876,0.9976928,0.000044862227,0.0004581698,0.0000035105986],"about_ca_topic_score_codex":0.00036641414,"about_ca_topic_score_gemma":0.0004224835,"teacher_disagreement_score":0.0014722638,"about_ca_system_score_codex":0.0003364424,"about_ca_system_score_gemma":0.00025341308,"threshold_uncertainty_score":0.0049251914},"labels":[],"label_agreement":null},{"id":"W1966217582","doi":"10.1007/s00262-004-0572-2","title":"Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; CD22; Conjugate; Antibody; Monoclonal antibody; Epitope; Saporin; Linker; Chemistry; Immunotoxin; Humanized antibody; Molecular biology; Biochemistry; Cancer research; Biology; Immunology","score_opus":0.03108353627508348,"score_gpt":0.36627156694315505,"score_spread":0.33518803066807157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966217582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839087,0.004546311,0.005176222,0.0003006568,0.00011204806,0.00016262801,0.00010193087,0.00017727842,0.005514326],"genre_scores_gemma":[0.99520665,0.0014715935,0.0016944426,0.00007390522,0.000012431298,0.000047746795,0.00012126946,0.0000150845235,0.0013567898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999026,0.000021245016,0.0000043118876,0.000014351947,0.000022938219,0.00003457845],"domain_scores_gemma":[0.9999502,0.0000114405575,0.00000835909,0.000009993641,0.0000059748327,0.000014143515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020708682,0.00027676625,0.0004068338,0.0003271711,0.00021915643,0.0003293935,0.00032204943,0.0003646062,0.0007505553],"category_scores_gemma":[0.00020981807,0.00013464644,0.00016471955,0.0003766704,0.00018624635,0.00021325811,0.0003051647,0.00050111336,0.00018160413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024432132,0.00091083144,0.0019527429,0.0003089302,0.00016875238,0.00062006986,0.00017223472,0.00876852,0.8894629,0.003920936,0.0022930817,0.088977754],"study_design_scores_gemma":[0.0021165968,0.007807282,0.008938625,0.00004376824,0.00019696938,0.0018951296,0.00005424485,0.015974551,0.940417,0.00044786758,0.02208019,0.000027797396],"about_ca_topic_score_codex":0.0017737166,"about_ca_topic_score_gemma":0.003919931,"teacher_disagreement_score":0.0017737166,"about_ca_system_score_codex":0.00063532416,"about_ca_system_score_gemma":0.0004146512,"threshold_uncertainty_score":0.0046096444},"labels":[],"label_agreement":null},{"id":"W1970361217","doi":"10.1007/s00262-012-1301-x","title":"EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Monocytic leukemia; Acute promyelocytic leukemia; Biology; Cancer research; Microglia; Promyelocytic leukemia protein; Leukemia; Cellular differentiation; Inflammation; In vitro; Neuroinflammation; Cell biology; Immunology; Cell culture; Gene; Biochemistry; Retinoic acid","score_opus":0.008818941915864353,"score_gpt":0.2503635377057203,"score_spread":0.24154459578985593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970361217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952211,0.0015757768,0.0012637281,0.00008660394,0.000023181134,0.000014115381,0.00026007893,0.00004623654,0.0015092369],"genre_scores_gemma":[0.9969913,0.0005634622,0.0006706494,0.000031960306,0.0000063099146,0.000015672003,0.00022610264,0.000011855713,0.0014827277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975747,0.000031397016,0.00002669259,0.000041729374,0.000053586333,0.00008905179],"domain_scores_gemma":[0.9999001,0.000023920504,0.000019337525,0.000014619577,0.000014227274,0.000027905638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002005474,0.00025236592,0.0003056198,0.00018956931,0.00019302331,0.00044503238,0.00012051661,0.00021237138,0.0012626101],"category_scores_gemma":[0.00014888775,0.00011505267,0.0001916682,0.00018807303,0.0002727851,0.00028288667,0.00016414163,0.0006209148,0.0003607974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023630966,0.000014166657,0.00011477221,0.00001873803,0.0000023968373,0.00001275653,0.00001497208,0.00004767915,0.99862015,0.000097338765,0.000019782172,0.0008009882],"study_design_scores_gemma":[0.000010986517,0.00012970917,0.0011622943,0.0000021947985,0.000012748984,0.000034781675,0.00001859465,0.00015957071,0.9975413,0.00002919215,0.00089695,0.0000017709438],"about_ca_topic_score_codex":0.0006725938,"about_ca_topic_score_gemma":0.001123031,"teacher_disagreement_score":0.0012626101,"about_ca_system_score_codex":0.0003157453,"about_ca_system_score_gemma":0.00035592215,"threshold_uncertainty_score":0.0042238235},"labels":[],"label_agreement":null},{"id":"W1970846528","doi":"10.1007/s00262-009-0802-8","title":"IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"In vivo; Medicine; Proinflammatory cytokine; Immune system; Cytokine; Melanoma; Immunotherapy; Cancer research; Pharmacology; Immunology; Biology; Inflammation","score_opus":0.015989217561995468,"score_gpt":0.25141568541364157,"score_spread":0.2354264678516461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970846528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97700435,0.01049035,0.004417306,0.0007020704,0.00016530155,0.000063952626,0.0003060232,0.00015316818,0.006697469],"genre_scores_gemma":[0.99111104,0.004194783,0.0013516366,0.00015068555,0.00012893231,0.000034237797,0.00040134785,0.000021312626,0.002606019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980146,0.00005538308,0.000012826338,0.000016599402,0.000060493607,0.000053182157],"domain_scores_gemma":[0.9997284,0.000092920636,0.000045325007,0.000044132943,0.000026984077,0.00006234471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047414438,0.00042448886,0.0003749902,0.000436029,0.00020470668,0.00035477473,0.00010479251,0.00027118152,0.0011373806],"category_scores_gemma":[0.00020359366,0.00011873248,0.00028783924,0.0002294275,0.00029682915,0.00020233633,0.00014782225,0.0011386089,0.00032848906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001689236,0.0010337937,0.0015438843,0.00015224598,0.00003570098,0.00014834157,0.00004239839,0.00040280333,0.96360505,0.00027667533,0.00047035253,0.030599443],"study_design_scores_gemma":[0.0003015538,0.004845942,0.0050394125,0.000017489492,0.00006408748,0.00070732075,0.000036211466,0.00073958654,0.9825386,0.00021681178,0.005487104,0.0000059230742],"about_ca_topic_score_codex":0.00018742034,"about_ca_topic_score_gemma":0.00024920044,"teacher_disagreement_score":0.0011373806,"about_ca_system_score_codex":0.00013509837,"about_ca_system_score_gemma":0.00029017054,"threshold_uncertainty_score":0.003804922},"labels":[],"label_agreement":null},{"id":"W1972057331","doi":"10.1007/s00262-011-1180-6","title":"Epidemiology: allergy history, IgE, and cancer","year":2011,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa","funders":"","keywords":"Allergy; Epidemiology; Medicine; Immunology; Cancer; Immunoglobulin E; Internal medicine; Antibody","score_opus":0.12772817679672357,"score_gpt":0.37119056783823046,"score_spread":0.24346239104150688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972057331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005943982,0.9993831,0.00002887675,0.0001627056,0.00013371001,0.000001939147,0.00001313354,0.0000016743967,0.0002154498],"genre_scores_gemma":[0.0004201076,0.99894387,0.000046361365,0.00011944006,0.0002966161,0.0000023605057,0.000019366553,3.297929e-7,0.00015150275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995963,0.0000865434,0.000085972744,0.0000771323,0.00012403025,0.000030071247],"domain_scores_gemma":[0.999064,0.00047977845,0.00024474418,0.000018948986,0.00014421904,0.000048322443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073544105,0.0012260515,0.002462085,0.0034769617,0.00026900452,0.0012077482,0.0009035208,0.0014120357,0.003680827],"category_scores_gemma":[0.0018343778,0.00042142384,0.0009969263,0.005337828,0.0006297373,0.0014768512,0.00080481224,0.0016322557,0.0009749296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012276221,0.000118672666,0.0027949826,0.04745571,0.00049404614,0.00031578063,0.00006761796,0.0004081453,0.0004641112,0.0015947458,0.043557625,0.9026059],"study_design_scores_gemma":[0.00007548481,0.0001734078,0.017176578,0.0363028,0.0015807741,0.004613964,0.00025011526,0.0002419221,0.00023985843,0.0028069918,0.9364756,0.00006247046],"about_ca_topic_score_codex":0.0036367397,"about_ca_topic_score_gemma":0.00633076,"teacher_disagreement_score":0.003680827,"about_ca_system_score_codex":0.0008481931,"about_ca_system_score_gemma":0.001814874,"threshold_uncertainty_score":0.012313604},"labels":[],"label_agreement":null},{"id":"W1974625087","doi":"10.1007/s00262-006-0243-6","title":"Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke","year":2006,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Chemistry; Cytotoxicity; Carcinogen; Cytotoxic T cell; Reactive oxygen species; Tumor necrosis factor alpha; Alveolar macrophage; Lipopolysaccharide; Molecular biology; Cell culture; DNA damage; Pharmacology; Cancer research; Macrophage; Biochemistry; Immunology; Biology; In vitro; DNA","score_opus":0.008906055607518249,"score_gpt":0.2500969224728424,"score_spread":0.24119086686532412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974625087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968359,0.0010845923,0.0005049249,0.000092963695,0.000036701833,0.000011472441,0.00007429468,0.00004297587,0.0013161582],"genre_scores_gemma":[0.9969618,0.00058703695,0.00028310716,0.000040890412,0.000013399493,0.000018244888,0.00021575276,0.000008250025,0.0018716621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997317,0.000053466065,0.000021171998,0.00002223549,0.00006276849,0.000108562475],"domain_scores_gemma":[0.99980587,0.000042794836,0.000038590373,0.00003734077,0.000024890001,0.00005054886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022180814,0.00038813843,0.00040175498,0.00024195746,0.00023986405,0.0003644886,0.00024429266,0.00026678498,0.0017158965],"category_scores_gemma":[0.00018753296,0.00021562641,0.00035693764,0.00014994145,0.00033394032,0.00017773225,0.00026886247,0.00075026316,0.0005774425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008995875,0.00014229341,0.00054893305,0.00002269175,0.0000074889563,0.000079848454,0.000014345764,0.0000410623,0.99680555,0.00007809017,0.00004132437,0.0013189126],"study_design_scores_gemma":[0.00011240035,0.0009480624,0.015274586,0.0000095988435,0.000022103748,0.0004023139,0.000039806215,0.00077858375,0.9813089,0.00009068449,0.0010067261,0.0000062384424],"about_ca_topic_score_codex":0.00064808317,"about_ca_topic_score_gemma":0.0010131085,"teacher_disagreement_score":0.0017158965,"about_ca_system_score_codex":0.0002561529,"about_ca_system_score_gemma":0.0003572561,"threshold_uncertainty_score":0.0057402253},"labels":[],"label_agreement":null},{"id":"W1978607297","doi":"10.1007/s00262-010-0929-7","title":"Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Vaccination; Immunology; Epitope; Antigen; Immunogenicity; Immunotherapy; Medicine; T cell; CD8; Virology; Biology; Cancer research; Immune system","score_opus":0.006159829555518113,"score_gpt":0.23266311830948155,"score_spread":0.22650328875396344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978607297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849241,0.0067464076,0.0055554216,0.0008195376,0.00012402867,0.000099227014,0.000023782026,0.00008793659,0.0016196574],"genre_scores_gemma":[0.99494153,0.0012201483,0.003020936,0.00021196064,0.00007514825,0.00005202236,0.000028521968,0.000016415943,0.00043324524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914515,0.0004088029,0.00006868614,0.00010779909,0.00017522635,0.00009431942],"domain_scores_gemma":[0.999413,0.0003349953,0.000089644134,0.00006869872,0.00003451491,0.00005920952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018675429,0.0003219401,0.0006294565,0.00017260762,0.00023346017,0.00028732678,0.0003707874,0.00058354734,0.00042657673],"category_scores_gemma":[0.001162008,0.00019723747,0.00034124707,0.000098149554,0.00035101385,0.00035344737,0.00029202388,0.00071477384,0.00021359367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006972865,0.0013096016,0.0125320805,0.00062474946,0.00026559248,0.0007545712,0.0004669829,0.0032286092,0.7057967,0.0006691821,0.00083250646,0.2665465],"study_design_scores_gemma":[0.0013407972,0.0806489,0.05053334,0.0002810127,0.0010684595,0.008522145,0.00049326743,0.013567108,0.81414807,0.0020003172,0.027345428,0.000051095023],"about_ca_topic_score_codex":0.00031835082,"about_ca_topic_score_gemma":0.00075363496,"teacher_disagreement_score":0.0018675429,"about_ca_system_score_codex":0.00020824237,"about_ca_system_score_gemma":0.0002590009,"threshold_uncertainty_score":0.009876668},"labels":[],"label_agreement":null},{"id":"W1979479636","doi":"10.1007/s00262-015-1662-z","title":"The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Elsa U. Pardee Foundation","keywords":"Radiation therapy; Cytotoxic T cell; Glioma; Immunotherapy; Temozolomide; Medicine; Cell therapy; Cancer research; CD8; Immune system; Parenchyma; Immunology; Cell; Pathology; Biology; Internal medicine; In vitro","score_opus":0.025060749338043902,"score_gpt":0.30951494330881996,"score_spread":0.28445419397077604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979479636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98699594,0.0057726456,0.00094222155,0.0005079826,0.00010234513,0.00003947631,0.00008778471,0.000035369732,0.005516256],"genre_scores_gemma":[0.99861836,0.0006042193,0.00010677745,0.0001028943,0.000054238968,0.000011903282,0.0000674823,0.0000038124394,0.00043027784],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99983895,0.00006989932,0.000008538509,0.000020004023,0.000028135606,0.00003437126],"domain_scores_gemma":[0.99973613,0.000088779554,0.00006805193,0.000046596037,0.000021074125,0.000039303784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030957608,0.00018451466,0.00033465328,0.00012561918,0.00022642444,0.00036138072,0.00018866626,0.0002484124,0.001682269],"category_scores_gemma":[0.00079059484,0.000056717803,0.00028720163,0.00014354497,0.00027928015,0.00025201414,0.00020151018,0.00064760534,0.00030298613],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0515623,0.002405794,0.091431156,0.0007538238,0.00068518193,0.0017745913,0.00037054555,0.0031372982,0.095211685,0.0024027582,0.0030164514,0.74724853],"study_design_scores_gemma":[0.007438124,0.21641555,0.4757232,0.0004354643,0.0025219258,0.02696895,0.0011560892,0.009509061,0.17288987,0.005563475,0.081301965,0.00007633644],"about_ca_topic_score_codex":0.00039998637,"about_ca_topic_score_gemma":0.0006973669,"teacher_disagreement_score":0.001682269,"about_ca_system_score_codex":0.00035766163,"about_ca_system_score_gemma":0.000501967,"threshold_uncertainty_score":0.005627811},"labels":[],"label_agreement":null},{"id":"W1981785446","doi":"10.1007/s00262-009-0752-1","title":"Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Program for New Century Excellent Talents in University; Chinese Academy of Medical Sciences; Chinese Academy of Sciences; National Natural Science Foundation of China; Academy of Medical Sciences","keywords":"Autophagy; Major histocompatibility complex; MHC class I; Cell biology; Biology; CTL*; Regulator; Antigen; Cytolysis; Antigen processing; Immunology; Melanoma; Cytotoxic T cell; Cancer research; Apoptosis; CD8; Genetics","score_opus":0.02402543236678481,"score_gpt":0.3092619242453719,"score_spread":0.28523649187858713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981785446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643373,0.00084567873,0.0005835887,0.00013987094,0.000061558734,0.000016703065,0.00042603526,0.000034801295,0.0014578986],"genre_scores_gemma":[0.99661833,0.0003846294,0.00044274688,0.000042900163,0.000008267657,0.00002042052,0.00031368493,0.0000105874715,0.0021583687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998388,0.000027983904,0.000019962685,0.000029115366,0.000023821538,0.000060303017],"domain_scores_gemma":[0.99992204,0.0000151642935,0.000018219327,0.000018140769,0.000008973347,0.000017488517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015514472,0.00024158196,0.0002706902,0.00021519694,0.00026358213,0.00045335703,0.00013815814,0.00028076104,0.0018541798],"category_scores_gemma":[0.000079682206,0.00014360932,0.00036610305,0.00018408798,0.00021860152,0.00027370834,0.00018636361,0.0008933733,0.00061488175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045348698,0.000032661228,0.0002815065,0.00003409669,0.000004997325,0.000070595765,0.000027084316,0.000050305985,0.99823546,0.00016462151,0.000085107094,0.00056005083],"study_design_scores_gemma":[0.000043834625,0.00016645691,0.0044603352,0.0000064113524,0.000011784109,0.00015674968,0.000100964295,0.0005431964,0.9924045,0.00007161237,0.0020303973,0.0000036552042],"about_ca_topic_score_codex":0.0011824421,"about_ca_topic_score_gemma":0.0010669332,"teacher_disagreement_score":0.0018541798,"about_ca_system_score_codex":0.00042230714,"about_ca_system_score_gemma":0.00026734438,"threshold_uncertainty_score":0.0062028766},"labels":[],"label_agreement":null},{"id":"W1985361047","doi":"10.1007/s00262-011-1054-y","title":"Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research; University of Saskatchewan","keywords":"Cytotoxic T cell; Immunology; CD8; Immunity; CTL*; CCL20; CD40; Immune system; Interleukin 17; Biology; Cancer research; In vitro; Chemokine","score_opus":0.022262624137514717,"score_gpt":0.26466978817854075,"score_spread":0.24240716404102602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985361047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735188,0.0150641175,0.0041611246,0.0004436176,0.00025426687,0.00010338915,0.0001402625,0.00014466785,0.0061697704],"genre_scores_gemma":[0.9924845,0.0029425486,0.0018162017,0.00016512963,0.00020955443,0.00008441311,0.00008748091,0.000029123576,0.0021811503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965286,0.0000931936,0.000019950465,0.00003766791,0.00006283505,0.0001335469],"domain_scores_gemma":[0.99978775,0.00003956445,0.000049375638,0.000031911455,0.000029485704,0.0000620097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004831893,0.00060019275,0.0005335812,0.0005372907,0.00025122656,0.0007283981,0.00026804343,0.0005194814,0.0023885714],"category_scores_gemma":[0.000284194,0.00020296179,0.0003123477,0.00015830001,0.0003855081,0.0005205567,0.00028046142,0.0015282634,0.00056996115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003173919,0.00053145684,0.0061814743,0.0004997534,0.00004393642,0.0005389729,0.00015625554,0.00033578728,0.9147476,0.0036945695,0.00068101776,0.06941518],"study_design_scores_gemma":[0.00087933074,0.006682387,0.045682788,0.00028552426,0.00045102517,0.004459939,0.0006726497,0.0033429528,0.89908665,0.0045934026,0.033830192,0.00003314618],"about_ca_topic_score_codex":0.00006422467,"about_ca_topic_score_gemma":0.000115105235,"teacher_disagreement_score":0.0023885714,"about_ca_system_score_codex":0.00020349331,"about_ca_system_score_gemma":0.00028920526,"threshold_uncertainty_score":0.007990539},"labels":[],"label_agreement":null},{"id":"W1986527011","doi":"10.1007/s00262-011-1108-1","title":"Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; General Hospital of People’s Liberation Army","keywords":"Colorectal cancer; Immune tolerance; Immune system; Granzyme B; CD8; Cancer research; T cell; Flow cytometry; Cytotoxic T cell; Medicine; Tumor microenvironment; Immunology; Peripheral tolerance; Cancer; Metastasis; Biology; Internal medicine; In vitro","score_opus":0.035642921361739084,"score_gpt":0.32476055564479683,"score_spread":0.28911763428305776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986527011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635017,0.0014859545,0.00031486634,0.00014035478,0.00004447029,0.0000056862445,0.00002462797,0.000029773,0.0016041284],"genre_scores_gemma":[0.99807656,0.00029963272,0.000096804986,0.00003504727,0.00001695865,0.0000039574647,0.000034870573,0.000004571024,0.0014313906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998698,0.000028273387,0.000005755992,0.000011474734,0.000022626047,0.00006201544],"domain_scores_gemma":[0.9999207,0.000009605468,0.000018088487,0.000008381754,0.0000071230806,0.000035951645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010805141,0.00011197433,0.00014332682,0.00021130189,0.00015942079,0.00030678252,0.000111285524,0.00020886854,0.0018333625],"category_scores_gemma":[0.000138012,0.000106419124,0.00015257923,0.00010229917,0.00010361147,0.00013511254,0.00016709481,0.00060525857,0.0003205549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009970996,0.00020925181,0.0017672427,0.000066946755,0.000012644398,0.0001381168,0.000026299762,0.00013686159,0.9853581,0.00046429125,0.00042093245,0.010402141],"study_design_scores_gemma":[0.00036571952,0.006278412,0.07710734,0.00003897271,0.00012855238,0.0022719337,0.00029091982,0.003616722,0.8932632,0.0009370937,0.015687045,0.000014135927],"about_ca_topic_score_codex":0.0001939021,"about_ca_topic_score_gemma":0.00038736936,"teacher_disagreement_score":0.0018333625,"about_ca_system_score_codex":0.00016925881,"about_ca_system_score_gemma":0.0001208917,"threshold_uncertainty_score":0.006133139},"labels":[],"label_agreement":null},{"id":"W1986659029","doi":"10.1007/s00262-014-1597-9","title":"Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Mesothelioma; Immune system; Cancer research; Natural killer T cell; Natural killer cell; CD1D; Chemotherapy; Immunology; Biology; T cell; Cytotoxic T cell; Medicine; Pathology; Internal medicine; In vitro","score_opus":0.00585166177811634,"score_gpt":0.24617989010386745,"score_spread":0.24032822832575113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986659029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708444,0.0007525525,0.00080497464,0.00009016337,0.000039552597,0.00002746986,0.000096198055,0.000054496348,0.001050118],"genre_scores_gemma":[0.9978338,0.00031470432,0.0005277349,0.000037441037,0.000020801865,0.000042264917,0.00013740156,0.000008751128,0.0010771311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980193,0.000042793727,0.000017000073,0.000027266458,0.00003244804,0.000078567515],"domain_scores_gemma":[0.99987423,0.000029933295,0.000030916864,0.000025746127,0.000009058829,0.000030084631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001901876,0.00039179315,0.00028874847,0.00033856634,0.00020985608,0.0002347541,0.00018604012,0.00031376746,0.00088380434],"category_scores_gemma":[0.00019204667,0.00018139803,0.00029851063,0.00013280769,0.00026471468,0.00020304736,0.00014298924,0.0010026323,0.0002489205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009917688,0.00030031631,0.00033617704,0.00004836632,0.0000056896833,0.00008185721,0.000030551306,0.00024911397,0.9953643,0.00014524675,0.00008250457,0.0023640767],"study_design_scores_gemma":[0.00017623791,0.001996983,0.0038677987,0.000008361678,0.000028665268,0.00022261507,0.000031440453,0.0015161511,0.99046445,0.00010007079,0.001582073,0.000005086009],"about_ca_topic_score_codex":0.0003044269,"about_ca_topic_score_gemma":0.0006108135,"teacher_disagreement_score":0.00088380434,"about_ca_system_score_codex":0.00023326458,"about_ca_system_score_gemma":0.00020345375,"threshold_uncertainty_score":0.0029566884},"labels":[],"label_agreement":null},{"id":"W1991758119","doi":"10.1007/s00262-005-0010-0","title":"Monoclonal antibody therapy of chronic lymphocytic leukemia","year":2005,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Alemtuzumab; Chronic lymphocytic leukemia; Rituximab; Medicine; Fludarabine; Monoclonal antibody; Monoclonal antibody therapy; Immunology; Chemotherapy; Oncology; Leukemia; Antibody; Cancer research; Internal medicine; Cyclophosphamide","score_opus":0.06360689097298267,"score_gpt":0.4219103626378996,"score_spread":0.35830347166491694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991758119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096688214,0.9986406,0.00009575461,0.00015974032,0.00026898287,0.000005502368,0.000008991913,0.0000050020144,0.0007187914],"genre_scores_gemma":[0.00079074304,0.9977678,0.0001622703,0.0003150342,0.00022963398,0.000007702547,0.000027282154,0.0000010407794,0.00069849845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998418,0.00003451283,0.000022620427,0.000024734743,0.000057124747,0.000019182171],"domain_scores_gemma":[0.9997733,0.00010820439,0.000037836926,0.000006180521,0.000052783867,0.000021739006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064661575,0.0009437428,0.0017452128,0.0018324824,0.00024901045,0.0007241888,0.0009833664,0.000982898,0.002514972],"category_scores_gemma":[0.00069741905,0.00024421533,0.000523459,0.0016568273,0.00038989368,0.0008814461,0.00047357343,0.0017266489,0.001482618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017780179,0.00010148392,0.00013094388,0.009445126,0.00011039522,0.00022740373,0.000024605433,0.0003357735,0.0013265873,0.001937647,0.04024603,0.94593614],"study_design_scores_gemma":[0.00012269242,0.00017819683,0.00061055995,0.002438052,0.00019686422,0.0011345603,0.000023715838,0.00009186364,0.000409364,0.0008125898,0.9939691,0.000012429429],"about_ca_topic_score_codex":0.0013814555,"about_ca_topic_score_gemma":0.0030290817,"teacher_disagreement_score":0.002514972,"about_ca_system_score_codex":0.00066697755,"about_ca_system_score_gemma":0.0007955332,"threshold_uncertainty_score":0.008413374},"labels":[],"label_agreement":null},{"id":"W1993461896","doi":"10.1007/s00262-005-0088-4","title":"Photodynamic therapy-generated vaccine for cancer therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Photodynamic therapy; Cancer therapy; Medicine; Vaccine therapy; Cancer; Internal medicine; Immunotherapy; Chemistry","score_opus":0.029245854917919967,"score_gpt":0.35418348161245405,"score_spread":0.3249376266945341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993461896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9125618,0.038041826,0.020278977,0.0048526092,0.001200407,0.0009834578,0.0004813884,0.00014146909,0.021458114],"genre_scores_gemma":[0.9581282,0.016597888,0.0106096985,0.0009327257,0.00027136513,0.00032430553,0.0006416616,0.00003527426,0.01245888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997429,0.00011696316,0.0000127915555,0.00003309301,0.000039869585,0.00005437363],"domain_scores_gemma":[0.99983907,0.00006822185,0.000019872748,0.000024565885,0.000029424067,0.000018801758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013433242,0.00055156474,0.00030516938,0.0005328288,0.00028819457,0.0005525977,0.0004569771,0.0008291589,0.004317858],"category_scores_gemma":[0.0005603277,0.00016749966,0.00036508447,0.00022288828,0.000488752,0.00085298106,0.00033797862,0.0012089676,0.0005886368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017414585,0.0033771936,0.0009212319,0.00069371186,0.00010498753,0.00020922079,0.00027758678,0.0010390963,0.9241716,0.015766645,0.0022952303,0.049401995],"study_design_scores_gemma":[0.0008860384,0.009906253,0.002141827,0.00013818081,0.00018609074,0.0009079918,0.000274288,0.0017472366,0.9207006,0.0045197527,0.05857404,0.000017774719],"about_ca_topic_score_codex":0.00045065716,"about_ca_topic_score_gemma":0.0003622216,"teacher_disagreement_score":0.004317858,"about_ca_system_score_codex":0.0005583998,"about_ca_system_score_gemma":0.000710189,"threshold_uncertainty_score":0.014444649},"labels":[],"label_agreement":null},{"id":"W1995856925","doi":"10.1007/s002620100209","title":"ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells","year":2001,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Gene transfer; Biology; B cell; Gene; Cancer research; Immunology; Genetics; Antibody","score_opus":0.01283724045608944,"score_gpt":0.265895345861642,"score_spread":0.25305810540555257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995856925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452294,0.0023213231,0.009027844,0.00009728504,0.0000515598,0.00007515211,0.00024827852,0.00037935257,0.003276378],"genre_scores_gemma":[0.99034625,0.00060940266,0.0040069064,0.00002896253,0.000020188141,0.000048962138,0.00063778023,0.00008301556,0.0042186393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958783,0.00008116103,0.000021880347,0.00006326942,0.00010546207,0.00014035597],"domain_scores_gemma":[0.99940526,0.00021441373,0.000088482026,0.00012782951,0.00006225874,0.00010172289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005376621,0.00026563293,0.00044431852,0.0006894374,0.00029031886,0.000665833,0.0003204956,0.0004827938,0.0018695315],"category_scores_gemma":[0.00034707654,0.00022999762,0.00035038282,0.00027512063,0.0005143829,0.0004008527,0.00028487216,0.0008049177,0.0007719535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009942625,0.000032606597,0.00012020566,0.000020841413,0.000003514705,0.000018919725,0.000014796811,0.00003023107,0.998336,0.00021221899,0.000035474553,0.0010758054],"study_design_scores_gemma":[0.000024828016,0.00033845007,0.0009573939,0.0000043915884,0.00001167091,0.00017990434,0.000014525209,0.0004881088,0.9960603,0.00005672187,0.0018599431,0.0000038515586],"about_ca_topic_score_codex":0.0007327994,"about_ca_topic_score_gemma":0.0006783268,"teacher_disagreement_score":0.0018695315,"about_ca_system_score_codex":0.0003664594,"about_ca_system_score_gemma":0.0003254076,"threshold_uncertainty_score":0.006254196},"labels":[],"label_agreement":null},{"id":"W2000236470","doi":"10.1007/s00262-010-0864-7","title":"Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Epitope; Antibody; Monoclonal antibody; Polyclonal antibodies; Molecular biology; Hybridoma technology; In vitro; Antiserum; Biology; Monoclonal; Idiotype; Chemistry; Biochemistry; Immunology","score_opus":0.007873734694821182,"score_gpt":0.255271408390457,"score_spread":0.24739767369563578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000236470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850042,0.0043422594,0.0035345654,0.00012277398,0.00016624233,0.00006368537,0.00032032834,0.00014371237,0.0063023027],"genre_scores_gemma":[0.99044234,0.0021926619,0.0018876258,0.00007324726,0.000061115694,0.00007989102,0.0009698469,0.000030117033,0.004263086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996623,0.00009262253,0.000023805636,0.000026968786,0.00006215579,0.00013208017],"domain_scores_gemma":[0.9997794,0.0000990594,0.000026892632,0.000033631728,0.000024636234,0.00003635323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030509196,0.0007674657,0.00041972572,0.0004626466,0.00022870653,0.00028853904,0.0005056987,0.00040290426,0.0019094932],"category_scores_gemma":[0.00020817369,0.0002441681,0.00047950653,0.0002841073,0.00019651851,0.000184368,0.00022526809,0.0010023047,0.0006987952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005002334,0.00025897584,0.00012383611,0.000061520725,0.000012087397,0.000063868036,0.000015510419,0.00019742508,0.99598265,0.00015077731,0.00011848809,0.0025146466],"study_design_scores_gemma":[0.000032158783,0.00072936906,0.0009898959,0.000003505493,0.000014785656,0.00009294578,0.000005690471,0.00071705633,0.99642146,0.000014915299,0.00097608275,0.000002161862],"about_ca_topic_score_codex":0.0016434753,"about_ca_topic_score_gemma":0.0013114949,"teacher_disagreement_score":0.0019094932,"about_ca_system_score_codex":0.0004218939,"about_ca_system_score_gemma":0.00029903676,"threshold_uncertainty_score":0.0063878894},"labels":[],"label_agreement":null},{"id":"W2001989483","doi":"10.1007/s00262-006-0158-2","title":"Targeted and shielded adenovectors for cancer therapy","year":2006,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute","funders":"","keywords":"Viral vector; Virology; Oncolytic virus; Vector (molecular biology); Virotherapy; Biology; Context (archaeology); Neutralizing antibody; Transduction (biophysics); Virus; Recombinant DNA; Genetics","score_opus":0.045714452088127154,"score_gpt":0.37577552125980956,"score_spread":0.33006106917168243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001989483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040825084,0.9945221,0.0020647133,0.0002584856,0.00059404224,0.000014108293,0.000025761012,0.000037181428,0.0020753162],"genre_scores_gemma":[0.0031794196,0.989817,0.0022469999,0.00032883414,0.00025109432,0.000037528243,0.00008709034,0.000007869378,0.0040441277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983644,0.000024806992,0.00001494508,0.000027051412,0.000075299555,0.00002142146],"domain_scores_gemma":[0.9999076,0.000041703017,0.000014979406,0.000006774244,0.000018224537,0.0000106382295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007126891,0.0013745184,0.0013787852,0.0012572657,0.00029059523,0.0008775908,0.0012814184,0.0013797974,0.0023254512],"category_scores_gemma":[0.00038094024,0.0004151266,0.00045940292,0.001190364,0.0007988011,0.0013346215,0.00057223043,0.0026644217,0.0019326528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021810214,0.000176608,0.00010789489,0.00558554,0.00008210176,0.0004533474,0.00006861226,0.0010442917,0.034478493,0.015833884,0.031337567,0.9106135],"study_design_scores_gemma":[0.000057397123,0.0001143099,0.00029347488,0.0005477564,0.00006326341,0.0013869685,0.000023486866,0.00022203045,0.009200999,0.003420997,0.9846466,0.000022811975],"about_ca_topic_score_codex":0.0006323758,"about_ca_topic_score_gemma":0.0012089935,"teacher_disagreement_score":0.0023254512,"about_ca_system_score_codex":0.00085711706,"about_ca_system_score_gemma":0.00067282584,"threshold_uncertainty_score":0.0077794194},"labels":[],"label_agreement":null},{"id":"W2004009702","doi":"10.1007/s00262-002-0315-1","title":"Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma","year":2002,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Melanoma; Lymph; Lymph node; Adjuvant therapy; Stage (stratigraphy); Population; Clinical endpoint; Adjuvant; Confidence interval; Oncology; Internal medicine; Surgery; Randomized controlled trial; Pathology; Cancer; Cancer research; Biology","score_opus":0.02387573056888997,"score_gpt":0.2750086496644934,"score_spread":0.2511329190956034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004009702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872177,0.0027043081,0.0012153647,0.0012381744,0.0019065555,0.0032018474,0.0006300583,0.00014799468,0.0017381003],"genre_scores_gemma":[0.9884934,0.001032603,0.0013498999,0.0012057918,0.00076393684,0.0030158095,0.0005884552,0.00003957498,0.0035106326],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99875116,0.0007132757,0.000065356355,0.00019679866,0.000064124346,0.00020924887],"domain_scores_gemma":[0.9980259,0.0008030938,0.00027772767,0.0002897652,0.00009499915,0.0005086701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028171919,0.00211161,0.0050897705,0.00055320025,0.00068909914,0.0013723093,0.0016376621,0.0029855783,0.005331027],"category_scores_gemma":[0.0027932979,0.0010042475,0.0021732035,0.00061486824,0.0025218907,0.001400535,0.0007186346,0.005236762,0.001245199],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9921578,0.002520368,0.00020384057,0.00011093532,0.00033039515,0.0000115401845,0.000016527982,0.00021131922,0.00084152876,0.000071208204,0.00018470285,0.003339859],"study_design_scores_gemma":[0.9446222,0.05342686,0.0005561929,0.000013391508,0.00037880114,0.000010213541,0.0000130274,0.00031180956,0.0003061533,0.0001406832,0.00021237462,0.000008210804],"about_ca_topic_score_codex":0.0017881417,"about_ca_topic_score_gemma":0.002308199,"teacher_disagreement_score":0.005331027,"about_ca_system_score_codex":0.0011953879,"about_ca_system_score_gemma":0.0016624761,"threshold_uncertainty_score":0.017834127},"labels":[],"label_agreement":null},{"id":"W2009827668","doi":"10.1007/s00262-013-1416-8","title":"An introduction to mass cytometry: fundamentals and applications","year":2013,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mass cytometry; Cytometry; Mass spectrometry; Flow cytometry; Physics; Inductively coupled plasma mass spectrometry; Chemistry; Analytical Chemistry (journal); Computer science; Nanotechnology; Materials science; Chromatography; Biology; Molecular biology","score_opus":0.025788554107201704,"score_gpt":0.3311461908520582,"score_spread":0.3053576367448565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009827668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009739495,0.98930794,0.00568868,0.0011435573,0.0017538707,0.000017456707,0.00006245415,0.000070488204,0.0018582534],"genre_scores_gemma":[0.0013226937,0.9821953,0.006189419,0.0025344025,0.0035657324,0.0000666914,0.00011124147,0.000024535635,0.0039899726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992894,0.000115457624,0.00005839496,0.00013506657,0.0003482262,0.000053465963],"domain_scores_gemma":[0.9988838,0.00067290873,0.00007998639,0.000041692827,0.0002530872,0.000068621564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016754462,0.0018615455,0.0020663529,0.0037205087,0.0005377567,0.002033937,0.0019907316,0.003012263,0.004882532],"category_scores_gemma":[0.0016028121,0.0009607803,0.0008010944,0.003749264,0.0021810532,0.0033734897,0.0017401669,0.0051056813,0.0056017404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090191825,0.00013478716,0.00018632,0.009006694,0.000050770323,0.00019200084,0.00009238845,0.00078255765,0.016994786,0.017625285,0.124811746,0.83003247],"study_design_scores_gemma":[0.000009448698,0.000056084795,0.00030563533,0.00068960845,0.000020912536,0.00084709586,0.000032585343,0.00032140987,0.0030505063,0.008369076,0.9862575,0.000040113617],"about_ca_topic_score_codex":0.0008854091,"about_ca_topic_score_gemma":0.0013299463,"teacher_disagreement_score":0.004882532,"about_ca_system_score_codex":0.0014569777,"about_ca_system_score_gemma":0.0013011327,"threshold_uncertainty_score":0.016333759},"labels":[],"label_agreement":null},{"id":"W2009871132","doi":"10.1007/s00262-014-1555-6","title":"Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ruth och Richard Julins Stiftelse; Cancerfonden; Cancer Research Society","keywords":"FOXP3; Chemokine; Biology; CCL17; Immunology; Cancer research; Population; Regulatory T cell; Immune system; T cell; Medicine; IL-2 receptor; CXCL10","score_opus":0.022766435703176328,"score_gpt":0.2699485758962462,"score_spread":0.2471821401930699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009871132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965513,0.00052960485,0.0009772794,0.00012858026,0.00003418028,0.000018760371,0.0007456352,0.00017871804,0.00083586463],"genre_scores_gemma":[0.9941947,0.00037488926,0.0012416213,0.00007411217,0.000038332753,0.00004232917,0.0006406856,0.00008905768,0.0033043723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964046,0.000037921807,0.00003246886,0.000091675385,0.00009780205,0.00009963187],"domain_scores_gemma":[0.99908507,0.000091746166,0.00028958815,0.00006400085,0.00005767126,0.00041198422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016843854,0.00071313477,0.00049146573,0.0014626544,0.00030459353,0.0005017017,0.00024041216,0.0007042013,0.0031044302],"category_scores_gemma":[0.00025351119,0.00052591984,0.0003903282,0.00029635098,0.00052857737,0.0004558998,0.00024020755,0.0013647901,0.00064297346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059349916,0.000039881423,0.0003704774,0.00001842496,0.0000029561297,0.00017212753,0.000011577811,0.000032019627,0.9983217,0.00004911406,0.000025180932,0.00036294048],"study_design_scores_gemma":[0.00015518762,0.0008785365,0.039632715,0.000009474751,0.00005113749,0.0026998047,0.00015928467,0.0011134862,0.95348287,0.00022637924,0.0015704231,0.000020722864],"about_ca_topic_score_codex":0.0008128444,"about_ca_topic_score_gemma":0.00090512395,"teacher_disagreement_score":0.0031044302,"about_ca_system_score_codex":0.00036107542,"about_ca_system_score_gemma":0.00029719216,"threshold_uncertainty_score":0.0103853345},"labels":[],"label_agreement":null},{"id":"W2013102110","doi":"10.1007/s00262-006-0269-9","title":"Assessment of CD4+  T cells specific for the tumor antigen SSX-1 in cancer-free individuals","year":2006,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Epitope; Antigen; Biology; Immunology; Cancer research; Molecular biology","score_opus":0.01781743128537293,"score_gpt":0.29625226828824136,"score_spread":0.2784348370028684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013102110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822336,0.00026474925,0.00023200775,0.000019616424,0.000008337711,0.000018743433,0.000049972143,0.000009236172,0.0011738982],"genre_scores_gemma":[0.99751663,0.00011999663,0.0002483767,0.00005413946,0.000016846676,0.000033078442,0.00010704403,0.0000034021211,0.0019004467],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982315,0.00005129096,0.000011473214,0.00003696358,0.00003308594,0.000044053653],"domain_scores_gemma":[0.99981993,0.00006937368,0.000017234239,0.000018082232,0.00003818117,0.00003724037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028857536,0.00027666386,0.0002517248,0.0006189242,0.00041881026,0.00035011486,0.00017156565,0.00058540347,0.0021349033],"category_scores_gemma":[0.00067485747,0.00015155177,0.00012897022,0.00017966515,0.00018605308,0.0002491622,0.0001941989,0.00034383225,0.0003405665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066106827,0.0009080692,0.26502213,0.00020251331,0.00007952915,0.0018467881,0.0017079591,0.00047068959,0.68184745,0.0004758448,0.00069742434,0.040131014],"study_design_scores_gemma":[0.00024198965,0.012415627,0.73419887,0.000051671814,0.00038119397,0.0071123326,0.0021145346,0.0029996526,0.23084098,0.0010401059,0.008554951,0.00004808999],"about_ca_topic_score_codex":0.0006773653,"about_ca_topic_score_gemma":0.00053430843,"teacher_disagreement_score":0.0021349033,"about_ca_system_score_codex":0.00012525794,"about_ca_system_score_gemma":0.00008952511,"threshold_uncertainty_score":0.007141888},"labels":[],"label_agreement":null},{"id":"W2013475297","doi":"10.1007/s00262-005-0014-9","title":"Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); Vancouver Biotech (Canada)","funders":"Science Foundation Ireland","keywords":"Bystander effect; Immune system; Heat shock protein; Cancer research; Cytotoxic T cell; CTL*; Genetic enhancement; CD8; Immunology; Adenoviridae; Suicide gene; Biology; Antigen; Immunity; Prostate cancer; Cancer; In vitro; Gene","score_opus":0.018975968104635477,"score_gpt":0.3149503204333605,"score_spread":0.29597435232872504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013475297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861639,0.0054863007,0.0027305942,0.00054636237,0.0001647147,0.00005634091,0.0001251933,0.0003065787,0.0044200104],"genre_scores_gemma":[0.99526346,0.0019170011,0.0007360315,0.00008911499,0.000039871342,0.000014348809,0.000112450536,0.000011678056,0.001816127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993026,0.000010459453,0.0000021085586,0.000008169223,0.000022451282,0.000026523192],"domain_scores_gemma":[0.9999653,0.000006588079,0.0000069611065,0.0000043924592,0.000003901696,0.000012841318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106196516,0.0002626935,0.00024049998,0.00020278944,0.00015156377,0.00020026937,0.00015406207,0.00020631858,0.0014856594],"category_scores_gemma":[0.00007433239,0.000077206605,0.00022689838,0.0001309204,0.0002352605,0.0001298472,0.00011936148,0.0007846809,0.0001919879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005034841,0.00025349483,0.00015208492,0.000057934005,0.000014142434,0.000057110115,0.000019942087,0.000269591,0.98509336,0.00039427596,0.0003531457,0.012831568],"study_design_scores_gemma":[0.00014352264,0.0038547984,0.004874837,0.000009085445,0.000060217935,0.0004982674,0.000029563362,0.0010035939,0.9825815,0.00022907309,0.0067068147,0.000008737287],"about_ca_topic_score_codex":0.00067173026,"about_ca_topic_score_gemma":0.0014846128,"teacher_disagreement_score":0.0014856594,"about_ca_system_score_codex":0.0002170387,"about_ca_system_score_gemma":0.00024350526,"threshold_uncertainty_score":0.0049699545},"labels":[],"label_agreement":null},{"id":"W2014153856","doi":"10.1007/s00262-008-0502-9","title":"Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Health Canada","funders":"","keywords":"Eosinophil; Cytokine; Proinflammatory cytokine; Cancer research; In vivo; Melanoma; Immune system; Eosinophilia; Medicine; Immunology; Biology; Inflammation","score_opus":0.03501808798597774,"score_gpt":0.3459635204963543,"score_spread":0.3109454325103766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014153856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689204,0.0009925206,0.0009694868,0.000079827514,0.000050504605,0.000038113718,0.00005773921,0.00007592203,0.00084391405],"genre_scores_gemma":[0.9974005,0.0004916831,0.00074287655,0.000049063878,0.00002642011,0.000033488825,0.0001251371,0.000009689874,0.001121163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998443,0.000030924493,0.000009030827,0.00001556168,0.0000358971,0.000064216576],"domain_scores_gemma":[0.9999286,0.00001998644,0.000013643769,0.000008334084,0.0000043900786,0.000025082507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018455107,0.00021967232,0.00028615235,0.00027995487,0.00013091229,0.00026772774,0.00013493562,0.00022240556,0.001315138],"category_scores_gemma":[0.00013755754,0.00010958965,0.00025286328,0.00013426437,0.00022177029,0.00018770504,0.00020185404,0.0009639982,0.00025752667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010197676,0.00045877224,0.00053368235,0.000046056848,0.000014749362,0.000112264126,0.000020901385,0.00019092727,0.9868002,0.00012527886,0.0001612569,0.010516175],"study_design_scores_gemma":[0.0003442002,0.003975707,0.007644157,0.000006771827,0.000042318916,0.00041021244,0.000024775396,0.0010416531,0.9846185,0.00009760592,0.0017883142,0.0000057910743],"about_ca_topic_score_codex":0.00021357862,"about_ca_topic_score_gemma":0.0004159303,"teacher_disagreement_score":0.001315138,"about_ca_system_score_codex":0.00017540556,"about_ca_system_score_gemma":0.00028130203,"threshold_uncertainty_score":0.0043995976},"labels":[],"label_agreement":null},{"id":"W2014709975","doi":"10.1007/s00262-004-0626-5","title":"A phase I/II trial of oxidized autologous tumor vaccines during the “watch and wait” phase of chronic lymphocytic leukemia","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Stage (stratigraphy); Leukemia; Internal medicine; Clinical trial; Vaccination; Cancer; Gastroenterology; Surgery; Oncology; Immunology","score_opus":0.019490794958685425,"score_gpt":0.3403630314449678,"score_spread":0.3208722364862824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014709975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795157,0.0006914668,0.00021392018,0.00023234265,0.0000868119,0.00018221763,0.00008811149,0.000032152802,0.0005214485],"genre_scores_gemma":[0.99788326,0.0004405311,0.00033757274,0.00022547512,0.00005766267,0.00020917972,0.0002652928,0.000008304799,0.0005726749],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997054,0.00011571031,0.000009889362,0.000037074384,0.000016932436,0.00011500217],"domain_scores_gemma":[0.99938416,0.00014129882,0.00007615924,0.00006262006,0.000022448761,0.00031338295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010329693,0.0007302862,0.0013517876,0.0003153885,0.00039412655,0.00094620435,0.00056110584,0.00095985795,0.0015936929],"category_scores_gemma":[0.00057451945,0.0002827106,0.00065074954,0.00026411697,0.0011301903,0.0009500694,0.00033310565,0.002976808,0.0002860997],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7990882,0.044762798,0.0055234153,0.00039727078,0.000772494,0.000280454,0.00033890852,0.003535471,0.05167953,0.001313962,0.0029092447,0.08939827],"study_design_scores_gemma":[0.4006232,0.5769816,0.006084441,0.00002883437,0.00041199572,0.0002560109,0.00015621883,0.0019719559,0.010442761,0.0007165105,0.0022954843,0.000031014402],"about_ca_topic_score_codex":0.0011497369,"about_ca_topic_score_gemma":0.002065837,"teacher_disagreement_score":0.0015936929,"about_ca_system_score_codex":0.00069929817,"about_ca_system_score_gemma":0.0010249907,"threshold_uncertainty_score":0.005462885},"labels":[],"label_agreement":null},{"id":"W2015348628","doi":"10.1007/s00262-010-0823-3","title":"Growth inhibition of tumor cells in vitro by using monoclonal antibodies against gonadotropin-releasing hormone receptor","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Monoclonal antibody; Gonadotropin-releasing hormone receptor; Receptor; Molecular biology; Antibody; Growth hormone receptor; Biology; Western blot; MTT assay; Hybridoma technology; Cell growth; Gonadotropin-releasing hormone; Endocrinology; Hormone; Immunology; Luteinizing hormone; Biochemistry; Gene","score_opus":0.012007769206107495,"score_gpt":0.2624601781923464,"score_spread":0.2504524089862389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015348628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855729,0.0042441236,0.003331338,0.00030595055,0.00021711599,0.00007679982,0.00030233423,0.00015409946,0.005795226],"genre_scores_gemma":[0.989994,0.0028888215,0.002247825,0.00009303874,0.00007729973,0.000081531485,0.0008561646,0.000029584306,0.0037318124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998247,0.00003715045,0.000012500983,0.00002455518,0.000030872437,0.00007021534],"domain_scores_gemma":[0.99983287,0.00009233934,0.000016546059,0.000022295966,0.000013922527,0.000022006117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026331338,0.0006263885,0.00033944641,0.00047340145,0.00025935945,0.00031845068,0.00034981608,0.00028698347,0.0018787392],"category_scores_gemma":[0.00016484526,0.00025735536,0.00054186105,0.0002632077,0.00021175086,0.00021065779,0.0002438519,0.000921885,0.00047084596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037509663,0.00028316505,0.0001739781,0.000060760383,0.000015355234,0.000050213413,0.000033925004,0.00025826102,0.99447906,0.00019936038,0.00020056922,0.0038701768],"study_design_scores_gemma":[0.00010930576,0.0010224201,0.0017829429,0.0000072372713,0.000027694367,0.00011955919,0.000018973871,0.0015063098,0.9934861,0.00004658036,0.001869099,0.0000037465988],"about_ca_topic_score_codex":0.0022563676,"about_ca_topic_score_gemma":0.0025454948,"teacher_disagreement_score":0.0022563676,"about_ca_system_score_codex":0.00038812144,"about_ca_system_score_gemma":0.00038092496,"threshold_uncertainty_score":0.006285012},"labels":[],"label_agreement":null},{"id":"W2016064123","doi":"10.1007/s002620000157","title":"4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages","year":2001,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research Society","keywords":"Chemistry; Cytokine; Immune system; Carcinogen; Tumor necrosis factor alpha; Nitrosamine; Carcinogenesis; Cancer research; Biochemistry; Immunology; Biology","score_opus":0.013128372068523719,"score_gpt":0.2874231714665887,"score_spread":0.27429479939806495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016064123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772257,0.0011231985,0.00036585212,0.000087180226,0.000040594485,0.000014483606,0.000114510796,0.000018575589,0.0005129853],"genre_scores_gemma":[0.996772,0.0008793817,0.00039023889,0.00007562212,0.000032882992,0.000034363773,0.00017598506,0.0000057527723,0.0016336676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999863,0.000035700985,0.0000126769755,0.000018476878,0.000017099079,0.00005303976],"domain_scores_gemma":[0.9999275,0.000022717126,0.000011928724,0.000014421869,0.000008519532,0.000015004524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001933689,0.00028935113,0.00032220513,0.00018556463,0.0001744841,0.00023781821,0.00011000793,0.00030308144,0.00139582],"category_scores_gemma":[0.00012201427,0.00015240649,0.0002655329,0.00015014647,0.00023955254,0.00021723621,0.00012635079,0.00055079773,0.00029613604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013307795,0.000093394454,0.00018010991,0.000025022257,0.000004730913,0.00007252711,0.000027459384,0.000038364953,0.9972556,0.000050621606,0.000024624174,0.0008967581],"study_design_scores_gemma":[0.00014029781,0.0017302327,0.0063611893,0.0000071418976,0.000021768983,0.00014436505,0.000068435256,0.00028689398,0.99054366,0.0000680529,0.00062391255,0.0000041242583],"about_ca_topic_score_codex":0.00042006013,"about_ca_topic_score_gemma":0.00076187775,"teacher_disagreement_score":0.00139582,"about_ca_system_score_codex":0.00012269166,"about_ca_system_score_gemma":0.00016961798,"threshold_uncertainty_score":0.0046694875},"labels":[],"label_agreement":null},{"id":"W2017174620","doi":"10.1007/s00262-008-0630-2","title":"TGF-alpha as a candidate tumor antigen for renal cell carcinomas","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal General Hospital; McGill University Health Centre; Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Health Research Foundation","keywords":"Immunotherapy; Immunogenicity; Cancer research; Cancer immunotherapy; Antigen; Renal cell carcinoma; Major histocompatibility complex; Transforming growth factor; Kidney cancer; Cancer; Biology; Medicine; Immunology; Immune system; Pathology; Internal medicine","score_opus":0.012716227679694492,"score_gpt":0.2680008353082106,"score_spread":0.2552846076285161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017174620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833725,0.008334602,0.002892124,0.00049211096,0.00006331539,0.000032636133,0.00005640218,0.00006155736,0.0046948646],"genre_scores_gemma":[0.9956928,0.0015993357,0.00093715376,0.000046631045,0.000036097,0.000008827099,0.00007564219,0.0000040838654,0.0015994515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995303,0.000016864713,0.0000023991347,0.000004962213,0.000008456213,0.000014236103],"domain_scores_gemma":[0.9999237,0.000025591999,0.000010935853,0.0000067523965,0.000012270711,0.000020665448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020435253,0.00015979577,0.00016787396,0.0003416033,0.00016921187,0.0003635646,0.00023426356,0.00037530833,0.0015308231],"category_scores_gemma":[0.0002076242,0.00010522187,0.00016917395,0.00017585352,0.0001502725,0.0002709869,0.00012192379,0.00032579407,0.00039201954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023907998,0.00019316102,0.011205165,0.00017803772,0.000022746202,0.0028747974,0.00006177802,0.0008119186,0.95072985,0.002997241,0.0003958575,0.028138604],"study_design_scores_gemma":[0.0003142668,0.0021323888,0.041148134,0.000047742044,0.00018789258,0.0087517155,0.00025847234,0.008668637,0.91366124,0.0033183459,0.021493481,0.000017729246],"about_ca_topic_score_codex":0.00036675524,"about_ca_topic_score_gemma":0.00023716877,"teacher_disagreement_score":0.0015308231,"about_ca_system_score_codex":0.00026919256,"about_ca_system_score_gemma":0.00023215167,"threshold_uncertainty_score":0.005121112},"labels":[],"label_agreement":null},{"id":"W2022215700","doi":"10.1007/s00262-013-1420-z","title":"Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"Public Health Agency of Canada","keywords":"Antigen; Pancreatic tumor; Monoclonal antibody; Tumor antigen; Antibody; Pancreatic cancer; Cancer research; Flow cytometry; Immunohistochemistry; Tumor M2-PK; Biology; Pathology; Immunotherapy; Cancer; Medicine; Molecular biology; Colorectal cancer; Immunology; Immune system; Internal medicine","score_opus":0.055090801880527444,"score_gpt":0.3320206182949923,"score_spread":0.27692981641446485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022215700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942794,0.0017735866,0.0020166247,0.00009907032,0.000058356083,0.00006804856,0.00032385267,0.00009774436,0.0012834729],"genre_scores_gemma":[0.9935859,0.0013195418,0.0017591317,0.000051741583,0.000019315728,0.00006658403,0.0007732797,0.000020407702,0.0024041175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997359,0.00004556697,0.000015672866,0.00004001493,0.00007066211,0.00009209276],"domain_scores_gemma":[0.99982506,0.00003416206,0.000030150675,0.000024214738,0.00004141699,0.00004509814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045900105,0.00044518808,0.0004582596,0.0004283546,0.00019951386,0.00032835786,0.00052028487,0.00049514906,0.0008508194],"category_scores_gemma":[0.0002552375,0.00017749786,0.00030439266,0.00023862973,0.0003376213,0.00033598248,0.00012132246,0.0011884205,0.00024335648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094057363,0.00064035837,0.00017263331,0.00007970598,0.000016681664,0.000047506048,0.000021029156,0.0007159234,0.99321705,0.000117100324,0.00022031866,0.0038111876],"study_design_scores_gemma":[0.0001046689,0.0042604674,0.0011519665,0.000006380102,0.000049184884,0.0001549472,0.000011618238,0.0017913434,0.9910034,0.000033739863,0.001425579,0.0000067166534],"about_ca_topic_score_codex":0.002678195,"about_ca_topic_score_gemma":0.0033347083,"teacher_disagreement_score":0.002678195,"about_ca_system_score_codex":0.00068588083,"about_ca_system_score_gemma":0.0007515283,"threshold_uncertainty_score":0.005325258},"labels":[],"label_agreement":null},{"id":"W2023606464","doi":"10.1007/s00262-005-0043-4","title":"Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer; Cancer Research Society","keywords":"Infiltration (HVAC); Lewis lung carcinoma; Extracellular matrix; Pathology; Lung; Laminin; Fibronectin; Carcinoma; Adoptive cell transfer; Biology; CD8; Cancer research; Chemistry; Medicine; Immune system; Metastasis; T cell; Cancer; Immunology; Cell biology; Internal medicine; Materials science","score_opus":0.013741179310353333,"score_gpt":0.2512170495308257,"score_spread":0.23747587022047234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023606464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984022,0.00013728983,0.00045440806,0.000012783616,0.0000042855286,0.000008314706,0.000041722833,0.00001146703,0.00092756405],"genre_scores_gemma":[0.99905723,0.00006857924,0.00020949912,0.0000062319646,0.0000055185874,0.000010477934,0.000068293964,0.0000025890147,0.00057170354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998704,0.000030247778,0.000009481773,0.00002293724,0.000025594538,0.000041200772],"domain_scores_gemma":[0.99966085,0.00015682357,0.000057810033,0.000024649808,0.000026485339,0.0000734751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019467888,0.00018629609,0.00016914186,0.0004273305,0.00011470694,0.0002900126,0.000110863664,0.00029048885,0.002666243],"category_scores_gemma":[0.0004449687,0.00018014666,0.00011273899,0.0001330597,0.000203107,0.0002463444,0.000138945,0.00037544235,0.00040287984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063227373,0.00013095076,0.0153339375,0.000016008484,0.000006051828,0.00015240355,0.00003101044,0.00011463381,0.9816698,0.00009539527,0.000029560248,0.0017878751],"study_design_scores_gemma":[0.000045097466,0.002220818,0.4003876,0.0000069616995,0.00004600909,0.003206076,0.00026910804,0.0044738664,0.5880563,0.00025582124,0.0010177239,0.000014681872],"about_ca_topic_score_codex":0.00027026288,"about_ca_topic_score_gemma":0.00029717377,"teacher_disagreement_score":0.002666243,"about_ca_system_score_codex":0.000087163215,"about_ca_system_score_gemma":0.00010981152,"threshold_uncertainty_score":0.008919418},"labels":[],"label_agreement":null},{"id":"W2026118569","doi":"10.1007/s00262-003-0465-9","title":"A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Chemistry; Immunotherapy; Cancer research; Antigen; Antibody; Effector; Molecular biology; Cancer immunotherapy; In vitro; Immune system; Immunology; Biology; Biochemistry","score_opus":0.012509150809547977,"score_gpt":0.30198856096472776,"score_spread":0.2894794101551798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026118569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92486596,0.009278635,0.05824051,0.0004474208,0.00027008684,0.00025357943,0.0008385669,0.0007689518,0.0050361906],"genre_scores_gemma":[0.9826659,0.0024318334,0.010855138,0.000091684524,0.000041313004,0.00012524596,0.00074529083,0.000067112895,0.0029764546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998741,0.00002656846,0.000011222426,0.000019594689,0.000026141244,0.000042345768],"domain_scores_gemma":[0.99994564,0.000013805703,0.000009105809,0.000008318915,0.00000721069,0.000015981543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036519728,0.0005232395,0.00033984147,0.00064480375,0.00017608424,0.00035464828,0.0004405844,0.00036837393,0.00094676396],"category_scores_gemma":[0.00015088043,0.00019408319,0.00022295884,0.00022187435,0.00026227633,0.00046805892,0.00031148858,0.0009973862,0.00034421566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006624513,0.00019430653,0.0001741824,0.00009913849,0.0000131512425,0.00009504795,0.000022963732,0.0004286466,0.9856317,0.0012315154,0.00024221608,0.011204669],"study_design_scores_gemma":[0.00011870952,0.00061705825,0.00039697805,0.0000027882522,0.0000240792,0.00030332652,0.0000056478616,0.0012361197,0.99466115,0.00012561455,0.0025028654,0.0000057328543],"about_ca_topic_score_codex":0.00031553948,"about_ca_topic_score_gemma":0.00033457892,"teacher_disagreement_score":0.00094676396,"about_ca_system_score_codex":0.00026256306,"about_ca_system_score_gemma":0.00030104627,"threshold_uncertainty_score":0.003167212},"labels":[],"label_agreement":null},{"id":"W2028889402","doi":"10.1007/s00262-006-0221-z","title":"Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy","year":2006,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Photodynamic therapy; Cancer research; Lewis lung carcinoma; Complement system; Gene; Heat shock protein; Biology; CD46; TLR4; Gene expression; Molecular biology; Antibody; Immunology; Cancer; Immune system; Chemistry; Metastasis","score_opus":0.016356166312462776,"score_gpt":0.3135551602929163,"score_spread":0.2971989939804535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028889402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878746,0.00027080422,0.00031274185,0.00004636074,0.000009368517,0.000009630167,0.000089527806,0.000006956216,0.00046713703],"genre_scores_gemma":[0.9978734,0.0001460904,0.00024208035,0.000024177662,0.0000043158984,0.000020191907,0.00014302955,0.0000037308978,0.0015430378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984276,0.000023459133,0.0000085703505,0.000023688626,0.00003345535,0.00006802019],"domain_scores_gemma":[0.9998692,0.000044737426,0.000021021568,0.000015893536,0.000018398045,0.00003081845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017991816,0.00013777753,0.00022444676,0.00042184768,0.00026362762,0.00023669846,0.00014434283,0.0003092109,0.0018019001],"category_scores_gemma":[0.0002163412,0.000112153546,0.0002563088,0.0002566925,0.00041302526,0.00016305715,0.00011295087,0.0005306742,0.0001813171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014523325,0.00012884855,0.0013033656,0.000018747809,0.000007785412,0.00008250318,0.000051197992,0.00008908181,0.995097,0.00028407856,0.00007375373,0.0014111907],"study_design_scores_gemma":[0.0000708258,0.0009728111,0.021356542,0.0000041745498,0.000034147688,0.00032297857,0.0001333044,0.001131097,0.97456205,0.00019376061,0.0012114382,0.0000068706872],"about_ca_topic_score_codex":0.0021405097,"about_ca_topic_score_gemma":0.0015318299,"teacher_disagreement_score":0.0021405097,"about_ca_system_score_codex":0.00056335656,"about_ca_system_score_gemma":0.00033127388,"threshold_uncertainty_score":0.0060279965},"labels":[],"label_agreement":null},{"id":"W2029582744","doi":"10.1007/s00262-011-1125-0","title":"Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Myeloid-derived Suppressor Cell; Immunosuppression; Immunology; Immune system; Cancer research; In vitro; T cell; Tumor microenvironment; Suppressor; Biology; Cancer","score_opus":0.016464510460400216,"score_gpt":0.22549443356793644,"score_spread":0.20902992310753624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029582744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940996,0.0018744833,0.0014033697,0.00021419126,0.0000955882,0.00003434497,0.0003006803,0.00017858722,0.0017991778],"genre_scores_gemma":[0.99500257,0.00076644396,0.00070797635,0.00015153119,0.00009214193,0.00003803422,0.00091680174,0.000042013406,0.0022824723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959725,0.00007343735,0.000030111309,0.000035114863,0.00010511012,0.00015902093],"domain_scores_gemma":[0.99960417,0.00011288476,0.00007694285,0.000048241625,0.00004434908,0.00011336658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032010503,0.0007813936,0.0006295521,0.0007606829,0.00021190556,0.00046675085,0.00034946442,0.00042170513,0.0014882371],"category_scores_gemma":[0.00034240994,0.0001842557,0.00038270795,0.00020606282,0.00037770037,0.00016809149,0.00023648054,0.0013126682,0.00062953983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005393402,0.0001240929,0.00029571485,0.000039281636,0.000009189033,0.00006561319,0.000015754014,0.00009336264,0.9967962,0.000080156395,0.0001263711,0.0018149542],"study_design_scores_gemma":[0.00013532389,0.0009933704,0.004639784,0.00001026189,0.000029169072,0.00029329868,0.000019949675,0.000922439,0.9915269,0.00007493649,0.0013494481,0.000005194678],"about_ca_topic_score_codex":0.00062778755,"about_ca_topic_score_gemma":0.00079036737,"teacher_disagreement_score":0.0014882371,"about_ca_system_score_codex":0.00035446827,"about_ca_system_score_gemma":0.00040549706,"threshold_uncertainty_score":0.004978657},"labels":[],"label_agreement":null},{"id":"W2032554019","doi":"10.1007/s00262-004-0518-8","title":"The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"University of Chicago; Northwestern University; Coleman Foundation","keywords":"Monocyte; Chemistry; Cancer research; Cell biology; Immunology; Biology","score_opus":0.005959138944381274,"score_gpt":0.23799786486019942,"score_spread":0.23203872591581814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032554019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979803,0.0005171306,0.0002059968,0.000119202006,0.000044204928,0.000029875995,0.00008817396,0.0000140869815,0.0010010093],"genre_scores_gemma":[0.9983386,0.00024453033,0.0002174937,0.0000842933,0.00003162386,0.000022542648,0.00026376313,0.000007218076,0.00078992464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997887,0.00007851607,0.000013888799,0.000019077985,0.00002309326,0.000076657605],"domain_scores_gemma":[0.9997762,0.00007813488,0.000013722589,0.000030596773,0.000024706433,0.00007670769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003503407,0.00017460942,0.00029069136,0.00020313081,0.00026050018,0.00038252596,0.00017569079,0.00026943034,0.0021986365],"category_scores_gemma":[0.00045462977,0.00013295126,0.00026531552,0.00008890102,0.00019614842,0.00020110674,0.00023684019,0.0008064443,0.0003731332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030262735,0.0012367247,0.005507135,0.00013402716,0.00004511988,0.00031570194,0.00018943498,0.00017953519,0.933882,0.00034825088,0.00093089195,0.026968572],"study_design_scores_gemma":[0.0057612206,0.03495757,0.090228096,0.000078464414,0.00033956856,0.0021377348,0.000422615,0.0016274827,0.84587085,0.0006106629,0.017929995,0.00003560289],"about_ca_topic_score_codex":0.00059302984,"about_ca_topic_score_gemma":0.0007625649,"teacher_disagreement_score":0.0021986365,"about_ca_system_score_codex":0.0002010216,"about_ca_system_score_gemma":0.0002897401,"threshold_uncertainty_score":0.0073551536},"labels":[],"label_agreement":null},{"id":"W2034550161","doi":"10.1007/s00262-011-0970-1","title":"Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Pharmaceutical Research and Manufacturers of America Foundation","keywords":"Adjuvant; Cationic polymerization; Cancer research; Chemistry; Medicine; Oncology; Organic chemistry","score_opus":0.030620574768450603,"score_gpt":0.28220292600818275,"score_spread":0.25158235123973216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034550161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944883,0.0012589607,0.0025575142,0.000056385637,0.000022695811,0.000017047956,0.000054622175,0.000024803092,0.001519725],"genre_scores_gemma":[0.9963081,0.0006368603,0.0014020312,0.000036126505,0.0000088606985,0.000011324299,0.00007813922,0.000008458244,0.0015100902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999274,0.000016782518,0.0000057859506,0.000009437531,0.000015303072,0.000025295381],"domain_scores_gemma":[0.99995506,0.000011121157,0.000008260318,0.0000061462097,0.000008154598,0.000011300309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019255313,0.0001969124,0.00015005759,0.000111944755,0.00007120501,0.0001401145,0.0001236477,0.00017106156,0.0009363559],"category_scores_gemma":[0.00014631558,0.00008890102,0.00010495431,0.00009864197,0.00010823663,0.0001672046,0.00018546486,0.000260341,0.0002074548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003718769,0.000034042212,0.00014652847,0.000042481723,0.0000040778973,0.00006245154,0.000010380574,0.00036410103,0.9946227,0.00035873384,0.000065309105,0.00391742],"study_design_scores_gemma":[0.00002828619,0.00035678002,0.00037062913,0.000002747217,0.000010427146,0.00015628425,0.000006083597,0.00086327014,0.9970005,0.000053570206,0.0011482876,0.0000030287595],"about_ca_topic_score_codex":0.00022447779,"about_ca_topic_score_gemma":0.0002840144,"teacher_disagreement_score":0.0009363559,"about_ca_system_score_codex":0.000117388314,"about_ca_system_score_gemma":0.00015140271,"threshold_uncertainty_score":0.0031324625},"labels":[],"label_agreement":null},{"id":"W2035883420","doi":"10.1007/s00262-009-0800-x","title":"Activation of innate immunity to reduce lung metastases in breast cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Fungal Biology and Applications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Metastasis; Innate immune system; Breast cancer; Cancer research; Immune system; Lung cancer; Cancer; In vivo; Lung; Immunology; Oncology; Biology; Internal medicine","score_opus":0.018901890313624478,"score_gpt":0.3393542446060559,"score_spread":0.3204523542924314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035883420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059194,0.00418828,0.0015366887,0.00084813964,0.00013342651,0.000058456786,0.00008525275,0.00011590428,0.0024419038],"genre_scores_gemma":[0.99502987,0.0014183209,0.000856568,0.00017630284,0.000044058103,0.000035691726,0.000103044564,0.00001248227,0.0023237336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989104,0.000024886498,0.0000040837635,0.000012172233,0.000025668105,0.000042183277],"domain_scores_gemma":[0.99993837,0.000010521335,0.000010355826,0.000009854909,0.0000069152575,0.000024001718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021603612,0.00015293552,0.00031807504,0.00022901488,0.00015076551,0.00027646666,0.00025401276,0.00022625114,0.0028699697],"category_scores_gemma":[0.0001899252,0.00009547535,0.00022396086,0.00012984646,0.0002572678,0.0001504034,0.00016189954,0.001132296,0.00029279946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035196964,0.0032559042,0.0012506971,0.0002151856,0.000062722815,0.00008699551,0.00006806563,0.00067867606,0.90153575,0.0011130148,0.001765797,0.086447544],"study_design_scores_gemma":[0.0021653376,0.026308892,0.020268772,0.00008320941,0.00020206634,0.0009275525,0.00016236471,0.0037145223,0.9267733,0.0015003119,0.017871246,0.00002245644],"about_ca_topic_score_codex":0.0005364367,"about_ca_topic_score_gemma":0.001384316,"teacher_disagreement_score":0.0028699697,"about_ca_system_score_codex":0.0001895713,"about_ca_system_score_gemma":0.00034048661,"threshold_uncertainty_score":0.009600997},"labels":[],"label_agreement":null},{"id":"W2036493466","doi":"10.1007/s002620000117","title":"A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells","year":2000,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"MUC1; Mucin; Cell culture; Biology; Transfection; Cancer research; In vitro; Cell; Immune system; Molecular biology; Immunology","score_opus":0.019691908200398664,"score_gpt":0.31393363001880764,"score_spread":0.29424172181840896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036493466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555176,0.00044901666,0.0021478399,0.000120989054,0.000035502766,0.000043434728,0.00034369103,0.0001010804,0.0012066573],"genre_scores_gemma":[0.99659723,0.00024527192,0.0010254391,0.000047097015,0.00002001041,0.000035785568,0.00045240286,0.000034398698,0.001542431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963224,0.000109545355,0.000039886807,0.000040557305,0.00006795316,0.000109807785],"domain_scores_gemma":[0.9994405,0.0002313603,0.00010216008,0.000079991754,0.000025014973,0.00012100784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035999276,0.0006089427,0.00037881554,0.000564239,0.0002095214,0.00039866753,0.00032098364,0.00054460193,0.0018171741],"category_scores_gemma":[0.00029977522,0.000240717,0.00046616056,0.0002584668,0.0004128715,0.00028529836,0.0003612925,0.0013604409,0.00054861675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021652438,0.00013454257,0.00013232461,0.000016610977,0.000005903951,0.000074234464,0.000015397889,0.00019755703,0.9984522,0.00018601719,0.00003972325,0.0005288608],"study_design_scores_gemma":[0.000028937391,0.00073329866,0.0014297466,0.0000043146924,0.00001453341,0.00023307986,0.000018755938,0.0012104086,0.9956632,0.000043924618,0.0006157629,0.0000039765036],"about_ca_topic_score_codex":0.0006210938,"about_ca_topic_score_gemma":0.0007507785,"teacher_disagreement_score":0.0018171741,"about_ca_system_score_codex":0.00038784827,"about_ca_system_score_gemma":0.00029782354,"threshold_uncertainty_score":0.006079018},"labels":[],"label_agreement":null},{"id":"W2039121998","doi":"10.1007/s00262-012-1206-8","title":"Photodynamic therapy–generated cancer vaccine elicits acute phase and hormonal response in treated mice","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immune system; Glucocorticoid; Downregulation and upregulation; Cancer research; Hormone; Cancer vaccine; Immunology; Acute-phase protein; Vaccination; Photodynamic therapy; Medicine; Serum amyloid P component; Biology; Immunotherapy; Gene; Internal medicine; Chemistry; Inflammation","score_opus":0.023214393484940015,"score_gpt":0.3639522562686452,"score_spread":0.34073786278370516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039121998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920636,0.0008226012,0.0031557565,0.00043217232,0.00028929106,0.00016561635,0.0007431193,0.00018938277,0.0021384156],"genre_scores_gemma":[0.9908386,0.00064874237,0.0020143555,0.00020587842,0.00013160895,0.00020393406,0.00072177034,0.00005633934,0.0051787333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964285,0.000053450403,0.000027850901,0.00008333486,0.000060928574,0.00013155589],"domain_scores_gemma":[0.9996159,0.00008940114,0.00009273394,0.000059175924,0.000034962373,0.00010790286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039237173,0.0008641417,0.00048925326,0.0007775412,0.0003094778,0.0004099868,0.00032722505,0.0007646431,0.0024255188],"category_scores_gemma":[0.00025466384,0.0003241687,0.0006451461,0.00032384036,0.00058347505,0.0004909617,0.00020977085,0.0027602385,0.00061953126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017110471,0.0009607011,0.00032932364,0.00006146643,0.000013728348,0.00009001206,0.00005889819,0.0003481281,0.9939096,0.0002979609,0.00016410786,0.0020550461],"study_design_scores_gemma":[0.00021938977,0.0029371376,0.0013636005,0.000007004636,0.00003271126,0.00014864234,0.00006506814,0.0011706576,0.992485,0.00012530519,0.001437537,0.000007975542],"about_ca_topic_score_codex":0.000386975,"about_ca_topic_score_gemma":0.00051164033,"teacher_disagreement_score":0.0024255188,"about_ca_system_score_codex":0.00040589538,"about_ca_system_score_gemma":0.00043358665,"threshold_uncertainty_score":0.008114159},"labels":[],"label_agreement":null},{"id":"W2039696496","doi":"10.1007/s00262-008-0476-7","title":"TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Atomic Energy of Canada Limited","keywords":"Immunity; Immunology; Cancer research; Virology; Medicine; Immune system","score_opus":0.01697777195574972,"score_gpt":0.26551415149597196,"score_spread":0.24853637954022223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039696496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945069,0.00065165287,0.0024099082,0.00024159427,0.00010811248,0.00011423353,0.00032337892,0.00016959096,0.0014745487],"genre_scores_gemma":[0.9931369,0.00049702177,0.002538528,0.000080362865,0.00006296665,0.00012317518,0.0004082294,0.000040911684,0.0031119562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994703,0.000113392045,0.000042546682,0.00008391025,0.00013057198,0.00015931843],"domain_scores_gemma":[0.99958163,0.00009773232,0.00010196348,0.00006408569,0.00003353672,0.000121073535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000488483,0.0012912547,0.0007782755,0.0010600468,0.0002905182,0.0006144851,0.00041379017,0.0008707146,0.001138963],"category_scores_gemma":[0.00025203338,0.0003091325,0.0005711284,0.00028220998,0.0006294007,0.0006514765,0.00031996315,0.003019485,0.0004181528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013248945,0.0006049045,0.00014329002,0.000061027215,0.00001302816,0.00011364204,0.00003853698,0.00049422565,0.995141,0.00045063187,0.00009162055,0.0015231813],"study_design_scores_gemma":[0.00019593556,0.0021820606,0.0006407751,0.00001283548,0.00004015977,0.00017015547,0.000022623552,0.0028409732,0.9928169,0.00013737046,0.0009318119,0.00000835619],"about_ca_topic_score_codex":0.00068332715,"about_ca_topic_score_gemma":0.00096723146,"teacher_disagreement_score":0.0012912547,"about_ca_system_score_codex":0.0005229593,"about_ca_system_score_gemma":0.00053839985,"threshold_uncertainty_score":0.0038101673},"labels":[],"label_agreement":null},{"id":"W2040005202","doi":"10.1007/s00262-009-0698-3","title":"Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"National Cancer Institute","keywords":"CD8; Null cell; Biology; Cytotoxic T cell; Adoptive cell transfer; Infiltration (HVAC); Phenotype; Cancer research; T lymphocyte; Immunology; Mammary tumor; Immune system; Cell culture; T cell; In vitro; Gene; Cancer; Genetics; Breast cancer","score_opus":0.01716905634115013,"score_gpt":0.2431229921209047,"score_spread":0.2259539357797546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040005202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976883,0.00040845876,0.0008081301,0.00005163208,0.000019912168,0.000013370922,0.00016188671,0.000051262483,0.0007971019],"genre_scores_gemma":[0.9975085,0.0002632898,0.000598174,0.00006805232,0.000009244921,0.00002901005,0.00041942735,0.000026509697,0.0010776703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995436,0.00005920077,0.00004366457,0.00006073092,0.00011449094,0.0001783528],"domain_scores_gemma":[0.9995024,0.0001089815,0.00013942535,0.00008041511,0.000032577485,0.0001361831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024076887,0.00035656674,0.00029760046,0.00076254783,0.00016821478,0.0005107448,0.00022470542,0.00045567736,0.0010495315],"category_scores_gemma":[0.00028878535,0.0002632722,0.00029245185,0.00031399282,0.00036819102,0.00027996395,0.00042914363,0.0012354844,0.0003437269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018329329,0.000040699164,0.00045560848,0.000008925971,0.0000056683275,0.000035335674,0.000014411787,0.000044319895,0.9986778,0.000050394647,0.00001468456,0.00046878422],"study_design_scores_gemma":[0.00004595765,0.0007952821,0.015908457,0.0000060530297,0.00003809511,0.0010404647,0.00010964389,0.0006205834,0.9804694,0.000119091565,0.00083547336,0.000011537088],"about_ca_topic_score_codex":0.00038526946,"about_ca_topic_score_gemma":0.00050901336,"teacher_disagreement_score":0.0010495315,"about_ca_system_score_codex":0.0002542868,"about_ca_system_score_gemma":0.00012982776,"threshold_uncertainty_score":0.0035110116},"labels":[],"label_agreement":null},{"id":"W2041507780","doi":"10.1007/s00262-010-0861-x","title":"Phenotypic characterization of chronic inflammation in a rare case of endobronchial carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"Institut Du Cancer de Montréal","keywords":"Phenotype; Inflammation; Medicine; Carcinoma; Pathology; Biology; Internal medicine; Genetics; Gene","score_opus":0.009713388647332986,"score_gpt":0.2675888687790458,"score_spread":0.2578754801317128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041507780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990721,0.0011609335,0.001742284,0.00039717613,0.0000479254,0.0000813201,0.00010243214,0.000054538385,0.0056923544],"genre_scores_gemma":[0.998692,0.00020564848,0.000534808,0.000091402544,0.0001399144,0.000016479995,0.000058559304,0.000008298334,0.00025297198],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99943846,0.00008516376,0.00006309501,0.00011943152,0.000071052964,0.00022282486],"domain_scores_gemma":[0.99813,0.0007463384,0.00026070012,0.00023726809,0.00012287984,0.00050274516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047748594,0.0008254962,0.0007867395,0.0017391482,0.0012276272,0.0008883308,0.0006966219,0.0020591796,0.0018578635],"category_scores_gemma":[0.0030208474,0.0005067463,0.00051884993,0.00073804194,0.0011865727,0.0010083305,0.0009819514,0.0010411057,0.00059676345],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027269035,0.00006570195,0.040619187,0.00006383904,0.000011762839,0.94569063,0.00033968384,0.0000690769,0.010408352,0.00034735736,0.00014478677,0.0019668946],"study_design_scores_gemma":[0.000027430402,0.0002135126,0.039182846,0.000016952778,0.000039723414,0.9564425,0.0003153866,0.0005002966,0.0024133115,0.0002807143,0.0005528433,0.0000144462065],"about_ca_topic_score_codex":0.0005625072,"about_ca_topic_score_gemma":0.0004880613,"teacher_disagreement_score":0.0020591796,"about_ca_system_score_codex":0.00037295578,"about_ca_system_score_gemma":0.00028155744,"threshold_uncertainty_score":0.0062152147},"labels":[],"label_agreement":null},{"id":"W2043730939","doi":"10.1007/s00262-008-0534-1","title":"MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Intraepithelial lymphocyte; CD8; Colorectal cancer; Cancer research; Medicine; Biology; Immunology; Internal medicine; Immune system; Cancer","score_opus":0.01566053570161138,"score_gpt":0.25379718272415674,"score_spread":0.23813664702254536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043730939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940632,0.00069947273,0.0007610306,0.00007350958,0.000018993096,0.000032220407,0.00014547876,0.000107322,0.004098772],"genre_scores_gemma":[0.99428046,0.0002023021,0.00080287893,0.000060390747,0.00004297376,0.000034596345,0.00025176976,0.000031009065,0.004293511],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999845,0.00002008489,0.000007915532,0.000032863987,0.00002295447,0.00007116014],"domain_scores_gemma":[0.9998111,0.000039360904,0.000029094434,0.000041522682,0.000026438189,0.000052463012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001042339,0.0002480063,0.00024089699,0.00036152077,0.00015904287,0.00042731868,0.00014233004,0.00022361008,0.004120691],"category_scores_gemma":[0.00014540293,0.00014874058,0.00013585486,0.00018275043,0.00012770595,0.00035866,0.00027669582,0.00057442556,0.0012651905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034562105,0.0001127694,0.009228916,0.000040529325,0.000009777884,0.00024111447,0.00005064663,0.0000765163,0.9799278,0.00026998285,0.00036012015,0.009336179],"study_design_scores_gemma":[0.000138079,0.001455803,0.115257226,0.000025191828,0.00007101234,0.0036840967,0.00045712947,0.0025062382,0.8592906,0.00037860125,0.016719237,0.000016736594],"about_ca_topic_score_codex":0.0003311337,"about_ca_topic_score_gemma":0.00052150874,"teacher_disagreement_score":0.004120691,"about_ca_system_score_codex":0.0001910573,"about_ca_system_score_gemma":0.0001044792,"threshold_uncertainty_score":0.013785064},"labels":[],"label_agreement":null},{"id":"W2047936140","doi":"10.1007/s00262-011-0988-4","title":"Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Paclitaxel; Prostate cancer; Medicine; In vivo; CD8; Cancer research; Granulocyte macrophage colony-stimulating factor; Prostate; Cancer vaccine; Cancer; Immune system; Immunology; Immunotherapy; Pharmacology; Internal medicine; Biology; Cytokine","score_opus":0.021770899518367692,"score_gpt":0.26841634934599146,"score_spread":0.24664544982762376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047936140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958593,0.00083982997,0.0013553606,0.0001948671,0.000099045086,0.000056525758,0.00026729683,0.00013948296,0.0011883699],"genre_scores_gemma":[0.9951769,0.0006758346,0.001034867,0.00005836739,0.000039987975,0.00005211944,0.00030602337,0.000029218685,0.0026266328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998307,0.000027161355,0.000010170463,0.000026637632,0.000035256093,0.00007009346],"domain_scores_gemma":[0.9998654,0.000027899321,0.000034041608,0.000015913893,0.000011350305,0.000045293447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015702413,0.0004868588,0.00047373938,0.00044452824,0.00016261837,0.00033201405,0.00030011634,0.00053178176,0.0010726062],"category_scores_gemma":[0.00011591691,0.00017014588,0.00028583087,0.00021931759,0.00033870435,0.00037179815,0.00012844396,0.0014823943,0.0003291784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001251865,0.0007326984,0.00013906552,0.00007269857,0.000009752226,0.000056343804,0.000022690567,0.00042175406,0.99392116,0.00019100605,0.00017391017,0.003007014],"study_design_scores_gemma":[0.00011772395,0.0024389515,0.0009977553,0.000007172918,0.000033770957,0.00011498119,0.000013814207,0.0018887555,0.9932373,0.00007273196,0.0010701013,0.000007052626],"about_ca_topic_score_codex":0.00071448437,"about_ca_topic_score_gemma":0.00079557067,"teacher_disagreement_score":0.0010726062,"about_ca_system_score_codex":0.0003432051,"about_ca_system_score_gemma":0.00041874562,"threshold_uncertainty_score":0.0035882592},"labels":[],"label_agreement":null},{"id":"W2048296690","doi":"10.1007/s00262-015-1689-1","title":"Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Cancer Research UK","keywords":"Nivolumab; Pembrolizumab; Medicine; Diabetes mellitus; Ipilimumab; Immunology; Type 1 diabetes; Adverse effect; Immune system; Insulin; Antibody; Immunotherapy; Internal medicine; Endocrinology","score_opus":0.04472514907973334,"score_gpt":0.30520106641164596,"score_spread":0.2604759173319126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048296690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9063539,0.025152627,0.011895879,0.019887956,0.0027320497,0.00058270467,0.0007401498,0.00052739517,0.032127287],"genre_scores_gemma":[0.9742837,0.006160014,0.004205653,0.00393493,0.0058988384,0.000098420394,0.00024732106,0.00007636962,0.005094815],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99878436,0.00013530985,0.000114539675,0.0003762982,0.00014844915,0.0004409945],"domain_scores_gemma":[0.99736834,0.00080149533,0.0004217506,0.00034059735,0.00017086235,0.0008969121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059627055,0.0040476294,0.0025963096,0.005019423,0.0055846423,0.0036925846,0.0031523127,0.015222545,0.004274962],"category_scores_gemma":[0.0044192486,0.002591756,0.0037674068,0.0032797905,0.0031580671,0.005921235,0.0034292291,0.008842966,0.0021875405],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023298246,0.00004493271,0.0009652892,0.000018972616,0.0000073844894,0.99780613,0.00007026263,0.000035641573,0.0001954308,0.00013749723,0.00016504593,0.0005300768],"study_design_scores_gemma":[0.00001080268,0.000030295101,0.0006384379,0.000009736195,0.000016927323,0.99836427,0.000075983844,0.00019548772,0.00017917008,0.00015784374,0.00031149125,0.0000094967345],"about_ca_topic_score_codex":0.0027135103,"about_ca_topic_score_gemma":0.0024537072,"teacher_disagreement_score":0.015222545,"about_ca_system_score_codex":0.0033193564,"about_ca_system_score_gemma":0.001284729,"threshold_uncertainty_score":0.024083674},"labels":[],"label_agreement":null},{"id":"W2049238163","doi":"10.1007/s00262-007-0442-9","title":"Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immune system; Isotype; Antibody; Immunotherapy; Immunology; Cancer; Cytotoxic T cell; Biology; Tumor progression; Monoclonal antibody; Cancer research; In vitro; Genetics","score_opus":0.02348148156817673,"score_gpt":0.30540169978430703,"score_spread":0.2819202182161303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049238163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963182,0.02505415,0.003341861,0.000842438,0.00018932065,0.000048818845,0.0004551487,0.000089108726,0.0067970734],"genre_scores_gemma":[0.9936985,0.0038004303,0.00086495327,0.00019542473,0.00024982786,0.00002843086,0.00024507218,0.000022266531,0.0008950354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996062,0.00014637731,0.00002890017,0.000059287195,0.000071727656,0.000087456756],"domain_scores_gemma":[0.9986172,0.00046328484,0.00041842207,0.00010313349,0.00022451018,0.00017338846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008167307,0.00030214209,0.0006349086,0.0018720094,0.00026186006,0.0010026242,0.00037327665,0.0004933197,0.002160921],"category_scores_gemma":[0.002390879,0.00015481088,0.0002775389,0.0010106951,0.0004983634,0.0007830275,0.00037852043,0.0010747173,0.00037965554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005923053,0.0008348917,0.6814959,0.00040960274,0.00023884785,0.00094597373,0.00031540004,0.0011789928,0.1568813,0.006224462,0.0022864551,0.14326513],"study_design_scores_gemma":[0.00004565811,0.0006440499,0.97394794,0.000045398814,0.00015532029,0.001234432,0.00037430972,0.0012227213,0.016149582,0.0023848435,0.003767427,0.000028339764],"about_ca_topic_score_codex":0.00045489747,"about_ca_topic_score_gemma":0.0004383363,"teacher_disagreement_score":0.002160921,"about_ca_system_score_codex":0.00036102018,"about_ca_system_score_gemma":0.0002713962,"threshold_uncertainty_score":0.0072289705},"labels":[],"label_agreement":null},{"id":"W2049948883","doi":"10.1007/s00262-010-0934-x","title":"Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Bayer Canada","keywords":"Nerve growth factor; Metastasis; Prostate cancer; Antibody; Matrigel; Cancer research; Cell migration; In vitro; Cancer; Cancer cell; Autocrine signalling; Prostate; Monoclonal antibody; Cell culture; Medicine; Chemistry; Biology; Internal medicine; Immunology; Receptor; Angiogenesis; Biochemistry","score_opus":0.016448437575376337,"score_gpt":0.28272034889987985,"score_spread":0.2662719113245035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049948883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869279,0.003018713,0.0032959143,0.00020606782,0.00011467422,0.000069093425,0.00014105304,0.00012206391,0.006104409],"genre_scores_gemma":[0.99072415,0.0019331716,0.0013545085,0.00007136965,0.000059843846,0.0000455691,0.00040401475,0.000023220324,0.005384113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998598,0.000027982702,0.0000050092294,0.000013838974,0.000026683614,0.00006660945],"domain_scores_gemma":[0.9998592,0.00006809985,0.000013817259,0.000018600515,0.000013427929,0.0000268249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020189714,0.00043039233,0.00022331586,0.00041527202,0.00022557155,0.00025622008,0.00042266215,0.00029555362,0.002093159],"category_scores_gemma":[0.00022485865,0.00019005798,0.00031726973,0.00015864182,0.00027545687,0.00020485019,0.00019177877,0.0009284759,0.00054416526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005413064,0.00092520745,0.0002801693,0.00008680201,0.000025263305,0.00007768106,0.000048111575,0.0006756799,0.9866209,0.00056585233,0.0005690365,0.009584029],"study_design_scores_gemma":[0.00016265456,0.0026768693,0.003331548,0.000013054132,0.000042403914,0.00040416303,0.000032509015,0.003010179,0.9862132,0.00021575186,0.0038892578,0.000008320216],"about_ca_topic_score_codex":0.0026755598,"about_ca_topic_score_gemma":0.0051537864,"teacher_disagreement_score":0.0026755598,"about_ca_system_score_codex":0.00036684863,"about_ca_system_score_gemma":0.0004682783,"threshold_uncertainty_score":0.0070023537},"labels":[],"label_agreement":null},{"id":"W2052261454","doi":"10.1007/s00262-013-1412-z","title":"EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ludwig Institute for Cancer Research; Cancer Research Society","keywords":"Antigen; Biology; Cancer research; Molecular biology; Telomerase; Gene; Cell culture; Lymphoblast; Virology; Immunology; Genetics","score_opus":0.00772460788773911,"score_gpt":0.24856657095736326,"score_spread":0.24084196306962416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052261454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803899,0.0057033184,0.006218275,0.00036972202,0.00042293,0.00020794633,0.0009373148,0.00051403494,0.0052365],"genre_scores_gemma":[0.99077785,0.0027654862,0.002232821,0.00008127545,0.00008841403,0.00013570301,0.0009523705,0.000056914894,0.0029091083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995834,0.00016632583,0.00003247921,0.000037077283,0.00011233537,0.00006822282],"domain_scores_gemma":[0.99966264,0.00015729686,0.00003627394,0.000070806615,0.000030206731,0.000042830834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059682265,0.0005480403,0.00045074936,0.00086086546,0.00029033268,0.0007498508,0.00053148513,0.000626344,0.0025334938],"category_scores_gemma":[0.00043588315,0.0002869583,0.0003064449,0.00046625565,0.00036631775,0.000534406,0.00032581892,0.0019944564,0.0010320663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084751623,0.0005586176,0.0003216594,0.000109568384,0.000026955051,0.0000943532,0.00010280391,0.0006259837,0.98893017,0.0009500661,0.0005933523,0.0068388875],"study_design_scores_gemma":[0.00028646336,0.0019249626,0.0012958304,0.00001823229,0.00009238904,0.0002347125,0.000047514142,0.0018869943,0.9874885,0.0002872471,0.0064294455,0.000007770064],"about_ca_topic_score_codex":0.00053306366,"about_ca_topic_score_gemma":0.0006724438,"teacher_disagreement_score":0.0025334938,"about_ca_system_score_codex":0.00037072628,"about_ca_system_score_gemma":0.00038409376,"threshold_uncertainty_score":0.008475363},"labels":[],"label_agreement":null},{"id":"W2053039983","doi":"10.1007/s00262-011-1088-1","title":"Widespread expressions of immunoglobulin superfamily proteins in cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; National Yang-Ming University","keywords":"Immunoglobulin superfamily; Biology; T-cell receptor; Antibody; Molecular biology; CD3; Monoclonal antibody; Cancer cell; CD8; Epitope; Cell adhesion molecule; Immune system; T cell; Cancer; Cell biology; Immunology; Genetics","score_opus":0.06949275593754785,"score_gpt":0.3452892438547073,"score_spread":0.27579648791715944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053039983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98481226,0.0057476847,0.003378796,0.0001649135,0.000038335438,0.000018492216,0.00025012202,0.000101037804,0.0054883244],"genre_scores_gemma":[0.99503577,0.0013977351,0.000957871,0.00004274655,0.000040297422,0.000020666761,0.00031071875,0.000012443693,0.0021817817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981624,0.000026088876,0.000017679773,0.000040146275,0.000050675506,0.0000492448],"domain_scores_gemma":[0.99971956,0.000072375275,0.00004072383,0.00005567004,0.000065330576,0.00004636366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019353455,0.00014782578,0.00017036698,0.00075672305,0.00035574727,0.0004253616,0.00013446026,0.00030893186,0.002085473],"category_scores_gemma":[0.00031220092,0.00012329202,0.00022627681,0.000619193,0.0002789821,0.00025682568,0.0004304383,0.0003844055,0.0005194403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017918227,0.000023048733,0.0039854217,0.000053980148,0.000018913932,0.00025010278,0.000072541596,0.000042961685,0.9870956,0.0005008586,0.0001336878,0.007643623],"study_design_scores_gemma":[0.00007939733,0.00070895057,0.23160155,0.000055374436,0.00019327742,0.008906933,0.0008911499,0.0012444552,0.7238662,0.0019945055,0.03043394,0.000024190627],"about_ca_topic_score_codex":0.00036106733,"about_ca_topic_score_gemma":0.00036166832,"teacher_disagreement_score":0.002085473,"about_ca_system_score_codex":0.00019865303,"about_ca_system_score_gemma":0.0001926712,"threshold_uncertainty_score":0.0069766045},"labels":[],"label_agreement":null},{"id":"W2061990495","doi":"10.1007/s00262-008-0586-2","title":"Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Terry Fox Research Institute","funders":"","keywords":"Paclitaxel; FOXP3; CD8; TLR9; Cytotoxic T cell; Immune system; IL-2 receptor; Agonist; Cancer research; Biology; T cell; Immunology; Pharmacology; Receptor; Internal medicine; Medicine; Cancer; Gene expression; In vitro","score_opus":0.005736430475352894,"score_gpt":0.21111194420224988,"score_spread":0.205375513726897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061990495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928865,0.00081327424,0.0010818741,0.00036778176,0.00008490226,0.000036075577,0.0007343069,0.00032264888,0.0036726936],"genre_scores_gemma":[0.9879231,0.0009695404,0.0012888489,0.00013177801,0.000042745356,0.000051151586,0.0008578677,0.00006309816,0.00867189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997367,0.00003503413,0.00001498709,0.000034653818,0.00006672739,0.00011185023],"domain_scores_gemma":[0.99981135,0.000027366623,0.00005787219,0.000023846182,0.000011249752,0.00006828857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012403917,0.0006126732,0.00047049418,0.0007578004,0.00024477293,0.00045186013,0.00031734898,0.00072337425,0.002253294],"category_scores_gemma":[0.00011282599,0.0002581725,0.0003604366,0.00026753457,0.00048916537,0.00034222263,0.00012779183,0.0018494151,0.0007286963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001698664,0.00043591284,0.00013768997,0.0000505565,0.000010189904,0.00007883597,0.00001530811,0.0004333002,0.993032,0.0002575699,0.00033625244,0.0035138193],"study_design_scores_gemma":[0.00013431255,0.0014832307,0.0011595334,0.0000071965283,0.000026118054,0.00012217838,0.00001827807,0.0008502694,0.99439055,0.000079566475,0.0017207327,0.000008043604],"about_ca_topic_score_codex":0.00089311454,"about_ca_topic_score_gemma":0.0015762962,"teacher_disagreement_score":0.002253294,"about_ca_system_score_codex":0.0005100031,"about_ca_system_score_gemma":0.00045033472,"threshold_uncertainty_score":0.0075380206},"labels":[],"label_agreement":null},{"id":"W2065093310","doi":"10.1007/s00262-005-0698-x","title":"Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages","year":2005,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Cytotoxic T cell; Interleukin 12; Cancer research; Cytotoxicity; Macrophage; Melanoma; Antibody; Immunology; Immunotherapy; Cancer immunotherapy; Biology; Chemistry; Immune system; In vitro","score_opus":0.022763342405974458,"score_gpt":0.2807844999294116,"score_spread":0.2580211575234372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065093310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222434,0.0031967028,0.0025731733,0.00017032804,0.00007200357,0.000031346666,0.00008641484,0.00006454617,0.0015810647],"genre_scores_gemma":[0.99551743,0.0013581146,0.0011319333,0.00005317685,0.00003750779,0.000031952255,0.000103545644,0.0000067512833,0.0017595543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998969,0.000024697118,0.0000061237365,0.000011772783,0.000021221893,0.000039288218],"domain_scores_gemma":[0.9999651,0.000010070904,0.0000074967825,0.0000052312275,0.000003433348,0.000008716057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013027346,0.00023995806,0.00030797053,0.0001798456,0.00011750961,0.0002831465,0.000120152625,0.00022477379,0.0007251329],"category_scores_gemma":[0.00008208862,0.000107980246,0.00019762262,0.00010095641,0.0001924872,0.00019400254,0.00016351008,0.0006580831,0.00019570622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008468351,0.00010128843,0.0003139971,0.000049873626,0.000007750845,0.00009682076,0.000018156708,0.00014920118,0.9894673,0.00023685138,0.00011883075,0.008593074],"study_design_scores_gemma":[0.0002709068,0.0016128062,0.0051345527,0.000007702556,0.000040532428,0.00054891285,0.000030351277,0.0010439812,0.98737925,0.00020019355,0.0037248945,0.000005975643],"about_ca_topic_score_codex":0.00016046011,"about_ca_topic_score_gemma":0.00033795464,"teacher_disagreement_score":0.0007251329,"about_ca_system_score_codex":0.00021454768,"about_ca_system_score_gemma":0.00022246112,"threshold_uncertainty_score":0.0024257898},"labels":[],"label_agreement":null},{"id":"W2075251333","doi":"10.1007/s00262-004-0582-0","title":"NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin","year":2004,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University","funders":"","keywords":"Infiltration (HVAC); Apoptosis; Natural killer cell; Cancer research; Cell; Immune system; Cytotoxicity; Chemistry; In vitro; Biology; Immunology","score_opus":0.014507130838923436,"score_gpt":0.24399563942463437,"score_spread":0.22948850858571093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075251333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863203,0.0067948857,0.0031446451,0.00019864166,0.00005809247,0.000048251233,0.00004910498,0.00009471138,0.0032912898],"genre_scores_gemma":[0.99706084,0.00099026,0.0005273072,0.000030326642,0.000021774867,0.000028039296,0.00004368515,0.0000059555123,0.0012917722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997726,0.00008123753,0.00001323109,0.000018040811,0.000044683853,0.000070164424],"domain_scores_gemma":[0.99991286,0.000025134552,0.000019212444,0.000017173195,0.000008317421,0.000017268878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029329985,0.00034228252,0.00040021012,0.00032940664,0.00025512656,0.00040887893,0.00029242394,0.00043130122,0.0011831705],"category_scores_gemma":[0.00020128033,0.00014877321,0.000264998,0.00013432687,0.00040522305,0.00050888746,0.00035006995,0.00076196704,0.00016735375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003035968,0.00024784604,0.0023230594,0.0002237753,0.00003675533,0.0004655668,0.000084513274,0.0008583213,0.9551036,0.005812197,0.00025605637,0.031552367],"study_design_scores_gemma":[0.0005210115,0.0019942005,0.04074552,0.00003715794,0.00018714547,0.0026539937,0.00011276907,0.007204612,0.93175554,0.0046300334,0.010131419,0.000026538974],"about_ca_topic_score_codex":0.00023141377,"about_ca_topic_score_gemma":0.0002792639,"teacher_disagreement_score":0.0011831705,"about_ca_system_score_codex":0.00044839765,"about_ca_system_score_gemma":0.00031373964,"threshold_uncertainty_score":0.0039581656},"labels":[],"label_agreement":null},{"id":"W2078410536","doi":"10.1007/s00262-014-1630-z","title":"N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Institute for Nanotechnology; National Research Council Canada; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Cancer research; Signal transduction; Kinase; STAT1; Cancer cell; IRF8; Biology; STAT3; Interferon; Cell biology; Chemistry; Internal medicine; Transcription factor; Cancer; Medicine; Immunology; Biochemistry; Gene","score_opus":0.01014323759916386,"score_gpt":0.2552685686839767,"score_spread":0.24512533108481283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078410536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951739,0.0015494899,0.00075515173,0.00021587273,0.00009340236,0.00003371974,0.0004338426,0.000063594845,0.001681188],"genre_scores_gemma":[0.994044,0.0012095333,0.0005794157,0.00012309712,0.000021598398,0.000034712797,0.0005815609,0.000011909843,0.0033943052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998871,0.000018958266,0.000009459694,0.000010173986,0.000022351936,0.000051899773],"domain_scores_gemma":[0.99993336,0.000015133462,0.00000949599,0.000009755813,0.000010813954,0.000021415834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009290146,0.00027514214,0.00027483987,0.00019085084,0.00020645969,0.00024572323,0.00019021553,0.00018554904,0.002220355],"category_scores_gemma":[0.00009607374,0.00011949541,0.00028246033,0.00022022157,0.00016055469,0.00010274879,0.00020323892,0.0006827937,0.000549097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027405822,0.00031458933,0.00051818416,0.00006371771,0.000022466105,0.000070506685,0.000036899284,0.0002804055,0.9904557,0.000064181266,0.00025161507,0.0051812264],"study_design_scores_gemma":[0.0002029271,0.002097889,0.005315357,0.000011610055,0.000043300133,0.000118608245,0.00010834571,0.000834372,0.98697716,0.00007049632,0.0042108083,0.000009104583],"about_ca_topic_score_codex":0.0026148963,"about_ca_topic_score_gemma":0.0045250542,"teacher_disagreement_score":0.0026148963,"about_ca_system_score_codex":0.00019698188,"about_ca_system_score_gemma":0.0005085844,"threshold_uncertainty_score":0.007427871},"labels":[],"label_agreement":null},{"id":"W2079310034","doi":"10.1007/pl00006690","title":"Murine hypodense eosinophils induce tumour cell apoptosis by a granzyme B-dependent mechanism","year":2001,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Dalhousie Medical Research Foundation","keywords":"Granzyme B; Cytotoxicity; Granzyme; Perforin; Eosinophil; Biology; Apoptosis; Molecular biology; Immunology; Biochemistry; In vitro","score_opus":0.013860942428479262,"score_gpt":0.260084338807258,"score_spread":0.24622339637877874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079310034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476177,0.0006871072,0.0025885864,0.00009071385,0.00003608038,0.0000540531,0.00017816096,0.000068607165,0.0015349041],"genre_scores_gemma":[0.996005,0.00039126808,0.0012969475,0.000045132645,0.000014631116,0.000036684534,0.00022645011,0.000017920196,0.0019661235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997328,0.00007686598,0.000019622548,0.000032919674,0.000056478482,0.00008122251],"domain_scores_gemma":[0.9997967,0.000053299445,0.000056684665,0.000038431215,0.000016018832,0.00003887025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024265029,0.00047530961,0.0002632235,0.00046875796,0.00015881784,0.00025119158,0.00022298584,0.00049468456,0.002115778],"category_scores_gemma":[0.00018661859,0.00023154926,0.00026986634,0.000116437484,0.00024660781,0.00024297998,0.00033201944,0.001117575,0.00055624975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000920947,0.00019810678,0.00036237942,0.000037818536,0.000010689102,0.00016447107,0.000025603338,0.00017387934,0.99503845,0.00038176466,0.0001287464,0.0025571957],"study_design_scores_gemma":[0.00030231042,0.0018571066,0.004492763,0.000017936676,0.000035461042,0.0007451809,0.000038517937,0.002152046,0.98813695,0.00023822374,0.001976644,0.000006850458],"about_ca_topic_score_codex":0.0002222296,"about_ca_topic_score_gemma":0.00039766775,"teacher_disagreement_score":0.002115778,"about_ca_system_score_codex":0.00022618817,"about_ca_system_score_gemma":0.00010821093,"threshold_uncertainty_score":0.007077992},"labels":[],"label_agreement":null},{"id":"W2080601172","doi":"10.1007/s00262-008-0453-1","title":"TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Bystander effect; Immune system; Immunotherapy; Cancer research; Immunology; Cancer immunotherapy; Biology; Cytokine; Cancer; Melanoma; Cancer cell","score_opus":0.011808396773576518,"score_gpt":0.26217129636619746,"score_spread":0.2503628995926209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080601172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379987,0.001583477,0.0010493584,0.00014308258,0.00006563336,0.000028229444,0.00008166272,0.00006558049,0.0031830065],"genre_scores_gemma":[0.99667966,0.00059837964,0.00043547203,0.00004888331,0.000029330895,0.00001915803,0.00008408553,0.0000145919885,0.0020903456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997929,0.000052790187,0.000010834709,0.000017854423,0.00005101019,0.00007468616],"domain_scores_gemma":[0.999856,0.00004187853,0.000029800842,0.00002333558,0.000012103535,0.000036807378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021556535,0.00046501533,0.0002574997,0.0003136236,0.00014152682,0.0003039348,0.00017885992,0.0003396638,0.0018745174],"category_scores_gemma":[0.00016831138,0.00013587791,0.0002657991,0.00010379718,0.00019630913,0.0001854615,0.00020811653,0.0009769994,0.00056376937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012801701,0.00003426039,0.000114411465,0.000015131196,0.0000027952447,0.000044591376,0.000007853998,0.00003767029,0.99878305,0.000097220756,0.000027214473,0.00070793886],"study_design_scores_gemma":[0.000052885203,0.0005508952,0.0017193947,0.000005245846,0.000013836064,0.00025847013,0.000022997108,0.00067361305,0.9952443,0.000087035856,0.0013693544,0.0000018086745],"about_ca_topic_score_codex":0.00038517982,"about_ca_topic_score_gemma":0.00037520906,"teacher_disagreement_score":0.0018745174,"about_ca_system_score_codex":0.00018303521,"about_ca_system_score_gemma":0.0002012884,"threshold_uncertainty_score":0.006270826},"labels":[],"label_agreement":null},{"id":"W2083355262","doi":"10.1007/s00262-015-1657-9","title":"Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Stichting Kinderen Kankervrij; KWF Kankerbestrijding","keywords":"NKG2D; Cytotoxicity; Cytolysis; Lymphokine-activated killer cell; Immunotherapy; Natural killer cell; Biology; dNaM; Cancer research; NK-92; Immunology; Cell biology; Interleukin 21; T cell; In vitro; Immune system; Biochemistry","score_opus":0.013202965102467636,"score_gpt":0.2531609153311134,"score_spread":0.23995795022864577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083355262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644285,0.001988114,0.0007031865,0.000031508473,0.000005750653,0.00002376908,0.00008107575,0.000021124315,0.00070270285],"genre_scores_gemma":[0.9981505,0.0005264166,0.0005501617,0.000024411926,0.000004702949,0.000037586633,0.00017843676,0.0000035290136,0.0005240878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996086,0.0001594963,0.00004384998,0.00003952741,0.00006480724,0.00008369415],"domain_scores_gemma":[0.99981934,0.00006178664,0.000035224104,0.00003081239,0.000017472386,0.000035329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038300687,0.00042889168,0.00036109556,0.000199872,0.00010443488,0.00037754705,0.0002751537,0.00035971933,0.0007010508],"category_scores_gemma":[0.00024714426,0.00015608649,0.00027726727,0.0000840478,0.00036808383,0.00032854636,0.00032108524,0.00040028238,0.0003254976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007493102,0.000105162835,0.002053071,0.00009078235,0.0000131627985,0.00022550464,0.00006293211,0.00031750795,0.9930276,0.00018602476,0.000026038415,0.0031428088],"study_design_scores_gemma":[0.00015712577,0.002407552,0.03295801,0.000024085519,0.00006677081,0.0016501233,0.00014884854,0.00268511,0.95800525,0.00016927518,0.001715011,0.000012814959],"about_ca_topic_score_codex":0.00033338397,"about_ca_topic_score_gemma":0.00035930873,"teacher_disagreement_score":0.0007010508,"about_ca_system_score_codex":0.00024831743,"about_ca_system_score_gemma":0.00029216727,"threshold_uncertainty_score":0.0023452044},"labels":[],"label_agreement":null},{"id":"W2085731453","doi":"10.1007/s00262-012-1230-8","title":"CA215 and GnRH receptor as targets for cancer therapy","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre of Excellence for Women's Health; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Monoclonal antibody; Epitope; Cancer; Cancer research; Cancer cell; Antibody; Ovarian cancer; Biology; Cytotoxicity; Targeted therapy; Medicine; Immunology; Internal medicine; In vitro; Biochemistry","score_opus":0.044804329150822726,"score_gpt":0.3792224906728907,"score_spread":0.334418161522068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085731453","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5702538,0.35090733,0.006436021,0.010363508,0.0023018338,0.00027477552,0.0003821686,0.000219768,0.058860693],"genre_scores_gemma":[0.91382426,0.06260527,0.003510599,0.0012222639,0.0007537015,0.00012264347,0.0003667951,0.00002898807,0.017565468],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998814,0.000027808734,0.000007855521,0.000010968102,0.000030032816,0.000041893898],"domain_scores_gemma":[0.9999248,0.00002366943,0.000013923793,0.0000074935574,0.000009218043,0.000020951804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048715566,0.00022274976,0.00029255584,0.00044641772,0.00027086007,0.0006728368,0.0005316736,0.0005593504,0.0027398719],"category_scores_gemma":[0.00032559378,0.00013439413,0.00023778462,0.00029431103,0.00040416987,0.00047810923,0.00032754807,0.00086301967,0.0005302441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004302606,0.0007657124,0.0045981994,0.001019488,0.00015491518,0.0016030594,0.00021392059,0.0020081887,0.5459121,0.027888121,0.015224159,0.39630955],"study_design_scores_gemma":[0.002430675,0.0072473777,0.015235755,0.0002502985,0.00033855342,0.007714907,0.0004210947,0.0045798724,0.45935804,0.009817547,0.49252453,0.00008134966],"about_ca_topic_score_codex":0.001104413,"about_ca_topic_score_gemma":0.002228026,"teacher_disagreement_score":0.0027398719,"about_ca_system_score_codex":0.000907162,"about_ca_system_score_gemma":0.0005401356,"threshold_uncertainty_score":0.009165823},"labels":[],"label_agreement":null},{"id":"W2089081257","doi":"10.1007/s00262-010-0887-0","title":"Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Immunotherapy; Cancer research; Cytotoxic T cell; Isopentenyl pyrophosphate; T cell; Peripheral blood mononuclear cell; Cancer immunotherapy; Cancer; Medicine; Cancer cell; Immune system; Immunology; Biology; In vitro; Internal medicine","score_opus":0.008097310660771144,"score_gpt":0.25239929525632576,"score_spread":0.2443019845955546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089081257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641824,0.00034018396,0.00073615,0.00009110552,0.00003184689,0.000063114945,0.00008425184,0.000043834218,0.002191267],"genre_scores_gemma":[0.99866307,0.00013074689,0.00044855033,0.000025507088,0.0000077610375,0.000016835698,0.00006841477,0.0000051592187,0.0006340455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999131,0.00001617429,0.000004060452,0.0000129202335,0.000018085573,0.000035682588],"domain_scores_gemma":[0.99996567,0.000010080048,0.000004319696,0.0000067800665,0.0000036724575,0.000009448176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010092271,0.00013620585,0.00018196694,0.00012554995,0.00014309523,0.00026551873,0.00011566109,0.00022561158,0.0013019299],"category_scores_gemma":[0.00012602001,0.000094699004,0.000113454545,0.000098737204,0.000108558816,0.00009005915,0.00015137586,0.00051408313,0.00033866114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011534025,0.00036448782,0.0009790256,0.00003204244,0.000011942082,0.00019789946,0.000038656977,0.0003892136,0.9811677,0.0003335783,0.0005358881,0.014796302],"study_design_scores_gemma":[0.0003680331,0.0023551062,0.0070823533,0.0000065335444,0.00004602452,0.0011297988,0.00003802729,0.0028702274,0.98003894,0.0001871219,0.005873121,0.000004780955],"about_ca_topic_score_codex":0.00035903978,"about_ca_topic_score_gemma":0.00054343574,"teacher_disagreement_score":0.0013019299,"about_ca_system_score_codex":0.0001570719,"about_ca_system_score_gemma":0.00017563584,"threshold_uncertainty_score":0.0043554306},"labels":[],"label_agreement":null},{"id":"W2089966068","doi":"10.1007/s00262-011-1047-x","title":"Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Calreticulin; Photodynamic therapy; Expression (computer science); Surface (topology); Group (periodic table); Cancer research; Internal medicine; Medicine; Chemistry; Biology; Cell biology; Mathematics; Computer science","score_opus":0.010463634441377552,"score_gpt":0.2547351051918924,"score_spread":0.24427147075051486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089966068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966192,0.0013105471,0.0012573743,0.000100364465,0.0000102155145,0.000015907248,0.00006662362,0.000022734463,0.0005969612],"genre_scores_gemma":[0.9981067,0.0003639757,0.0005559754,0.000019620173,0.000006964767,0.000012770451,0.00007987563,0.000005940262,0.00084806816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998803,0.000020586775,0.000008601468,0.000018673903,0.000026116111,0.000045741974],"domain_scores_gemma":[0.9998747,0.000018997776,0.000044753247,0.000016375889,0.000017442235,0.000027839858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018529799,0.00019600746,0.00020141876,0.0002702799,0.00018482862,0.00038356628,0.00013835853,0.0003436846,0.0009299545],"category_scores_gemma":[0.0002146811,0.0001327882,0.00018894098,0.00016894311,0.00023006056,0.0003782706,0.0002562372,0.0004596333,0.00019169816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040580952,0.000026104572,0.0013429046,0.000019523548,0.0000059572876,0.000051738887,0.000021295245,0.000043229873,0.9959722,0.000118142256,0.000020664305,0.001972447],"study_design_scores_gemma":[0.00003049698,0.00027711823,0.058774732,0.000005763732,0.000027380653,0.0004607259,0.00009582934,0.0017318536,0.93726856,0.00017981356,0.0011420281,0.0000057653597],"about_ca_topic_score_codex":0.00034110088,"about_ca_topic_score_gemma":0.00034925775,"teacher_disagreement_score":0.0009299545,"about_ca_system_score_codex":0.00045534436,"about_ca_system_score_gemma":0.00015214918,"threshold_uncertainty_score":0.0033038259},"labels":[],"label_agreement":null},{"id":"W2090674284","doi":"10.1007/s00262-011-1083-6","title":"Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Institute for Biological Sciences","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Polysialic acid; Conjugate; Immunization; Antibody; Medicine; Group A; Immunology; Cancer research; Cell; Chemistry; Internal medicine","score_opus":0.014581903922429659,"score_gpt":0.25844688750645256,"score_spread":0.2438649835840229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090674284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998447,0.00025057825,0.00024592364,0.00017515752,0.00002079681,0.00002144668,0.000017883487,0.000026987786,0.00079424196],"genre_scores_gemma":[0.999353,0.000080325226,0.00008484592,0.00008290402,0.00002090357,0.00000841934,0.00004333014,0.0000024897158,0.0003238323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989355,0.0000447096,0.0000052361343,0.000013276325,0.00001374795,0.0000294875],"domain_scores_gemma":[0.9998229,0.000058089117,0.000023688877,0.000022663098,0.0000135397,0.00005908931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035557436,0.00026666568,0.00029738716,0.0001460453,0.000301505,0.00023032833,0.00012116129,0.0003325348,0.0013278921],"category_scores_gemma":[0.00045793908,0.00012518009,0.00021881006,0.000088683075,0.00028520235,0.00021898911,0.00011769138,0.00055470667,0.00027105302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043263923,0.014744895,0.19635782,0.00024867,0.0003956458,0.0034723387,0.0009167071,0.00066637015,0.53950524,0.0006734444,0.0046948874,0.19506],"study_design_scores_gemma":[0.0074344934,0.24553375,0.525097,0.000052951465,0.0004779578,0.0070742075,0.00045898958,0.0024441874,0.20037156,0.0005027902,0.010523286,0.000028794404],"about_ca_topic_score_codex":0.00048685085,"about_ca_topic_score_gemma":0.0005636001,"teacher_disagreement_score":0.0013278921,"about_ca_system_score_codex":0.00023369156,"about_ca_system_score_gemma":0.00025848925,"threshold_uncertainty_score":0.0044422746},"labels":[],"label_agreement":null},{"id":"W2091633760","doi":"10.1007/s00262-013-1432-8","title":"Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"FOXP3; Immune system; Cancer research; Biology; Retinoic acid; Immunology; Antigen; CD8; Immune tolerance; Immunotherapy; Cell culture","score_opus":0.007739142365960905,"score_gpt":0.2331736637303327,"score_spread":0.22543452136437178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091633760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276346,0.0020454696,0.0021163514,0.00027652734,0.00014583269,0.000056287303,0.00009696216,0.00013863979,0.0023605113],"genre_scores_gemma":[0.99542207,0.0009646612,0.0013050694,0.00007873887,0.00006020428,0.000026376809,0.0001170009,0.00002192076,0.0020039338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996486,0.00008020804,0.000030725554,0.00004476532,0.00007090637,0.00012478349],"domain_scores_gemma":[0.99965715,0.000096035365,0.000072415976,0.00006039472,0.000031719548,0.000082283426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031089282,0.00043147747,0.0005587765,0.00031920115,0.0001637491,0.00046463253,0.00029516753,0.0004340823,0.0015511372],"category_scores_gemma":[0.00032288377,0.0001968236,0.00031065047,0.0001442926,0.00038632058,0.00038706354,0.00020208705,0.0018268226,0.00070433377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011475013,0.00031372916,0.00018403407,0.000049328315,0.000013371582,0.000033938406,0.000019064353,0.00032707746,0.991084,0.00019270554,0.000111389745,0.0065238434],"study_design_scores_gemma":[0.0001740999,0.0024113948,0.00084837025,0.000008552768,0.00004684138,0.00014223598,0.000023639377,0.0011308027,0.992815,0.000111314854,0.0022824625,0.00000525848],"about_ca_topic_score_codex":0.00030883026,"about_ca_topic_score_gemma":0.00042606122,"teacher_disagreement_score":0.0015511372,"about_ca_system_score_codex":0.00025033517,"about_ca_system_score_gemma":0.00045020418,"threshold_uncertainty_score":0.005189121},"labels":[],"label_agreement":null},{"id":"W2092275785","doi":"10.1007/s00262-013-1428-4","title":"Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Sonnenfeld Stiftung","keywords":"Medicine; Melanoma; Pegylated interferon; Internal medicine; Oncology; Alpha interferon; Interferon; Gastroenterology; Immunology; Cancer research","score_opus":0.019747786874383395,"score_gpt":0.3011801274234032,"score_spread":0.28143234054901983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092275785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879766,0.00027119488,0.0002681903,0.00002696986,0.000010861377,0.000020921003,0.00027716684,0.0000047606127,0.00032236255],"genre_scores_gemma":[0.99803597,0.00010838753,0.00041500796,0.00008098828,0.000017431412,0.000047562407,0.0007403984,0.0000033363015,0.0005508277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998323,0.00006741398,0.000009517169,0.000040349045,0.000025434454,0.00002505167],"domain_scores_gemma":[0.99975175,0.000076503966,0.00006347782,0.000027862516,0.000033658584,0.000046712048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050516083,0.0002188261,0.00032197326,0.0002284557,0.00013498272,0.00044631178,0.00012893701,0.0002620706,0.00077949866],"category_scores_gemma":[0.000660818,0.0001243887,0.00016671841,0.00022147024,0.00012397862,0.0001536853,0.00014930998,0.00034015506,0.00022411573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03229582,0.001069723,0.8267336,0.000092160284,0.00025245984,0.0003329811,0.00018707372,0.000753006,0.0940308,0.00014288025,0.00092192064,0.043187678],"study_design_scores_gemma":[0.0008702806,0.010321379,0.96125644,0.000022685095,0.00025718292,0.0008367695,0.00016596778,0.003932142,0.019431591,0.00024242776,0.0026487543,0.000014440207],"about_ca_topic_score_codex":0.00028608195,"about_ca_topic_score_gemma":0.0004038302,"teacher_disagreement_score":0.00077949866,"about_ca_system_score_codex":0.0001631861,"about_ca_system_score_gemma":0.00018083936,"threshold_uncertainty_score":0.0026715994},"labels":[],"label_agreement":null},{"id":"W2093949714","doi":"10.1007/s00262-005-0674-5","title":"Development of a whole cell vaccine for acute myeloid leukaemia","year":2005,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Immunotherapy; Minimal residual disease; Oncology; Disease; Myeloid; Internal medicine; Stem cell; Clinical trial; Haematopoiesis; Myeloid leukaemia; Immunology; Immune system; Leukemia; Biology","score_opus":0.0490583581798695,"score_gpt":0.3946298846418152,"score_spread":0.3455715264619457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093949714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064098457,0.9952678,0.0010711028,0.000410005,0.0006996398,0.000029733541,0.00002907059,0.000026229698,0.0018252796],"genre_scores_gemma":[0.002559589,0.99306643,0.0012186574,0.000626899,0.00022410402,0.000028744875,0.00010382858,0.000004263671,0.0021674389],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998481,0.00002340277,0.000016067792,0.000028118644,0.00006264309,0.00002160072],"domain_scores_gemma":[0.9998528,0.000060256716,0.000021702765,0.00000735696,0.000042097352,0.000015786174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006992529,0.0011296053,0.0017300097,0.0011199089,0.00027237553,0.00087006146,0.0010355696,0.001318992,0.0023730563],"category_scores_gemma":[0.00048207643,0.0003012573,0.00050808385,0.0009785678,0.0005085221,0.0011927378,0.0005250278,0.0022704643,0.0017879527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020306396,0.00018593422,0.00012418059,0.006434113,0.00008146891,0.000274296,0.00003500678,0.0006289123,0.011690943,0.0028263496,0.023535624,0.95398],"study_design_scores_gemma":[0.00013008098,0.00040701227,0.00051672105,0.0010974407,0.00015152316,0.001517136,0.000029699477,0.0001836104,0.0053310576,0.0012458585,0.9893712,0.000018712317],"about_ca_topic_score_codex":0.000962639,"about_ca_topic_score_gemma":0.0014270705,"teacher_disagreement_score":0.0023730563,"about_ca_system_score_codex":0.0006353962,"about_ca_system_score_gemma":0.00081934355,"threshold_uncertainty_score":0.007938683},"labels":[],"label_agreement":null},{"id":"W2095399328","doi":"10.1007/s00262-006-0276-x","title":"Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN","year":2007,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"CpG Oligodeoxynucleotide; Adjuvant; Immune system; Antigen; Acquired immune system; Immunopotentiator; Immunology; TLR9; Innate immune system; Chemistry; CpG site; Cancer research; Biology; DNA methylation; Biochemistry","score_opus":0.014257866176892457,"score_gpt":0.2784953889808427,"score_spread":0.26423752280395024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095399328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977602,0.00040305842,0.0011956199,0.000040822593,0.000016934771,0.000011126905,0.00003267982,0.000030099312,0.0005093868],"genre_scores_gemma":[0.9970732,0.00022524138,0.00092114764,0.000030191473,0.000007984654,0.000010404165,0.00007532922,0.000015852222,0.0016406596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992156,0.000012783268,0.000005878018,0.000013157056,0.00001790066,0.000028771845],"domain_scores_gemma":[0.9998981,0.000027742815,0.000026971393,0.000011520432,0.000012755555,0.000022940148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001535236,0.00026191174,0.00021558076,0.00012313928,0.0000611287,0.0001890464,0.00011558093,0.00027203266,0.00089271384],"category_scores_gemma":[0.00017696925,0.000121023666,0.0001561608,0.000066267596,0.00015457974,0.00020852053,0.00016829965,0.0004161379,0.0002599219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024893996,0.00004427543,0.0000642446,0.000025206506,0.000002828995,0.000015664275,0.000005816147,0.00014278185,0.9977843,0.000045837638,0.00002748128,0.0015926042],"study_design_scores_gemma":[0.00001564699,0.00035083576,0.0004158149,0.000002945789,0.000008798268,0.00003337359,0.0000033211363,0.0007922763,0.9980263,0.000009778506,0.0003388921,0.000001952725],"about_ca_topic_score_codex":0.0004638525,"about_ca_topic_score_gemma":0.00057984353,"teacher_disagreement_score":0.00089271384,"about_ca_system_score_codex":0.00017988628,"about_ca_system_score_gemma":0.00024803917,"threshold_uncertainty_score":0.0029864907},"labels":[],"label_agreement":null},{"id":"W2095408752","doi":"10.1007/s00262-012-1333-2","title":"CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"CD40; Cancer research; Tumor necrosis factor alpha; Endometrial cancer; Biology; Apoptosis; Cancer cell; Macrophage; Cancer; Tumor progression; PI3K/AKT/mTOR pathway; Signal transduction; Immunology; Medicine; Cell biology; Internal medicine; In vitro; Cytotoxic T cell","score_opus":0.030092769943370276,"score_gpt":0.29287978309801327,"score_spread":0.262787013154643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095408752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606377,0.0017383789,0.00073263556,0.00006941526,0.000011659358,0.0000111906675,0.00014333798,0.000016809967,0.0012127532],"genre_scores_gemma":[0.996965,0.0005587889,0.00057866704,0.000031248226,0.000007822979,0.000026659724,0.00018346889,0.000004131358,0.0016441098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998915,0.000020866122,0.0000062016697,0.000015915824,0.000015133781,0.00005040963],"domain_scores_gemma":[0.9999647,0.0000068294185,0.0000053346976,0.0000056979707,0.0000068204436,0.000010592612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013690534,0.00021669277,0.0001472153,0.00030619113,0.0001738149,0.00026084192,0.00010758373,0.0002480361,0.0019119241],"category_scores_gemma":[0.00011240579,0.00012089931,0.00016854923,0.00014353127,0.00014814228,0.00020212345,0.00023884006,0.0003660329,0.00033821812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053439086,0.000024537101,0.0013032203,0.000053827578,0.0000059289305,0.00019832423,0.000044938697,0.000033210952,0.9939557,0.00039125644,0.00007209785,0.003382726],"study_design_scores_gemma":[0.000090535796,0.0004964822,0.026582273,0.000017379307,0.00006773947,0.0022166427,0.00028127266,0.0011171647,0.9604346,0.00065259513,0.008034256,0.0000089092355],"about_ca_topic_score_codex":0.00031884073,"about_ca_topic_score_gemma":0.0004169885,"teacher_disagreement_score":0.0019119241,"about_ca_system_score_codex":0.00021048954,"about_ca_system_score_gemma":0.0001876179,"threshold_uncertainty_score":0.006396055},"labels":[],"label_agreement":null},{"id":"W2130519688","doi":"10.1007/s00262-008-0456-y","title":"Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Hepatitis C virus research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immune system; Biology; Virology; Hepatitis C virus; Humoral immunity; Proteome; Immunology; Human proteome project; Peptide sequence; Immunogenicity; Virus; Computational biology; Genetics; Proteomics; Gene","score_opus":0.10487288467256202,"score_gpt":0.4001129277995764,"score_spread":0.2952400431270144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130519688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865085,0.00040963342,0.0004440621,0.00001710456,0.000005388845,0.0000067588417,0.000035575333,0.0000046771565,0.00042597938],"genre_scores_gemma":[0.99954176,0.00007053657,0.00018873972,0.000015515308,0.00000888555,0.0000039662723,0.000036946625,0.000003816023,0.00012982213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996722,0.00013953922,0.00002307494,0.000041143998,0.000057777288,0.00006629185],"domain_scores_gemma":[0.9992046,0.0003965152,0.000171033,0.00005108715,0.000052815507,0.00012399157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006094127,0.00015216718,0.00024017732,0.00039704805,0.00016217132,0.00046705702,0.00013857374,0.00020266612,0.0015747667],"category_scores_gemma":[0.0010717319,0.00012363744,0.00018296576,0.00022403071,0.0002563513,0.0002663407,0.00027231788,0.00038029326,0.00015856771],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002408371,0.00008486011,0.0609011,0.000059495273,0.000078410805,0.00023071574,0.00007745075,0.0009561433,0.92586875,0.0006146734,0.00007303409,0.008647106],"study_design_scores_gemma":[0.000110624635,0.0033913194,0.43629104,0.000036274647,0.00025472886,0.00283679,0.00031289633,0.011326129,0.54160845,0.0015007971,0.0022872093,0.000043790562],"about_ca_topic_score_codex":0.00025927095,"about_ca_topic_score_gemma":0.00024405008,"teacher_disagreement_score":0.0015747667,"about_ca_system_score_codex":0.00015847459,"about_ca_system_score_gemma":0.0001730811,"threshold_uncertainty_score":0.005268097},"labels":[],"label_agreement":null},{"id":"W2134157043","doi":"10.1007/s00262-012-1353-y","title":"Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI","year":2012,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Western University","funders":"University Health Network","keywords":"Ferumoxytol; Cytotoxic T cell; Molecular biology; Cytotoxicity; Chemistry; Cancer research; Biology; In vitro; Medicine; Biochemistry","score_opus":0.0204625788586485,"score_gpt":0.2537292514652964,"score_spread":0.2332666726066479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134157043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561412,0.0017595679,0.030440949,0.0001853685,0.00009503121,0.00034316615,0.0010802693,0.0004881141,0.009466306],"genre_scores_gemma":[0.98209184,0.0005869784,0.009785275,0.00013052582,0.000037199607,0.00020060345,0.0014065492,0.000097369644,0.00566363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990475,0.000014593499,0.0000068448467,0.000017857274,0.000021624495,0.00003439805],"domain_scores_gemma":[0.99989307,0.000042099688,0.0000074657573,0.000026986669,0.000013925264,0.000016384422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033700117,0.000428296,0.00028424952,0.00025054434,0.00014722497,0.0002815749,0.0001866419,0.0003295989,0.0029092252],"category_scores_gemma":[0.0001440486,0.00013442681,0.00026553014,0.00014106752,0.00013827716,0.00018667661,0.00018088799,0.0008652494,0.0010098318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013298214,0.00004500399,0.00014399026,0.000014363331,0.0000033009867,0.00004649833,0.000026467207,0.00013763763,0.9967145,0.00014831776,0.00013711568,0.0024498461],"study_design_scores_gemma":[0.000029359586,0.00020671365,0.0011653515,0.0000036427723,0.000016061558,0.00021617796,0.000012272978,0.00058248267,0.99482805,0.00005274278,0.0028848436,0.00000222224],"about_ca_topic_score_codex":0.00039960165,"about_ca_topic_score_gemma":0.0005759474,"teacher_disagreement_score":0.0029092252,"about_ca_system_score_codex":0.00015118343,"about_ca_system_score_gemma":0.00014347723,"threshold_uncertainty_score":0.009732306},"labels":[],"label_agreement":null},{"id":"W2138582752","doi":"10.1007/s00262-008-0557-7","title":"Chordoma and chondrosarcoma gene profile: implications for immunotherapy","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Chondrosarcoma; Chordoma; Cancer research; Sarcoma; Biology; Pathology; Immunohistochemistry; Extracellular matrix; Medicine; Genetics","score_opus":0.03475966836548436,"score_gpt":0.32009206877311447,"score_spread":0.2853324004076301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138582752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927385,0.0028914164,0.0012746666,0.000719936,0.00003986094,0.000028773997,0.0004935898,0.00002700709,0.005250872],"genre_scores_gemma":[0.9952532,0.0011833815,0.0012739651,0.00020811014,0.000041131545,0.000017831026,0.00036671758,0.000008209068,0.0016474026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998248,0.000037823324,0.000018816487,0.00003285865,0.000048964062,0.000036708672],"domain_scores_gemma":[0.99967325,0.000106137544,0.00006713273,0.000019355055,0.00005707046,0.000077149205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002807493,0.00014398803,0.00030490005,0.00079937367,0.00024671695,0.00038444283,0.00027044566,0.00032569998,0.0019726043],"category_scores_gemma":[0.00071752013,0.000077068464,0.00014046753,0.00040190894,0.00032200982,0.0003095864,0.0001957919,0.00030321092,0.00038824836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032234467,0.00023371993,0.26496065,0.00019448466,0.000084125524,0.003641835,0.00026351414,0.00055351504,0.66334045,0.0021618537,0.0008419624,0.060500387],"study_design_scores_gemma":[0.00019150521,0.0022887136,0.8425729,0.00005291495,0.00026104963,0.035567686,0.001642136,0.0032378207,0.09736691,0.0033226025,0.013457637,0.000038139242],"about_ca_topic_score_codex":0.0011224134,"about_ca_topic_score_gemma":0.0013591426,"teacher_disagreement_score":0.0019726043,"about_ca_system_score_codex":0.0002806746,"about_ca_system_score_gemma":0.00038155206,"threshold_uncertainty_score":0.0065990686},"labels":[],"label_agreement":null},{"id":"W2141602361","doi":"10.1007/s00262-009-0711-x","title":"Soluble HLA/peptide monomers cross-linked with co-stimulatory antibodies onto a streptavidin core molecule efficiently stimulate antigen-specific T cell responses","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"European Commission; Kay Kendall Leukaemia Fund","keywords":"Antigen; T cell; Major histocompatibility complex; CD8; T-cell receptor; MHC restriction; Priming (agriculture); Cytotoxic T cell; CD28; Cell biology; Chemistry; Biology; Antibody; Molecular biology; MHC class I; Immunology; Immune system; Biochemistry; In vitro","score_opus":0.02508194718086599,"score_gpt":0.30544523929108275,"score_spread":0.28036329211021677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141602361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898774,0.0008867564,0.0050553544,0.00007590708,0.000081587525,0.000068583664,0.00011298135,0.00008754183,0.0037540344],"genre_scores_gemma":[0.99395365,0.00039934003,0.0023056343,0.00008199948,0.000031596854,0.000030815856,0.00024081182,0.00002945342,0.002926697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999708,0.000055236807,0.000015411524,0.000042190844,0.00006262004,0.00011665107],"domain_scores_gemma":[0.9997954,0.00007502574,0.000023687233,0.000028502041,0.00002054102,0.000056924036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022367577,0.0006197598,0.00035318919,0.00022850602,0.00015697037,0.00049150066,0.00022422109,0.00039779933,0.0027463604],"category_scores_gemma":[0.00019425372,0.00024758035,0.00028463136,0.00018788323,0.00018244679,0.0001759988,0.0004251054,0.0009792653,0.0013485169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010334827,0.0000523409,0.00011688432,0.000020126014,0.0000051526354,0.000027547252,0.0000106164425,0.00006170088,0.99847466,0.00008834839,0.000054648266,0.0009847205],"study_design_scores_gemma":[0.000047935257,0.00032828073,0.0014488453,0.000006084812,0.000020284235,0.00015743558,0.000026678972,0.001654451,0.9950033,0.00009281545,0.0012097033,0.0000042743873],"about_ca_topic_score_codex":0.000420089,"about_ca_topic_score_gemma":0.0009860942,"teacher_disagreement_score":0.0027463604,"about_ca_system_score_codex":0.00030882025,"about_ca_system_score_gemma":0.00031416467,"threshold_uncertainty_score":0.00918752},"labels":[],"label_agreement":null},{"id":"W2153757228","doi":"10.1007/s00262-007-0391-3","title":"Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas","year":2007,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"NKG2D; Cancer research; Immunotherapy; Cytotoxic T cell; T cell; Ex vivo; Medicine; Immunology; Biology; Immune system; In vivo; In vitro","score_opus":0.014498654562375183,"score_gpt":0.2596359900905667,"score_spread":0.24513733552819153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153757228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97983104,0.005271587,0.0030150854,0.0003807523,0.000107323925,0.00009290885,0.00020623328,0.000071054325,0.01102396],"genre_scores_gemma":[0.9943494,0.0014711766,0.000432334,0.000085720625,0.000027023041,0.000025944146,0.00026422576,0.000008646288,0.0033355833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990463,0.00003264799,0.000003830573,0.00001072327,0.000013407298,0.00003483896],"domain_scores_gemma":[0.99995863,0.000014425275,0.0000035543917,0.000010031482,0.0000050639164,0.000008345994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019832522,0.00024366297,0.00013992918,0.00019434393,0.000082424114,0.0002660656,0.00014466236,0.0002127439,0.0025150222],"category_scores_gemma":[0.0001312056,0.00007164302,0.00014290622,0.000084021034,0.0001622457,0.00013833545,0.00012125561,0.00045037243,0.0004770058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012697909,0.00033869583,0.0011674886,0.00014947075,0.000016968499,0.00022752042,0.00005365098,0.00081612973,0.9591488,0.0013431394,0.001036457,0.03443194],"study_design_scores_gemma":[0.0008507321,0.004150978,0.014760868,0.00008761511,0.00008593409,0.002546552,0.00013554444,0.004124964,0.9335303,0.002187949,0.03752525,0.000013310258],"about_ca_topic_score_codex":0.000357641,"about_ca_topic_score_gemma":0.0002519911,"teacher_disagreement_score":0.0025150222,"about_ca_system_score_codex":0.00016455722,"about_ca_system_score_gemma":0.00015162794,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2159926306","doi":"10.1007/s00262-009-0788-2","title":"Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells","year":2009,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Leids Universitair Medisch Centrum; Universiteit Leiden; Wallace H. Coulter Foundation; Cancer Research Institute; Bill and Melinda Gates Foundation","keywords":"ELISPOT; Peripheral blood mononuclear cell; Immunology; Medicine; Antigen; Chemistry; In vitro","score_opus":0.0256241263572497,"score_gpt":0.3322961344563678,"score_spread":0.3066720080991181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159926306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8899807,0.008976047,0.084914416,0.00048054525,0.0007401585,0.0025373963,0.003231771,0.00079405063,0.008345075],"genre_scores_gemma":[0.82510716,0.004137099,0.15057342,0.0007836038,0.0002062792,0.0040947204,0.007893586,0.00029193083,0.0069121546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9882123,0.00501,0.0017420803,0.0012147533,0.0033950105,0.00042588712],"domain_scores_gemma":[0.99671376,0.0012840491,0.0004238556,0.00046316686,0.0009784393,0.00013676022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061369985,0.0011044561,0.0007507636,0.00092051923,0.00076578325,0.0017666515,0.0010069904,0.0009949409,0.0015677081],"category_scores_gemma":[0.005411366,0.00048187544,0.0008038542,0.0007545301,0.00060572114,0.0006217091,0.0010665399,0.00079454266,0.0011575641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002115872,0.00042932882,0.005132849,0.00065897027,0.0000827076,0.0001272726,0.0004002199,0.0010464373,0.9741362,0.00033513544,0.0006491707,0.014885998],"study_design_scores_gemma":[0.000043712298,0.0015781017,0.0051115965,0.00010402249,0.00009668436,0.00023528753,0.00011088522,0.0020508457,0.9857373,0.0001108663,0.004771992,0.000048626756],"about_ca_topic_score_codex":0.0014294751,"about_ca_topic_score_gemma":0.0024663317,"teacher_disagreement_score":0.0061369985,"about_ca_system_score_codex":0.0005138443,"about_ca_system_score_gemma":0.0011326467,"threshold_uncertainty_score":0.03245592},"labels":[],"label_agreement":null},{"id":"W2165709521","doi":"10.1007/s00262-001-0261-3","title":"Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface","year":2002,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; Grantová Agentura České Republiky","keywords":"Biology; Virus; Virology; Fusion protein; Immune system; Molecular biology; Antibody; Hemagglutinin (influenza); Orthopoxvirus; Recombinant DNA; Recombinant virus; Poxviridae; Vaccinia; Gene; Immunology","score_opus":0.02861957685417678,"score_gpt":0.3068219827997302,"score_spread":0.27820240594555345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165709521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528754,0.00065554446,0.00044361287,0.00013347025,0.000095442396,0.000020306523,0.00006989523,0.000026932063,0.0032673017],"genre_scores_gemma":[0.9944208,0.0004125485,0.00021573262,0.00022377388,0.0000633633,0.000024596671,0.0003987601,0.000013220872,0.00422707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964106,0.00007427411,0.00001158765,0.000038724167,0.000050283703,0.0001840477],"domain_scores_gemma":[0.99977607,0.00009899079,0.000016886092,0.00002704506,0.00003186726,0.000049180828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002645999,0.00056572334,0.00031024765,0.00033753394,0.00031895717,0.0004976483,0.00020076723,0.00079515314,0.0055818493],"category_scores_gemma":[0.00042347034,0.00019062386,0.0004747357,0.00013864775,0.0002647876,0.0003156135,0.0003838291,0.0011346288,0.0012405686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014895187,0.0003384464,0.0007787382,0.00008045678,0.000022297578,0.0003826843,0.00005598227,0.0002015576,0.993364,0.00053342653,0.0004178245,0.00233519],"study_design_scores_gemma":[0.0002789549,0.0024927582,0.018548552,0.000046361427,0.000096992866,0.0015360514,0.00028500723,0.0038396914,0.96568877,0.0009238365,0.006246399,0.000016630342],"about_ca_topic_score_codex":0.00039482056,"about_ca_topic_score_gemma":0.0002110327,"teacher_disagreement_score":0.0055818493,"about_ca_system_score_codex":0.0005531465,"about_ca_system_score_gemma":0.00021696358,"threshold_uncertainty_score":0.018673182},"labels":[],"label_agreement":null},{"id":"W2167778723","doi":"10.1007/s00262-010-0948-4","title":"Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production","year":2010,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; Ontario Institute for Cancer Research; Vancouver Coastal Health Research Institute; Vancouver Coastal Health; McMaster University Medical Centre; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Immunology; Context (archaeology); Dendritic cell; Immune system; Cancer research; Biology","score_opus":0.007425037414359705,"score_gpt":0.24427050321278648,"score_spread":0.23684546579842677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167778723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994616,0.00089734443,0.0022041833,0.00012117541,0.00012856968,0.000036499812,0.00029303526,0.000081179955,0.0016219942],"genre_scores_gemma":[0.9969789,0.0003894892,0.0007638792,0.000045851808,0.000020219377,0.000020088411,0.0003501312,0.000019513034,0.0014120499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966764,0.000045288634,0.000026637352,0.000040777322,0.00009235596,0.00012730046],"domain_scores_gemma":[0.9996536,0.00012362885,0.0000694939,0.00006740361,0.000023020833,0.000062971994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021198195,0.00035562232,0.0003214678,0.0003306126,0.00024222035,0.00076216104,0.00015710441,0.00038182896,0.0020015703],"category_scores_gemma":[0.00022014558,0.00021687071,0.00036859245,0.0001941154,0.00043657655,0.00028738924,0.00022900636,0.001433109,0.00058571104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017001713,0.000032988948,0.00019125915,0.00001172938,0.0000041828016,0.00004759314,0.000012807762,0.00005129827,0.99875903,0.00012922384,0.000031135758,0.00055882416],"study_design_scores_gemma":[0.000043456475,0.00024746952,0.0020589987,0.0000034331047,0.000015724145,0.00030450887,0.000044077507,0.0006081692,0.9951833,0.00010909078,0.0013775581,0.0000042480765],"about_ca_topic_score_codex":0.00031582298,"about_ca_topic_score_gemma":0.00026660317,"teacher_disagreement_score":0.0020015703,"about_ca_system_score_codex":0.00022875083,"about_ca_system_score_gemma":0.000245464,"threshold_uncertainty_score":0.006695986},"labels":[],"label_agreement":null},{"id":"W2168311042","doi":"10.1007/s00262-011-1055-x","title":"Polyfunctionality of a DKK1 self-antigen-specific CD8+ T lymphocyte clone in lung cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research; Institut Du Cancer de Montréal","keywords":"Lung cancer; clone (Java method); Immunology; Antigen; CD8; Medicine; Virology; Biology; Gene; Oncology; Genetics","score_opus":0.02398129105500327,"score_gpt":0.27180652214474776,"score_spread":0.2478252310897445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168311042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972791,0.00055268104,0.00082748197,0.00008010916,0.00003221659,0.00001961765,0.0002014307,0.00005378357,0.00095359114],"genre_scores_gemma":[0.99692196,0.00020154608,0.0006202825,0.000060677437,0.000020182046,0.000036403253,0.0006290793,0.00002829977,0.0014814303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956137,0.00009529405,0.000052914944,0.000085971544,0.00007762498,0.00012686203],"domain_scores_gemma":[0.999529,0.00018263067,0.000045326076,0.00010054275,0.00004920052,0.000093368144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033585454,0.00040039403,0.0003396981,0.0005048999,0.00027979744,0.00052940025,0.00044128424,0.00043202093,0.0023535173],"category_scores_gemma":[0.00036973815,0.00027073637,0.0002875559,0.00023110308,0.0003053891,0.00032516973,0.00033419798,0.0016581306,0.00078229734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022826366,0.00007604389,0.00028209956,0.000020055324,0.0000050242174,0.000040262275,0.000011862378,0.00006284133,0.99828655,0.00007030047,0.00004296558,0.00087372825],"study_design_scores_gemma":[0.00012653659,0.0008655684,0.008773297,0.000009165493,0.00006093694,0.00091260526,0.000054358028,0.0019429662,0.9852201,0.00007384764,0.0019539034,0.0000067437054],"about_ca_topic_score_codex":0.00058009394,"about_ca_topic_score_gemma":0.0005856189,"teacher_disagreement_score":0.0023535173,"about_ca_system_score_codex":0.00049978745,"about_ca_system_score_gemma":0.00026713288,"threshold_uncertainty_score":0.007873297},"labels":[],"label_agreement":null},{"id":"W2234024195","doi":"10.1007/s00262-015-1785-2","title":"8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cancer immunotherapy; Cancer; Immunotherapy; Library science; Medicine; Internal medicine; Computer science","score_opus":0.009294974100002554,"score_gpt":0.2674305215908344,"score_spread":0.25813554749083184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234024195","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015402253,0.054193735,0.0034043912,0.1843413,0.1727748,0.0012997814,0.01211805,0.0011206007,0.55534506],"genre_scores_gemma":[0.013099046,0.008388092,0.001030992,0.0054525016,0.0037653616,0.00011741348,0.0037883488,0.00014339655,0.9642149],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984256,0.000086807595,0.000029181216,0.0001064017,0.0007601761,0.0005918191],"domain_scores_gemma":[0.9972458,0.000051529212,0.000044385302,0.000035313657,0.0013518531,0.0012712978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022745393,0.0009975994,0.0007294203,0.0012168607,0.0051292637,0.0039518415,0.0013437606,0.0029133128,0.1294209],"category_scores_gemma":[0.0017982577,0.00036384753,0.00075438083,0.0008146189,0.0009020705,0.00069895404,0.0023635547,0.0025662673,0.030209865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009983163,0.000041117128,0.0007050639,0.000055509052,0.000010334081,0.000048540638,0.0000405346,0.00010353243,0.00030620053,0.00035735895,0.9770299,0.021201963],"study_design_scores_gemma":[0.000018029481,0.000023829414,0.0033797172,0.000104836734,0.000010910297,0.000025324536,0.00022365959,0.000105010346,0.00015603921,0.00018510439,0.9957563,0.000011217929],"about_ca_topic_score_codex":0.7121586,"about_ca_topic_score_gemma":0.9461101,"teacher_disagreement_score":0.28784138,"about_ca_system_score_codex":0.018272497,"about_ca_system_score_gemma":0.04536981,"threshold_uncertainty_score":0.5790731},"labels":[],"label_agreement":null},{"id":"W2239178350","doi":"10.1007/s00262-015-1789-y","title":"Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Bladder cancer; Immunotherapy; Cancer research; Immunogenicity; TLR2; TLR3; Cytotoxic T cell; Cancer; Adjuvant; Immune system; Medicine; Immunology; Toll-like receptor; In vitro; Chemistry; Innate immune system; Internal medicine","score_opus":0.02437876967905506,"score_gpt":0.31402596941648786,"score_spread":0.2896471997374328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239178350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415726,0.0052117794,0.0012784274,0.00036616976,0.00045069706,0.00014196089,0.00021751676,0.00023847728,0.007937726],"genre_scores_gemma":[0.99481875,0.0017450596,0.0006607077,0.00012403111,0.00010089382,0.00006155493,0.00024832154,0.0000169701,0.0022237173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997552,0.00006419751,0.0000136022245,0.000028348684,0.000043395685,0.00009531563],"domain_scores_gemma":[0.9999063,0.000015842297,0.000021168384,0.000013936675,0.0000067776336,0.000035867703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024150872,0.00043278246,0.00036819506,0.00032369685,0.00022802656,0.00043504333,0.00024735217,0.0004687278,0.0026889045],"category_scores_gemma":[0.0001860114,0.00012720376,0.00039126165,0.0002800064,0.00028172502,0.00020326025,0.00032462706,0.001348973,0.0007997916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005263219,0.0022756793,0.00077783037,0.0002521743,0.00008356067,0.00015634207,0.000038890907,0.0012967408,0.93659955,0.00034189795,0.0016579335,0.051256165],"study_design_scores_gemma":[0.0018418283,0.035607677,0.027554868,0.00007578073,0.0003050802,0.00066617725,0.00009573088,0.0041218577,0.9115709,0.0002793117,0.017847622,0.000033287743],"about_ca_topic_score_codex":0.0007451192,"about_ca_topic_score_gemma":0.001498849,"teacher_disagreement_score":0.0026889045,"about_ca_system_score_codex":0.0002625703,"about_ca_system_score_gemma":0.00045526706,"threshold_uncertainty_score":0.008995295},"labels":[],"label_agreement":null},{"id":"W2510568091","doi":"10.1007/s00262-016-1877-7","title":"Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; CNIB","keywords":"Epitope; Human leukocyte antigen; Biology; Cytotoxic T cell; Antigen; Nectin; clone (Java method); Cancer immunotherapy; CD8; Immunology; Immunotherapy; Molecular biology; Cancer research; Cell; Immune system; Gene; Genetics; Cell adhesion; In vitro","score_opus":0.012238896327042992,"score_gpt":0.2622221440142092,"score_spread":0.24998324768716618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510568091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772877,0.00018697388,0.0010187041,0.00006325959,0.000014608965,0.000009038874,0.000047233385,0.0000066536077,0.0009247245],"genre_scores_gemma":[0.9965905,0.00015955811,0.0013166791,0.000072713505,0.000010706223,0.000008749572,0.00037992897,0.000007515269,0.0014536892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999498,0.000010151411,0.0000040327263,0.000010515908,0.000008970908,0.000016541462],"domain_scores_gemma":[0.99989176,0.000025555937,0.00001732815,0.000015359592,0.000017390828,0.000032614273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009149286,0.00014247722,0.000120279765,0.00009954475,0.00013601208,0.0002629313,0.00017542194,0.0002926426,0.0015148376],"category_scores_gemma":[0.00023856627,0.0000901351,0.00017841857,0.000055426575,0.000121855686,0.0001585925,0.00022967592,0.0005208604,0.00046179534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018433013,0.00003572922,0.00074560137,0.000017084116,0.0000043075784,0.00032167495,0.000022399367,0.00006928001,0.9967631,0.00014857702,0.000048683065,0.0016392355],"study_design_scores_gemma":[0.00010118729,0.0008816522,0.034022633,0.000024016168,0.00003746269,0.0061248625,0.00021993219,0.003989804,0.94889116,0.0005173284,0.0051764525,0.000013466313],"about_ca_topic_score_codex":0.00025130392,"about_ca_topic_score_gemma":0.00027156467,"teacher_disagreement_score":0.0015148376,"about_ca_system_score_codex":0.00026508342,"about_ca_system_score_gemma":0.00016399035,"threshold_uncertainty_score":0.005067706},"labels":[],"label_agreement":null},{"id":"W2524109460","doi":"10.1007/s00262-016-1906-6","title":"Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"FOXP3; Cytotoxic T cell; CD8; Cancer research; Immunology; Effector; Biology; Adjuvant; T cell; Antigen; Blocking antibody; Cytokine; Immune system; In vitro","score_opus":0.009830295630320715,"score_gpt":0.26167196302427037,"score_spread":0.25184166739394964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524109460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891493,0.0012189929,0.004856159,0.0005363218,0.0002733364,0.00009914015,0.00036430516,0.00047571887,0.00302677],"genre_scores_gemma":[0.99177915,0.0006120837,0.002439881,0.00014447041,0.000083045896,0.000112427224,0.00028502702,0.00005089655,0.0044930573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959856,0.000055397773,0.000027904805,0.00007889802,0.000094921095,0.00014424861],"domain_scores_gemma":[0.9997733,0.000041704694,0.00005870204,0.000035869023,0.000012796643,0.000077624114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003035971,0.00079358544,0.00047357168,0.00078223884,0.00028932496,0.00047790763,0.00044613887,0.0007319152,0.0019245681],"category_scores_gemma":[0.00019306825,0.00035106356,0.0004772996,0.00023118992,0.0006080475,0.00053453766,0.00026697223,0.0037350154,0.0004814682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001039555,0.0009188157,0.00017516459,0.00008286374,0.000012979164,0.00009643737,0.000039121645,0.0005389761,0.9906008,0.00072419626,0.00037420617,0.0053969445],"study_design_scores_gemma":[0.00023514945,0.002214884,0.00087021687,0.000012501878,0.000026608148,0.0002189091,0.000026943962,0.0027667675,0.9904332,0.00022973989,0.0029561298,0.000008886446],"about_ca_topic_score_codex":0.0005860145,"about_ca_topic_score_gemma":0.0010871907,"teacher_disagreement_score":0.0019245681,"about_ca_system_score_codex":0.00039162583,"about_ca_system_score_gemma":0.0005326064,"threshold_uncertainty_score":0.006438315},"labels":[],"label_agreement":null},{"id":"W2569695288","doi":"10.1007/s00262-016-1950-2","title":"Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"T cell; Immune system; Cancer research; CD8; Immunotherapy; Immunology; Immunity; Cytotoxic T cell; Cancer immunotherapy; Cancer; Biology; Medicine; Internal medicine; In vitro","score_opus":0.016891490023701924,"score_gpt":0.2921629740460029,"score_spread":0.27527148402230095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569695288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945971,0.0012580517,0.0012425651,0.00032805503,0.00018098063,0.00011340556,0.0006276665,0.00015363391,0.0014985318],"genre_scores_gemma":[0.99203086,0.0009854969,0.002055699,0.00013226854,0.000061977946,0.00017635309,0.0005370393,0.00004330217,0.0039770887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994466,0.00011643087,0.00005317342,0.00009807567,0.00011490389,0.00017090172],"domain_scores_gemma":[0.99957484,0.000051241463,0.000102713595,0.00006341951,0.000017089309,0.00019074224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039225694,0.0011804097,0.0007696368,0.0011758573,0.00032311626,0.0005294684,0.0005988822,0.0010024513,0.0016192248],"category_scores_gemma":[0.0001630318,0.0004248346,0.0007200928,0.00035354323,0.0007178201,0.000566533,0.0003085389,0.0023533492,0.0004155021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075744935,0.001663172,0.00054018304,0.000095162126,0.000063852516,0.00024074284,0.00003849098,0.00073098624,0.98463374,0.0004692087,0.00034526875,0.0036045916],"study_design_scores_gemma":[0.00077609555,0.009397545,0.002787998,0.000023831537,0.00020941785,0.0004701735,0.00008879927,0.0029192942,0.9802301,0.00027857706,0.0027898997,0.000028305403],"about_ca_topic_score_codex":0.0007839156,"about_ca_topic_score_gemma":0.0016321844,"teacher_disagreement_score":0.0016192248,"about_ca_system_score_codex":0.0005022395,"about_ca_system_score_gemma":0.00059370673,"threshold_uncertainty_score":0.0054168105},"labels":[],"label_agreement":null},{"id":"W2593397963","doi":"10.1007/s00262-017-1977-z","title":"Myeloid cells in circulation and tumor microenvironment of breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"United Arab Emirates University; Terry Fox Foundation","keywords":"Tumor microenvironment; Myeloid-derived Suppressor Cell; Myeloid; Breast cancer; Immune system; Cancer research; Cancer; Medicine; Immunology; Biology; Suppressor; Internal medicine","score_opus":0.007806617644043184,"score_gpt":0.23955849471584395,"score_spread":0.23175187707180075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593397963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833125,0.0008707715,0.000061173,0.00004069808,0.000005636771,0.0000046800224,0.00012027916,0.000005458581,0.00056000653],"genre_scores_gemma":[0.9989573,0.00030476713,0.00007990277,0.00003672638,0.000017368975,0.000008586139,0.00015012434,0.0000015224302,0.00044363618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998908,0.000025239806,0.000008787938,0.000032679374,0.000018514293,0.000023934292],"domain_scores_gemma":[0.9998672,0.0000297797,0.000044784247,0.0000065899335,0.000015205052,0.000036297457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008919713,0.00010892661,0.00018705952,0.00034524332,0.00018491305,0.00027152948,0.000057197736,0.00017047017,0.0018464247],"category_scores_gemma":[0.0003998421,0.000081770806,0.000055772856,0.00024046512,0.00008906615,0.00012060605,0.00012908956,0.00022114888,0.0002668801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023273404,0.00024466054,0.9066033,0.000094168114,0.000046498757,0.0017073684,0.0005940332,0.00006779338,0.062781766,0.00013958536,0.0006811274,0.024712445],"study_design_scores_gemma":[0.00002624176,0.00072209694,0.9878777,0.000015927653,0.00004625384,0.004661715,0.00036518284,0.00019840241,0.0039396575,0.00009265181,0.0020472899,0.000006879841],"about_ca_topic_score_codex":0.00033084842,"about_ca_topic_score_gemma":0.00042339164,"teacher_disagreement_score":0.0018464247,"about_ca_system_score_codex":0.00013370937,"about_ca_system_score_gemma":0.00009373946,"threshold_uncertainty_score":0.0061769485},"labels":[],"label_agreement":null},{"id":"W2606571211","doi":"10.1007/s00262-017-1996-9","title":"The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; BC Cancer Agency; Princess Margaret Cancer Centre; University of Guelph; Institute for Research in Immunology and Cancer; University of Alberta; Université de Montréal; Dalhousie University; University Health Network; University of Toronto","funders":"","keywords":"Summit; Immunotherapy; Cancer immunotherapy; Cancer; Medicine; Oncology; Geography; Internal medicine; Cartography","score_opus":0.021655016890104642,"score_gpt":0.30991624940816614,"score_spread":0.2882612325180615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606571211","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006624089,0.034085516,0.0022049604,0.16063423,0.16310562,0.00090105,0.035628427,0.0015634364,0.5952526],"genre_scores_gemma":[0.008700058,0.0032522394,0.0007176778,0.0031294874,0.0020775401,0.000077251025,0.0051365206,0.00023228845,0.97667694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973967,0.00014354594,0.000046953453,0.00019932061,0.001457494,0.0007560384],"domain_scores_gemma":[0.99550927,0.00013913267,0.00008858844,0.00011526102,0.0017692926,0.002378455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035090982,0.0012274805,0.0009787775,0.0014344355,0.004595355,0.008388224,0.0014781344,0.0033492374,0.18237235],"category_scores_gemma":[0.0037027365,0.00042110277,0.0008156784,0.0008809718,0.0015709506,0.0011046039,0.0036948659,0.003518495,0.06726654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008251494,0.000012954763,0.00019342227,0.000031552674,0.000004899492,0.00003194005,0.0000172627,0.00009186921,0.0001458828,0.0006886874,0.99205947,0.0066393986],"study_design_scores_gemma":[0.00001839015,0.000018634913,0.001708727,0.00008095626,0.000003989544,0.000011896559,0.00010358937,0.00009516689,0.00026385734,0.00037856816,0.9973055,0.000010628471],"about_ca_topic_score_codex":0.46932447,"about_ca_topic_score_gemma":0.7804746,"teacher_disagreement_score":0.53067553,"about_ca_system_score_codex":0.025344854,"about_ca_system_score_gemma":0.041802675,"threshold_uncertainty_score":0.9331854},"labels":[],"label_agreement":null},{"id":"W2613281651","doi":"10.1007/s00262-017-2013-z","title":"Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Health and Medical Research Council","keywords":"Immunotoxin; Saporin; Glioma; Monoclonal antibody; Chemistry; Pseudomonas exotoxin; Antibody; Molecular biology; Cell culture; In vitro; Cancer research; Cytotoxicity; Biology; Biochemistry; Immunology","score_opus":0.018064003743128602,"score_gpt":0.2801290360353377,"score_spread":0.26206503229220907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613281651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964128,0.0011572867,0.00056719896,0.00003950075,0.00003798634,0.000032602868,0.00032027464,0.0000400964,0.0013922025],"genre_scores_gemma":[0.9961153,0.00064865226,0.0005909867,0.000031630112,0.0000114603545,0.000033504828,0.0008328856,0.000014040396,0.0017214305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973196,0.00006267711,0.000032596654,0.000027218308,0.000052667943,0.00009284391],"domain_scores_gemma":[0.9997838,0.000075379445,0.000025133824,0.00002802341,0.000021443408,0.000066224304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026346606,0.00046909365,0.00048941234,0.00039055603,0.00016203191,0.00031376537,0.00022530912,0.00030210492,0.001276902],"category_scores_gemma":[0.00016785203,0.00021762263,0.0003261157,0.00030063928,0.00018096302,0.00024348366,0.00025915084,0.00059435866,0.0003557227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077802164,0.00015427357,0.00020456396,0.000054881817,0.000011342873,0.000037594455,0.000036457015,0.00014150029,0.99713933,0.0000770162,0.00006900785,0.0012960944],"study_design_scores_gemma":[0.000048611706,0.0013415781,0.0026424408,0.0000038210546,0.000025746227,0.00009635478,0.000026104402,0.00037092107,0.99473745,0.00002353097,0.00068006,0.0000033907631],"about_ca_topic_score_codex":0.001218303,"about_ca_topic_score_gemma":0.0022420243,"teacher_disagreement_score":0.001276902,"about_ca_system_score_codex":0.00025458785,"about_ca_system_score_gemma":0.00027617105,"threshold_uncertainty_score":0.004271686},"labels":[],"label_agreement":null},{"id":"W2613957521","doi":"10.1007/s00262-017-2009-8","title":"Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2–4, 2016","year":2017,"lang":"es","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; National Cancer Institute; National Institutes of Health; Augusta University; Moffitt Cancer Center; Georgia Research Alliance","keywords":"Cancer; Medicine; Immunotherapy; Oncology; Internal medicine","score_opus":0.016149254965996056,"score_gpt":0.3240649541124184,"score_spread":0.30791569914642236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613957521","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049073804,0.25139594,0.0071735648,0.39464024,0.25008026,0.0009725374,0.0028585745,0.00040916447,0.043395903],"genre_scores_gemma":[0.15407096,0.14688833,0.009287355,0.033416107,0.20843543,0.00082975015,0.0061019976,0.00035038035,0.4406197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911815,0.00015960835,0.000048978098,0.00012316511,0.00023711778,0.00031304354],"domain_scores_gemma":[0.99854517,0.00008920205,0.00013398759,0.0000311912,0.00041622273,0.00078410446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033523361,0.0012410005,0.0007361601,0.0009344273,0.0014709606,0.0020758742,0.00081863767,0.0029574698,0.012528439],"category_scores_gemma":[0.001364861,0.00042965898,0.0006725986,0.0003797808,0.0005508192,0.0010135589,0.0017693359,0.0023775718,0.0035506545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018105182,0.00026134652,0.007072128,0.0006128114,0.00008855977,0.0007722325,0.00022907827,0.0004342385,0.0055416543,0.0007776863,0.8559721,0.1264276],"study_design_scores_gemma":[0.00014318261,0.00034727654,0.017345274,0.00040985414,0.00009460769,0.0007431716,0.0003616407,0.0003987036,0.0023268033,0.00077972346,0.9770188,0.00003109835],"about_ca_topic_score_codex":0.0033725759,"about_ca_topic_score_gemma":0.022651348,"teacher_disagreement_score":0.012528439,"about_ca_system_score_codex":0.0026141452,"about_ca_system_score_gemma":0.004389064,"threshold_uncertainty_score":0.04191184},"labels":[],"label_agreement":null},{"id":"W2618639283","doi":"10.1007/s00262-017-2022-y","title":"In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; CHU Sainte-Justine Foundation; Fondation Charles-Bruneau","keywords":"Plasmacytoid dendritic cell; Immunology; Progenitor cell; Adoptive cell transfer; Cord blood; Dendritic cell; Biology; Cell biology; Cancer research; Immune system; T cell; Stem cell","score_opus":0.01204124404371414,"score_gpt":0.271988107185373,"score_spread":0.2599468631416588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618639283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94522583,0.0064905514,0.039762612,0.00038120014,0.00027759245,0.0003339363,0.0013584308,0.00037588656,0.005793946],"genre_scores_gemma":[0.9813225,0.0023510645,0.012050493,0.00015885048,0.00004176391,0.00012231822,0.0010316517,0.00004867033,0.0028726715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997781,0.00006710527,0.000024903864,0.00003152419,0.00006474854,0.000033679633],"domain_scores_gemma":[0.99993885,0.0000134027705,0.000013824211,0.000011580474,0.000009728087,0.000012524296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001763198,0.00031443857,0.00032482084,0.00020551497,0.00010321712,0.00034974687,0.00018536304,0.0002655443,0.0008338467],"category_scores_gemma":[0.00009723911,0.00011150839,0.00022449641,0.00013080036,0.00015824598,0.000098550954,0.0002715248,0.00071066694,0.0004399532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004535461,0.000030379682,0.0000582872,0.000047563917,0.0000033026513,0.00003190313,0.00001326436,0.00010427089,0.9981305,0.00009332283,0.00004470322,0.0013972129],"study_design_scores_gemma":[0.000021545116,0.0002866809,0.00045741152,0.000005410435,0.000017140657,0.00011151901,0.000008567432,0.00052361155,0.99337596,0.00003366836,0.005156201,0.000002270843],"about_ca_topic_score_codex":0.00018702741,"about_ca_topic_score_gemma":0.00024991974,"teacher_disagreement_score":0.0008338467,"about_ca_system_score_codex":0.00019801383,"about_ca_system_score_gemma":0.00014408884,"threshold_uncertainty_score":0.0027894974},"labels":[],"label_agreement":null},{"id":"W2743368247","doi":"10.1007/s00262-017-2050-7","title":"Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Metastasis; FOLFOX; Medicine; Cancer research; Tumor microenvironment; T-cell receptor; CD3; Immune system; Pathology; Colorectal cancer; T cell; Immunology; CD8; Internal medicine; Cancer; Oxaliplatin","score_opus":0.010384367648902718,"score_gpt":0.21415733157229988,"score_spread":0.20377296392339717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743368247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876106,0.00027718153,0.000090693975,0.00004466028,0.000006825844,0.0000041983485,0.00004380833,0.000012951397,0.0007586996],"genre_scores_gemma":[0.9996699,0.000042111693,0.000027525939,0.00001668234,0.0000112077505,0.0000015789212,0.00004946063,0.000002071593,0.00017950777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999007,0.000014269339,0.0000065799304,0.000019323914,0.000018131492,0.00004104155],"domain_scores_gemma":[0.9998103,0.00003465792,0.00007145347,0.000016738406,0.000013721068,0.000053107105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009105845,0.0002198012,0.00024626267,0.00038329707,0.00027515448,0.00035345712,0.0001122568,0.0002548708,0.002010277],"category_scores_gemma":[0.00041274735,0.00015995081,0.0000898789,0.0002478524,0.000323749,0.00029302787,0.00017485116,0.0002896371,0.00029302982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028760023,0.00018367598,0.7926008,0.00008923916,0.000062615494,0.0076173116,0.00040210146,0.0002636153,0.17310889,0.00026806557,0.0006693467,0.021858318],"study_design_scores_gemma":[0.000045759796,0.00054000935,0.9773186,0.0000067804153,0.00005823459,0.012229449,0.00046374652,0.0007018142,0.007328756,0.0001740229,0.0011247182,0.000008227998],"about_ca_topic_score_codex":0.0008430937,"about_ca_topic_score_gemma":0.0014311969,"teacher_disagreement_score":0.002010277,"about_ca_system_score_codex":0.00019394742,"about_ca_system_score_gemma":0.00014022303,"threshold_uncertainty_score":0.006725073},"labels":[],"label_agreement":null},{"id":"W2766789916","doi":"10.1007/s00262-017-2070-3","title":"Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; European Hematology Association","keywords":"Immune system; Precursor cell; Lymphoblastic Leukemia; Lymphocyte; Immunology; Leukemia; Cell; Biology; Medicine; Genetics","score_opus":0.014368648762514332,"score_gpt":0.2812484459597366,"score_spread":0.26687979719722227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766789916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725753,0.0007557949,0.0005505509,0.000021202117,0.000008289671,0.000011177505,0.00023506695,0.000051490817,0.0011089433],"genre_scores_gemma":[0.9981775,0.000273746,0.00029826938,0.000030057734,0.000015296191,0.00002820974,0.00067201816,0.000018366707,0.00048648857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999522,0.00010220759,0.000031226595,0.000055476743,0.00012991963,0.00015927895],"domain_scores_gemma":[0.9988508,0.00045691023,0.0002824273,0.00008126981,0.00015164098,0.00017684387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000509516,0.0002568232,0.0004893095,0.0010348388,0.00021141455,0.0010244665,0.00032006874,0.00037134756,0.0012362383],"category_scores_gemma":[0.0018918692,0.0002507159,0.00017387043,0.0006172109,0.00036407585,0.00057524873,0.0004410986,0.0010482345,0.00047908572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066623217,0.0003529179,0.79638386,0.00013108815,0.00006491253,0.0010170648,0.00083515426,0.0009074826,0.14222942,0.0006179695,0.0009450172,0.04985282],"study_design_scores_gemma":[0.000018327679,0.0007167127,0.96290636,0.000019353642,0.000060086466,0.0015189219,0.00038848666,0.00060425134,0.03148496,0.00018797671,0.0020815432,0.000012971344],"about_ca_topic_score_codex":0.00071658095,"about_ca_topic_score_gemma":0.0008214129,"teacher_disagreement_score":0.0012362383,"about_ca_system_score_codex":0.00046312535,"about_ca_system_score_gemma":0.00025224348,"threshold_uncertainty_score":0.0041356087},"labels":[],"label_agreement":null},{"id":"W2767608780","doi":"10.1007/s00262-017-2088-6","title":"Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Isfahan University of Medical Sciences; Iran National Science Foundation","keywords":"FOXP3; Immune system; Tumor microenvironment; Immunology; Regulatory T cell; Immunotherapy; Myeloid-derived Suppressor Cell; Cancer research; Melanoma; Population; Biology; T cell; Medicine; IL-2 receptor; Suppressor; Cancer","score_opus":0.01189419720479676,"score_gpt":0.2530133189182112,"score_spread":0.24111912171341446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767608780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914085,0.0010770003,0.0046624183,0.00048601627,0.00024742496,0.0001244894,0.00027351378,0.00047602894,0.0012446014],"genre_scores_gemma":[0.9926214,0.0008131863,0.0028481062,0.00016893494,0.0000848846,0.00010746119,0.00033329873,0.000042672975,0.0029799917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980515,0.0000240459,0.0000110804285,0.000049240687,0.00004507497,0.000065502936],"domain_scores_gemma":[0.9998124,0.000025122825,0.00006979315,0.00002582928,0.000013430452,0.00005337328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021293058,0.0007794188,0.0004801121,0.0005416563,0.00017869846,0.00031528238,0.00040004056,0.00068757357,0.0013419937],"category_scores_gemma":[0.00015895237,0.00020506985,0.00031412664,0.00014071929,0.00048916374,0.00038287384,0.0001572072,0.0019340015,0.00032651983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012340758,0.0011996647,0.00017017954,0.00008259687,0.000014688151,0.00007286819,0.00001865407,0.00049445714,0.98953056,0.0003862385,0.00030454373,0.006491328],"study_design_scores_gemma":[0.000867212,0.011959305,0.0017762312,0.00003294899,0.000088785055,0.00048956653,0.000036907455,0.0045596277,0.97572255,0.0003800358,0.0040712,0.000015531825],"about_ca_topic_score_codex":0.00041343493,"about_ca_topic_score_gemma":0.0007119603,"teacher_disagreement_score":0.0013419937,"about_ca_system_score_codex":0.00030955512,"about_ca_system_score_gemma":0.00040987955,"threshold_uncertainty_score":0.004489422},"labels":[],"label_agreement":null},{"id":"W2782401996","doi":"10.1007/s00262-017-2112-x","title":"Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Cytotoxic T cell; Ascites; Cancer research; Ex vivo; Medicine; Interleukin 21; Immunotherapy; Interleukin 12; Lymphokine-activated killer cell; Immunology; Cancer; Immune system; Biology; In vivo; Internal medicine; T cell; In vitro","score_opus":0.008768739890157445,"score_gpt":0.2335281708471058,"score_spread":0.22475943095694836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782401996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978746,0.0005061751,0.00034274813,0.000033904795,0.000042840875,0.00001596328,0.000081946586,0.000015968106,0.0010858865],"genre_scores_gemma":[0.99809736,0.00014990759,0.00022338999,0.000045205685,0.00002616631,0.000016142689,0.00030547308,0.000006095229,0.0011301641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987805,0.000029304601,0.000010934332,0.0000243798,0.000018572982,0.000038644648],"domain_scores_gemma":[0.9998665,0.000054917517,0.000012162721,0.000023753028,0.000013418298,0.00002916091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011208672,0.00019793908,0.00034965688,0.00015023699,0.00013233794,0.00029685037,0.00012260418,0.00019791586,0.00352006],"category_scores_gemma":[0.00038830593,0.000102707556,0.00015920901,0.00009763744,0.00014825801,0.00024004134,0.00029392884,0.000492547,0.0005548021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003832108,0.0004481618,0.012450103,0.00014714818,0.00002978475,0.0007400833,0.00026961823,0.00040823343,0.9522518,0.00022575387,0.00074254425,0.028454669],"study_design_scores_gemma":[0.0014292441,0.011469277,0.18469249,0.000071386654,0.00031009602,0.01001482,0.0009605021,0.0055363425,0.7628392,0.00092240307,0.021709489,0.000044744902],"about_ca_topic_score_codex":0.00013476358,"about_ca_topic_score_gemma":0.00016021809,"teacher_disagreement_score":0.00352006,"about_ca_system_score_codex":0.00007471174,"about_ca_system_score_gemma":0.0001295568,"threshold_uncertainty_score":0.011775792},"labels":[],"label_agreement":null},{"id":"W2792466245","doi":"10.1007/s00262-018-2132-1","title":"Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?","year":2018,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Invariant (physics); Biology; Medicine; Immunology; Mathematics; Mathematical physics","score_opus":0.03965931903474021,"score_gpt":0.3080847991816112,"score_spread":0.26842548014687095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792466245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057933095,0.9961851,0.00014262412,0.0016564531,0.001385107,0.0000017378511,0.00001034403,0.000008742944,0.00055186363],"genre_scores_gemma":[0.0012451636,0.9922395,0.00022545375,0.002130223,0.0030091435,0.000005315297,0.00002969043,0.000003554013,0.0011119879],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974364,0.00005767318,0.000027026648,0.000041515723,0.00008723736,0.000042877018],"domain_scores_gemma":[0.9994129,0.00027538097,0.0000583143,0.00002547264,0.00013402067,0.00009393199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103654,0.00067895744,0.0012915947,0.0010192052,0.00036394675,0.0016184433,0.0011429769,0.0023860876,0.0035418842],"category_scores_gemma":[0.0015230248,0.00023404877,0.00032294227,0.0009094268,0.0011741599,0.0029268642,0.0011692435,0.0043462575,0.0022780197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011274598,0.00005008591,0.00019046897,0.0064383443,0.000049956725,0.00019644371,0.00007455409,0.00020054147,0.0013198289,0.009923108,0.1273484,0.8540956],"study_design_scores_gemma":[0.000013542719,0.000045580797,0.0001890917,0.0012795842,0.00003009163,0.0005862376,0.00004323948,0.000047269412,0.00016487809,0.0034840305,0.99410665,0.000009813518],"about_ca_topic_score_codex":0.0005154376,"about_ca_topic_score_gemma":0.0010992666,"teacher_disagreement_score":0.0035418842,"about_ca_system_score_codex":0.0006431496,"about_ca_system_score_gemma":0.0012627466,"threshold_uncertainty_score":0.011848807},"labels":[],"label_agreement":null},{"id":"W2888614982","doi":"10.1007/s00262-018-2231-z","title":"PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois","year":2018,"lang":"fr","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Immunodominance; Virology; Biology; Immune system; Immunology; T cell","score_opus":0.025520738549925176,"score_gpt":0.3199907870929124,"score_spread":0.2944700485429872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888614982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964851,0.009839658,0.004693506,0.006017883,0.00067824096,0.00003659347,0.00020912952,0.00019849405,0.0134754535],"genre_scores_gemma":[0.99284124,0.0012163633,0.0008744124,0.000601935,0.000073944684,0.000018552242,0.00004905077,0.000022140013,0.004302316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996507,0.00006235652,0.000017683979,0.0000799738,0.00007607973,0.00011331651],"domain_scores_gemma":[0.9997863,0.000031462125,0.00003995788,0.00002527561,0.0000307577,0.00008633774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038488122,0.0002739138,0.00041736968,0.00017549438,0.0005602359,0.0019371271,0.00028083334,0.0006209399,0.0036922777],"category_scores_gemma":[0.00057049404,0.00023430063,0.00027992047,0.000108920496,0.00072010723,0.0010715318,0.0006707707,0.002291135,0.0007974728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025276267,0.00043654547,0.0036586104,0.00027293578,0.00006456029,0.000298755,0.00025111288,0.0014718244,0.899665,0.019196222,0.0079182135,0.06423864],"study_design_scores_gemma":[0.00066035864,0.004494164,0.030256527,0.00019999688,0.00023861347,0.0020629757,0.0022629637,0.022895249,0.7728266,0.018797092,0.14520939,0.000096076394],"about_ca_topic_score_codex":0.00030769172,"about_ca_topic_score_gemma":0.00077602925,"teacher_disagreement_score":0.0036922777,"about_ca_system_score_codex":0.00060335844,"about_ca_system_score_gemma":0.000661438,"threshold_uncertainty_score":0.012351871},"labels":[],"label_agreement":null},{"id":"W2890134385","doi":"10.1007/s00262-018-2244-7","title":"Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"Novartis Pharma; Klaus Tschira Stiftung; Roche; Merck Sharp and Dohme; Bristol-Myers Squibb","keywords":"Nivolumab; Pembrolizumab; Antibody; Immunotherapy; Flow cytometry; PD-L1; Medicine; Immunology; T cell; Mass cytometry; Immune system; Cancer research; Biology; Phenotype; Biochemistry","score_opus":0.027958930338670026,"score_gpt":0.3176974800295449,"score_spread":0.28973854969087487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890134385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741123,0.0054394547,0.01055247,0.00027618784,0.00017713974,0.0001876712,0.0015448555,0.00031424037,0.007395662],"genre_scores_gemma":[0.99251163,0.00043515186,0.0038515849,0.00029361018,0.0000648015,0.00012950395,0.0010284991,0.000023750861,0.001661437],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987684,0.00031234033,0.000083581624,0.00027817878,0.000391304,0.00016613853],"domain_scores_gemma":[0.9994054,0.00027273005,0.00008662966,0.000072810486,0.00012749703,0.000035044035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000838712,0.0004618422,0.0005437176,0.0009569674,0.00033254718,0.0011974814,0.00035523926,0.0009191941,0.0013879586],"category_scores_gemma":[0.0018642676,0.00030012697,0.0002477024,0.00049621117,0.00025265,0.0003689475,0.0003080839,0.00083729974,0.0006871337],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057976106,0.00045072584,0.6977695,0.00037022165,0.00021450667,0.0007579584,0.0006647709,0.0028628507,0.14685826,0.00090995914,0.0040699327,0.13927369],"study_design_scores_gemma":[0.00018502705,0.0028443958,0.6712981,0.00018875954,0.0005665019,0.0058706305,0.0008947844,0.038395494,0.25210512,0.001705197,0.02587196,0.00007401918],"about_ca_topic_score_codex":0.000516836,"about_ca_topic_score_gemma":0.0007688016,"teacher_disagreement_score":0.0013879586,"about_ca_system_score_codex":0.00037856985,"about_ca_system_score_gemma":0.00022128977,"threshold_uncertainty_score":0.004643142},"labels":[],"label_agreement":null},{"id":"W2890982083","doi":"10.1007/s00262-018-2240-y","title":"International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Schweiz; Merck Sharp and Dohme; University of Toronto; Weill Cornell Medical College; Boehringer Ingelheim; Takeda Pharmaceuticals U.S.A.; University of Manchester; Fundación Ramón Areces; Roche; Merck; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Cancer immunotherapy; Cancer; Immunotherapy; Geography; Library science; Medicine; Computer science; Internal medicine","score_opus":0.027392093562318004,"score_gpt":0.3273475082277839,"score_spread":0.29995541466546594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890982083","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018503143,0.45525545,0.005212597,0.09588606,0.2588003,0.00048777,0.0038784468,0.00070683385,0.16126946],"genre_scores_gemma":[0.059241116,0.19134985,0.0053124847,0.008481211,0.08843917,0.00034536378,0.0053434214,0.0004168066,0.64107066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993135,0.00014628297,0.000030385623,0.000113321286,0.0001665631,0.00023006015],"domain_scores_gemma":[0.9991609,0.000084114654,0.000061804145,0.000019524843,0.00022871887,0.00044502743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020625854,0.0015580195,0.0009202268,0.0011422591,0.00065396324,0.0021541857,0.0007769472,0.0018763561,0.03938488],"category_scores_gemma":[0.0009185725,0.00027930093,0.0008885683,0.00053521624,0.0005394426,0.00086868345,0.0014983154,0.0024703178,0.013069486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015031842,0.00029657403,0.0007836618,0.0008462122,0.00007731764,0.00029102352,0.000058466034,0.00046181245,0.0035719983,0.0019019885,0.8190848,0.17112295],"study_design_scores_gemma":[0.00019158068,0.0004893673,0.0026773296,0.0005687733,0.000086995424,0.0004185852,0.000118464384,0.00037551267,0.0021595387,0.00095865375,0.99193716,0.000017940658],"about_ca_topic_score_codex":0.0018741606,"about_ca_topic_score_gemma":0.00432132,"teacher_disagreement_score":0.03938488,"about_ca_system_score_codex":0.0016122098,"about_ca_system_score_gemma":0.0029304049,"threshold_uncertainty_score":0.13175553},"labels":[],"label_agreement":null},{"id":"W2911882091","doi":"10.1007/s00262-019-02307-x","title":"Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Medicine; Melanoma; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Aldesleukin; Population; Adverse effect; Chemotherapy; Interleukin 2; Immune system; Internal medicine; Oncology; Immunotherapy; Gastroenterology; Phases of clinical research; Clinical trial; Immunology; Cancer research","score_opus":0.03161818977587048,"score_gpt":0.3569993678410537,"score_spread":0.3253811780651832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911882091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97775877,0.001020118,0.0018283945,0.00075788173,0.00027442558,0.014854682,0.0012563094,0.00018119422,0.0020683769],"genre_scores_gemma":[0.9595522,0.0013363084,0.0067212395,0.0014079934,0.00029664524,0.021984767,0.0032382768,0.000057289108,0.0054052947],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993849,0.00030277655,0.000025634472,0.00009725059,0.00006171233,0.00012776219],"domain_scores_gemma":[0.9990522,0.00013641767,0.00014296219,0.00012726772,0.00007684377,0.0004643195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024452659,0.002725467,0.0023711629,0.00060584093,0.0005672608,0.0010746471,0.0014388874,0.0016782273,0.003141093],"category_scores_gemma":[0.0013509007,0.0007001254,0.0009321701,0.0005373929,0.001370307,0.00079892745,0.0004864251,0.0045317304,0.00080354477],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5972289,0.22953305,0.0056697945,0.000695929,0.0009656725,0.00047766205,0.00045732138,0.005367614,0.07391715,0.0008490198,0.0058226953,0.07901511],"study_design_scores_gemma":[0.5423082,0.44493148,0.004223921,0.000020785534,0.00014325448,0.00016144676,0.000039098926,0.0017100747,0.0041798837,0.0002540545,0.002008334,0.000019381601],"about_ca_topic_score_codex":0.00093501114,"about_ca_topic_score_gemma":0.0018761142,"teacher_disagreement_score":0.003141093,"about_ca_system_score_codex":0.0011272781,"about_ca_system_score_gemma":0.0026567779,"threshold_uncertainty_score":0.012931943},"labels":[],"label_agreement":null},{"id":"W2917568543","doi":"10.1007/s00262-018-02297-2","title":"Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Bureau of Reclamation; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Universidade de São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo; International Centre for Genetic Engineering and Biotechnology","keywords":"Cytotoxic T cell; Adjuvant; DNA vaccination; CD8; Cancer research; Immunotherapy; Medicine; Immunology; Cancer immunotherapy; Immunization; Biology; Immune system; In vitro","score_opus":0.009125941024972349,"score_gpt":0.25588506563723684,"score_spread":0.24675912461226449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917568543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952873,0.00058256654,0.0019405076,0.00024049466,0.000149038,0.0000809466,0.00029058813,0.00013254753,0.0012961483],"genre_scores_gemma":[0.9937509,0.00049207907,0.0019536433,0.00007742571,0.0000613852,0.00008268109,0.0003906252,0.000036203943,0.003155087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945134,0.00011341824,0.00004637377,0.00009262719,0.000098528944,0.00019768458],"domain_scores_gemma":[0.9994005,0.00017283509,0.00013446414,0.00009720482,0.000045347664,0.00014957531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004786872,0.001020147,0.000599485,0.0008617128,0.0002715929,0.0006658298,0.00043715604,0.0009946579,0.0016577566],"category_scores_gemma":[0.00034279784,0.0003511186,0.0005877589,0.00022449427,0.00063715695,0.0006975676,0.00023702455,0.003108126,0.00053648266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008926457,0.0009192597,0.00012650523,0.00004529162,0.000010330252,0.00007365992,0.00003039605,0.00034402596,0.996119,0.00027490454,0.00009266643,0.001071325],"study_design_scores_gemma":[0.00017825572,0.0038556645,0.00075767713,0.000013689248,0.000037619648,0.00017923846,0.000027829874,0.0030316408,0.99081707,0.00011481166,0.0009780009,0.000008574702],"about_ca_topic_score_codex":0.00090418436,"about_ca_topic_score_gemma":0.0010364135,"teacher_disagreement_score":0.0016577566,"about_ca_system_score_codex":0.0006404314,"about_ca_system_score_gemma":0.0005133117,"threshold_uncertainty_score":0.0055457354},"labels":[],"label_agreement":null},{"id":"W2984698492","doi":"10.1007/s00262-019-02423-8","title":"Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); McGill University","funders":"Council of Scientific and Industrial Research, India","keywords":"Immunity; Immunology; Glioma; Medicine; Cancer research; Immune system","score_opus":0.0069972628262776285,"score_gpt":0.25426345212806556,"score_spread":0.24726618930178793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984698492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963146,0.0013173713,0.0008461677,0.000078519966,0.000027827644,0.00001765329,0.00008805198,0.000058323265,0.0012514669],"genre_scores_gemma":[0.99798214,0.00034409875,0.00024175004,0.000040091363,0.000022875678,0.00002126168,0.00007323533,0.000012541748,0.0012619621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998393,0.000032743792,0.0000076179135,0.000020416264,0.000027833988,0.00007198062],"domain_scores_gemma":[0.99990535,0.000011144045,0.000022419186,0.000011681499,0.0000100221305,0.00003942668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001214265,0.00024805832,0.00031590788,0.00030988108,0.00017094008,0.00031065906,0.00011322152,0.0002815408,0.0014570027],"category_scores_gemma":[0.00010095294,0.00011314545,0.00014961895,0.00013151423,0.00021044558,0.00015247757,0.00018629468,0.0007184494,0.00046643926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080851855,0.00011420646,0.0010453338,0.00005622304,0.0000073781653,0.00025000353,0.000028527527,0.000055045857,0.9940882,0.00020463156,0.00015464518,0.003187252],"study_design_scores_gemma":[0.00017680485,0.0020559384,0.028166981,0.000024747975,0.00006397856,0.0029796367,0.00026900272,0.0010022438,0.957838,0.00040818803,0.007004103,0.000010513807],"about_ca_topic_score_codex":0.00042274257,"about_ca_topic_score_gemma":0.0006069995,"teacher_disagreement_score":0.0014570027,"about_ca_system_score_codex":0.00015959478,"about_ca_system_score_gemma":0.000200556,"threshold_uncertainty_score":0.00487417},"labels":[],"label_agreement":null},{"id":"W2992202553","doi":"10.1007/s00262-019-02444-3","title":"CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Toronto General Hospital; University Health Network","funders":"Akdeniz Üniversitesi; Canadian Cancer Society","keywords":"PEG ratio; Cancer research; Metastasis; Knockout mouse; Chemistry; Pharmacology; Doxorubicin; Receptor; Cancer; Medicine; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.016275529285348145,"score_gpt":0.2576513516733622,"score_spread":0.24137582238801403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992202553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588853,0.0008157293,0.0014798578,0.00018744846,0.00006202801,0.000027982087,0.00023029919,0.00013102121,0.0011771685],"genre_scores_gemma":[0.9954045,0.00058213924,0.0012021929,0.0000579036,0.000014681919,0.000031879114,0.00024754013,0.00001827029,0.002440964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999902,0.0000150358555,0.0000064844667,0.000020287558,0.000023269939,0.000032935484],"domain_scores_gemma":[0.99992466,0.000012649086,0.000018781253,0.0000067584333,0.000005492241,0.000031615582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012432845,0.0004214405,0.00033085252,0.00025384183,0.00009897919,0.00016767945,0.00016810751,0.00039303923,0.0012460996],"category_scores_gemma":[0.00008220527,0.00013658797,0.00017075324,0.000120057804,0.00021905823,0.00026292377,0.00010765587,0.00087814534,0.00028839192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049809605,0.00012585244,0.000040007857,0.000027311258,0.000004631215,0.000038338705,0.000009404519,0.00009411037,0.9977982,0.00007375152,0.000096508586,0.0011937439],"study_design_scores_gemma":[0.00007186727,0.0010825866,0.0011089826,0.00000447786,0.000020747617,0.00011414509,0.000011396632,0.0011688144,0.99553156,0.000037316586,0.0008434824,0.0000044828635],"about_ca_topic_score_codex":0.0006561983,"about_ca_topic_score_gemma":0.0009519029,"teacher_disagreement_score":0.0012460996,"about_ca_system_score_codex":0.00027764926,"about_ca_system_score_gemma":0.00019797853,"threshold_uncertainty_score":0.0041686296},"labels":[],"label_agreement":null},{"id":"W2995658490","doi":"10.1007/s00262-019-02453-2","title":"The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies","year":2019,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Antibiotics; Internal medicine; Oncology; Meta-analysis; Observational study; Hazard ratio; Proportional hazards model; Confidence interval; Microbiology","score_opus":0.26229063664934493,"score_gpt":0.4919036307089502,"score_spread":0.22961299405960528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995658490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056472863,0.9931953,0.00038888236,0.00010268659,0.00011169625,0.00005850163,0.00037790628,0.0000121772555,0.000105576146],"genre_scores_gemma":[0.22655487,0.7686465,0.0020344038,0.0010305246,0.00031411365,0.0002639337,0.0008832654,0.000035163484,0.00023730408],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99019814,0.0039484915,0.0034037733,0.0012433002,0.0008719008,0.0003344456],"domain_scores_gemma":[0.97965276,0.01566724,0.003012716,0.0007072945,0.0007644185,0.00019555389],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010660605,0.0024245705,0.016130093,0.0033407027,0.00050726556,0.0029182893,0.0019304208,0.0024535647,0.0025621282],"category_scores_gemma":[0.028453203,0.0015190438,0.034082603,0.0053225784,0.00079026166,0.0017399681,0.001744878,0.0025804648,0.00024931974],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029934964,0.000029474715,0.009529784,0.20793256,0.7659888,0.00011880418,0.00006387093,0.00044233812,0.00027793154,0.00010294282,0.00048873544,0.012031155],"study_design_scores_gemma":[0.0005140891,0.00014422875,0.006728812,0.008685544,0.98242515,0.000075357464,0.00003868541,0.000115250914,0.000089519686,0.0001662685,0.0009948519,0.0000222649],"about_ca_topic_score_codex":0.0062110736,"about_ca_topic_score_gemma":0.01278501,"teacher_disagreement_score":0.9975754,"about_ca_system_score_codex":0.00142378,"about_ca_system_score_gemma":0.0024449076,"threshold_uncertainty_score":0.05637932},"labels":[],"label_agreement":null},{"id":"W3001385031","doi":"10.1007/s00262-019-02469-8","title":"Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stimulation; T cell; T-cell receptor; Cell biology; Isopentenyl pyrophosphate; Cytotoxic T cell; FOXP3; Interleukin 21; Chemistry; Biology; Molecular biology; In vitro; Immunology; Endocrinology; Immune system; Biochemistry; Pyrophosphate","score_opus":0.01003175425846067,"score_gpt":0.22530157818302873,"score_spread":0.21526982392456806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001385031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978676,0.0004908693,0.0007240318,0.000011697808,0.0000068421155,0.0000089322975,0.000061172475,0.000015438205,0.00081330165],"genre_scores_gemma":[0.99899656,0.00015999183,0.00032822025,0.000011519753,0.000010612918,0.000009031142,0.000103339684,0.000006000904,0.00037473728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983084,0.000031188025,0.000014998125,0.00003061438,0.000038099348,0.000054178705],"domain_scores_gemma":[0.9998596,0.000028554286,0.000031585714,0.000022256898,0.000015752024,0.0000423068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010602743,0.0003463733,0.00022329114,0.00016595253,0.00007878129,0.00037617664,0.00015384555,0.00012525101,0.0013178826],"category_scores_gemma":[0.00012322678,0.000091065485,0.00013288864,0.00011504082,0.00015869961,0.0001302177,0.00018943145,0.00042389243,0.00028705708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045302262,0.0000072647695,0.00028671254,0.0000091901,0.0000012549157,0.000013218759,0.000005186156,0.000016486067,0.9992353,0.000015954967,0.0000036258243,0.00036046177],"study_design_scores_gemma":[0.000013025169,0.0002928974,0.01261264,0.0000071413433,0.000016621278,0.00036140057,0.000050978433,0.0006154192,0.9853265,0.000050732782,0.00064934924,0.0000032490925],"about_ca_topic_score_codex":0.00014647136,"about_ca_topic_score_gemma":0.00015288623,"teacher_disagreement_score":0.0013178826,"about_ca_system_score_codex":0.000087783315,"about_ca_system_score_gemma":0.00011658924,"threshold_uncertainty_score":0.0044087768},"labels":[],"label_agreement":null},{"id":"W3006927029","doi":"10.1007/s00262-020-02514-x","title":"CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Ministerio de Ciencia Tecnología y Telecomunicaciones; Consejo Nacional de Ciencia y Tecnología; Health Research Board","keywords":"Granzyme B; Cancer research; Cisplatin; Cytotoxic T cell; Granzyme; CD1D; Medicine; Immunology; Perforin; Biology; Natural killer T cell; Internal medicine; Chemotherapy; T cell; Immune system; CD8; In vitro","score_opus":0.0075807622802303775,"score_gpt":0.20883242223657714,"score_spread":0.20125165995634675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006927029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723923,0.0014161161,0.00016674622,0.000088960915,0.0000140337215,0.000005091842,0.0002465207,0.000021460119,0.0008018476],"genre_scores_gemma":[0.99882096,0.00030710088,0.000092061324,0.00004599058,0.00001530246,0.0000061825644,0.00024357012,0.0000045839006,0.00046417306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998716,0.000023529854,0.000012899543,0.00003416802,0.000024577559,0.000033270437],"domain_scores_gemma":[0.9996939,0.000063501626,0.00014964718,0.000016063414,0.000028490942,0.000048458343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011189216,0.00027957186,0.00045967998,0.00055642606,0.0003045227,0.0004724388,0.00018295302,0.00038250844,0.001799776],"category_scores_gemma":[0.0006855204,0.0001561127,0.00023154532,0.00057534827,0.00024827127,0.0002627128,0.00022212644,0.00042152568,0.00027310074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004143271,0.0002146998,0.9219079,0.00015363407,0.0001624311,0.0015749263,0.00017809613,0.00016363435,0.03539798,0.00011899363,0.0012254893,0.03475889],"study_design_scores_gemma":[0.000023756025,0.0002462576,0.9939334,0.000010464466,0.00008946801,0.0019489055,0.00011131375,0.00020865975,0.0021614684,0.000101317724,0.0011585915,0.00000654503],"about_ca_topic_score_codex":0.0008003173,"about_ca_topic_score_gemma":0.0007101931,"teacher_disagreement_score":0.001799776,"about_ca_system_score_codex":0.00023392428,"about_ca_system_score_gemma":0.00012392213,"threshold_uncertainty_score":0.0060207844},"labels":[],"label_agreement":null},{"id":"W3008016882","doi":"10.1007/s00262-020-02507-w","title":"miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Natural Science Foundation of China","keywords":"Immune system; Immunotherapy; Cancer research; microRNA; Biology; Dendritic cell; Cancer immunotherapy; CD8; T cell; Breast cancer; Immunology; Cancer","score_opus":0.011127870903196665,"score_gpt":0.2752890135284139,"score_spread":0.2641611426252172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008016882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9471725,0.009813668,0.017926874,0.0013856083,0.0013824796,0.00021875619,0.0013490603,0.0010372538,0.01971372],"genre_scores_gemma":[0.9889665,0.0011123496,0.0027332462,0.0003411457,0.000064115025,0.000059651145,0.0005339713,0.00010069823,0.0060883085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962425,0.00004482468,0.000028856379,0.00009209003,0.00010923641,0.00010069532],"domain_scores_gemma":[0.9998753,0.000018608354,0.000032831278,0.000016940112,0.000027641987,0.000028651575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028299593,0.0002634703,0.00034429753,0.0002589325,0.0003492651,0.0007471706,0.00023915703,0.00041455872,0.003596814],"category_scores_gemma":[0.0004350268,0.00020760913,0.00034717878,0.00012905891,0.00024709455,0.00026431723,0.00036178986,0.001022302,0.0012647827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007047411,0.000106918706,0.0016419267,0.00014843103,0.000040994473,0.00014161078,0.00004609036,0.00041958108,0.9747268,0.0014714459,0.0015568557,0.01899458],"study_design_scores_gemma":[0.00014836292,0.0004887456,0.0066337013,0.000025236457,0.0001103318,0.0004075067,0.00007116834,0.0036147058,0.9525594,0.0006061759,0.035318222,0.000016303642],"about_ca_topic_score_codex":0.00033851442,"about_ca_topic_score_gemma":0.0005941171,"teacher_disagreement_score":0.003596814,"about_ca_system_score_codex":0.0004448271,"about_ca_system_score_gemma":0.0004095823,"threshold_uncertainty_score":0.012032509},"labels":[],"label_agreement":null},{"id":"W3010582098","doi":"10.1007/s00262-020-02543-6","title":"Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Emberi Eroforrások Minisztériuma","keywords":"Adverse effect; Medicine; Immune system; Immunotherapy; Malignancy; Oncology; Cancer; Internal medicine; Immune checkpoint; Odds ratio; Disease; Immunology","score_opus":0.014139684498317888,"score_gpt":0.25937998291350695,"score_spread":0.24524029841518905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010582098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850816,0.00058414286,0.00013274979,0.00004391862,0.000006288362,0.000006382073,0.0001550486,0.0000044870444,0.0005587312],"genre_scores_gemma":[0.9996784,0.00007889581,0.000037773378,0.000015532769,0.000009646263,0.0000028961174,0.00010137121,0.0000011822223,0.00007427249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993337,0.00018489681,0.00011248674,0.00011856948,0.00015178985,0.00009861887],"domain_scores_gemma":[0.99514306,0.0013139023,0.0026292678,0.00022848538,0.00025826666,0.00042696216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006513219,0.00010191816,0.00025017053,0.00044990497,0.00019603904,0.0003223403,0.00012715612,0.00020835656,0.0012852087],"category_scores_gemma":[0.0038342914,0.00008104256,0.00025424364,0.000522295,0.00015830575,0.00024050067,0.0002081977,0.00045877884,0.000113820046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028278475,0.000019006457,0.9968184,0.0000065640156,0.00003570902,0.00007970493,0.000013039819,0.00006235931,0.00045086662,0.000011341559,0.000043458065,0.0021766762],"study_design_scores_gemma":[0.0000037733864,0.00014445286,0.9989427,0.0000026934201,0.000026290269,0.00038705362,0.00001928205,0.0001259276,0.00017794239,0.000014485824,0.00015379289,0.0000016778428],"about_ca_topic_score_codex":0.00055210147,"about_ca_topic_score_gemma":0.0008043315,"teacher_disagreement_score":0.0012852087,"about_ca_system_score_codex":0.00018045679,"about_ca_system_score_gemma":0.000158062,"threshold_uncertainty_score":0.0042994022},"labels":[],"label_agreement":null},{"id":"W3014484249","doi":"10.1007/s00262-020-02555-2","title":"The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Institute of Infection and Immunity; Alberta Cancer Foundation","keywords":"CTLA-4; Immune system; Immune checkpoint; Prednisone; T cell; Dexamethasone; Immunotherapy; Medicine; Jurkat cells; Peripheral blood mononuclear cell; Immunology; Blocking antibody; Internal medicine; Cancer research; Endocrinology; Antibody; Biology; In vitro","score_opus":0.014411720080116605,"score_gpt":0.25882429723489464,"score_spread":0.24441257715477804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014484249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448675,0.0033796986,0.00031411383,0.00015698228,0.0001952186,0.000026165859,0.00019911147,0.000030093837,0.0012118614],"genre_scores_gemma":[0.99802834,0.00071548874,0.00017890068,0.00009310126,0.000049203554,0.000020654306,0.00010510881,0.0000057211532,0.0008034753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958414,0.00008154445,0.000019281684,0.00004640197,0.000080761245,0.00018783407],"domain_scores_gemma":[0.9997526,0.00006262403,0.00004828266,0.000027323784,0.00001358663,0.00009557834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017365307,0.00031100016,0.00040031408,0.00027335787,0.0001698481,0.0005618786,0.00020847621,0.0003662874,0.00201444],"category_scores_gemma":[0.00045451822,0.000119688026,0.00028471794,0.00022634091,0.00043800278,0.00029491325,0.00015277941,0.0011504513,0.00040074115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021077516,0.0008095319,0.003932755,0.00014503203,0.000059553957,0.00026821156,0.00012873093,0.0007315743,0.94022465,0.00037946284,0.0004745351,0.031768493],"study_design_scores_gemma":[0.0022456504,0.02886427,0.09214475,0.00007403416,0.0003581974,0.0014175335,0.00086581823,0.002566326,0.8582253,0.0008972661,0.012271773,0.000069068126],"about_ca_topic_score_codex":0.0005368965,"about_ca_topic_score_gemma":0.0012286596,"teacher_disagreement_score":0.00201444,"about_ca_system_score_codex":0.00029129285,"about_ca_system_score_gemma":0.00049733697,"threshold_uncertainty_score":0.0067389607},"labels":[],"label_agreement":null},{"id":"W3018744837","doi":"10.1007/s00262-020-02581-0","title":"Patients’ NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Immunology; Cytotoxic T cell; Lymphokine-activated killer cell; Cancer research; Cell therapy; Immune system; Medicine; Interleukin 21; Biology; T cell; Cell biology; Stem cell","score_opus":0.020592750593905636,"score_gpt":0.26859008891558334,"score_spread":0.2479973383216777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018744837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606293,0.00071023084,0.00022676824,0.00011283275,0.0001373509,0.000032506927,0.000165416,0.00004502788,0.0025068219],"genre_scores_gemma":[0.9971155,0.0002194178,0.00023480653,0.0000639494,0.000020024443,0.000026602078,0.0003298403,0.0000036990061,0.0019862596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978095,0.00004197487,0.000014194817,0.000033538283,0.000036350688,0.00009299131],"domain_scores_gemma":[0.99990785,0.000024111887,0.000009766409,0.0000090945205,0.000008444976,0.000040686155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013547957,0.00022242864,0.0004807789,0.00011434286,0.00021061821,0.0003338302,0.00011110177,0.00028048895,0.005574025],"category_scores_gemma":[0.00028740102,0.000097095406,0.0002072004,0.00007893974,0.00015776626,0.00017324819,0.00025646278,0.0009404939,0.00063768245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0115589835,0.0018108564,0.0060616047,0.00030706284,0.00007770335,0.00051356625,0.00020874091,0.00074836664,0.9283712,0.00061618164,0.0034748602,0.046250906],"study_design_scores_gemma":[0.0018031962,0.018650051,0.05013206,0.00006282744,0.00022881076,0.0031656164,0.0006857907,0.0044605494,0.89280576,0.00043956333,0.027525406,0.00004042391],"about_ca_topic_score_codex":0.0007016109,"about_ca_topic_score_gemma":0.0015590503,"teacher_disagreement_score":0.005574025,"about_ca_system_score_codex":0.00030227835,"about_ca_system_score_gemma":0.00045333238,"threshold_uncertainty_score":0.018646955},"labels":[],"label_agreement":null},{"id":"W3021482038","doi":"10.1007/s00262-020-02569-w","title":"Blockade of CD73 delays glioblastoma growth by modulating the immune environment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Cancer research; Immune system; Tumor microenvironment; Flow cytometry; CD8; Glioma; Microglia; Immunotherapy; Chemistry; Biology; Medicine; Immunology; Inflammation","score_opus":0.007885377117079236,"score_gpt":0.22015370897944256,"score_spread":0.21226833186236332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021482038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925346,0.0033860574,0.0016660346,0.0006537049,0.0001903084,0.00003143251,0.00014607672,0.00014790776,0.004525013],"genre_scores_gemma":[0.9957956,0.0011524212,0.000505661,0.00007955468,0.00003107614,0.000016466396,0.000072610615,0.000007534395,0.0023390898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999423,0.000006145451,0.0000025187328,0.000006537377,0.000011941568,0.00003058657],"domain_scores_gemma":[0.9999641,0.0000049823648,0.000008098938,0.0000027654712,0.0000036686608,0.000016377386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006142871,0.00025804085,0.00016831444,0.00015097209,0.00015731472,0.00033079355,0.00013760936,0.00018313926,0.002037788],"category_scores_gemma":[0.000094924675,0.00006297814,0.000098864395,0.0001313568,0.00018515017,0.00021823624,0.00010313722,0.00070898293,0.0002648394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015795339,0.00044014407,0.0005208874,0.000071821676,0.000018124087,0.00017962312,0.000018637715,0.00048415246,0.9617892,0.0011701277,0.0011117008,0.03261597],"study_design_scores_gemma":[0.0002439727,0.0034151727,0.0052773994,0.000017948334,0.000050080358,0.00043187742,0.00012204424,0.0027886017,0.975696,0.00069942896,0.011244627,0.000012806353],"about_ca_topic_score_codex":0.0008294015,"about_ca_topic_score_gemma":0.0026782942,"teacher_disagreement_score":0.002037788,"about_ca_system_score_codex":0.00032420488,"about_ca_system_score_gemma":0.0005027115,"threshold_uncertainty_score":0.0068171024},"labels":[],"label_agreement":null},{"id":"W3038890558","doi":"10.1007/s00262-020-02650-4","title":"Characterizing caspase-1 involvement during esophageal disease progression","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"H2020 Marie Skłodowska-Curie Actions; Deutsche Krebshilfe","keywords":"Pyroptosis; Inflammasome; Inflammation; Caspase 1; Chemokine; CXCL1; Caspase 3; Cancer research; Medicine; Stromal cell; Apoptosis; Cytokine; Immunology; Pathology; Biology; Programmed cell death","score_opus":0.011710374301018591,"score_gpt":0.2633210635259597,"score_spread":0.2516106892249411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038890558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600984,0.008081675,0.0034016278,0.00019862138,0.00004577899,0.000055181994,0.0003845185,0.00005888805,0.0017639664],"genre_scores_gemma":[0.9967334,0.0011672686,0.0009305512,0.000047593374,0.000012873585,0.000020642503,0.00024631256,0.0000051706656,0.0008361677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998447,0.000030888958,0.0000162612,0.000037221624,0.000025041898,0.000046006156],"domain_scores_gemma":[0.99986947,0.000022205155,0.00004351213,0.000018590243,0.000021902715,0.000024299048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037118932,0.00026373094,0.0002450111,0.00050359184,0.0001603477,0.0005591526,0.00018823234,0.00048791405,0.0016683373],"category_scores_gemma":[0.00027293077,0.00013767852,0.00030060663,0.00021084344,0.00026698038,0.00058504345,0.00025311174,0.0007149932,0.00042417904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017294561,0.00008347494,0.00899401,0.000116507625,0.00002174235,0.0005185516,0.00006699396,0.00016309237,0.9805549,0.000502913,0.00012147211,0.0071268743],"study_design_scores_gemma":[0.00012175849,0.0015707996,0.10665865,0.00004579532,0.00011119061,0.006393491,0.00036810263,0.0025576425,0.87441313,0.0013683456,0.006372146,0.00001887791],"about_ca_topic_score_codex":0.00012633127,"about_ca_topic_score_gemma":0.00016713895,"teacher_disagreement_score":0.0016683373,"about_ca_system_score_codex":0.00029796557,"about_ca_system_score_gemma":0.00013586134,"threshold_uncertainty_score":0.0055811405},"labels":[],"label_agreement":null},{"id":"W3047001933","doi":"10.1007/s00262-020-02684-8","title":"Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Axitinib; Nivolumab; Pembrolizumab; Medicine; Ipilimumab; Sunitinib; Internal medicine; Oncology; Avelumab; Adverse effect; Renal cell carcinoma; Tolerability; Discontinuation; Cancer; Immunotherapy","score_opus":0.10894403212116735,"score_gpt":0.35650736083602647,"score_spread":0.24756332871485912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047001933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051498255,0.9930138,0.00035934997,0.00018559369,0.00008222352,0.00015595324,0.0007896033,0.000016632996,0.00024708034],"genre_scores_gemma":[0.2726631,0.721303,0.0019361814,0.0010808337,0.00023503312,0.00083607866,0.0016129754,0.000033516422,0.00029936287],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9915418,0.004280607,0.0020012,0.0010330868,0.00087541045,0.00026801435],"domain_scores_gemma":[0.97870857,0.015030694,0.0039469455,0.0005984787,0.0014384784,0.00027684632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010492329,0.0018258013,0.0143506555,0.005730008,0.0005022091,0.0021943268,0.0019181999,0.0015620585,0.0039442154],"category_scores_gemma":[0.023811674,0.0009175958,0.027587974,0.008312465,0.0004974913,0.0014164277,0.0010855688,0.001397844,0.00027360138],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014016598,0.000027291695,0.007992818,0.3356797,0.64354205,0.00012414217,0.000062228,0.0005116047,0.00015242177,0.00012629991,0.0007727616,0.0096069705],"study_design_scores_gemma":[0.0005033822,0.00017749543,0.007127008,0.028241582,0.9615417,0.00012149715,0.00004028728,0.0002660145,0.000070644965,0.00017219484,0.0017145877,0.000023612987],"about_ca_topic_score_codex":0.009057986,"about_ca_topic_score_gemma":0.021419048,"teacher_disagreement_score":0.0143506555,"about_ca_system_score_codex":0.0023764286,"about_ca_system_score_gemma":0.003021093,"threshold_uncertainty_score":0.05548936},"labels":[],"label_agreement":null},{"id":"W3049758264","doi":"10.1007/s00262-020-02693-7","title":"Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Universität Zürich; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Fingolimod; Medicine; Pembrolizumab; Cancer; Multiple sclerosis; Immune system; Tumor-infiltrating lymphocytes; Avelumab; Ipilimumab; Melanoma; Immunotherapy; Oncology; Internal medicine; Immunology; Cancer research","score_opus":0.017191812970620744,"score_gpt":0.2719546069558567,"score_spread":0.254762793985236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049758264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977742,0.00071744964,0.00003446627,0.00011883216,0.0000095742325,0.000008637728,0.00009919892,0.0000044037834,0.0012332638],"genre_scores_gemma":[0.99936277,0.00020328847,0.00003972158,0.00010087743,0.000019256466,0.000005838953,0.00010707943,0.000001135975,0.00015993835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998878,0.00002870989,0.000013420799,0.000019473644,0.000020084792,0.00003040877],"domain_scores_gemma":[0.99977297,0.000053282427,0.00008407249,0.000008912262,0.000015479076,0.000065271604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014899227,0.0001404627,0.0002287735,0.00041728595,0.00036978367,0.00042585089,0.000096671625,0.00048749827,0.00090863777],"category_scores_gemma":[0.0006327656,0.00008788063,0.00021233961,0.0003840502,0.00011238542,0.00017977018,0.00010898844,0.0004632068,0.0001200965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004361975,0.00048617818,0.9533639,0.000054947664,0.000115524796,0.008950071,0.0004101565,0.00025981013,0.009293609,0.00016385877,0.0010340916,0.021505944],"study_design_scores_gemma":[0.00022353535,0.0017411358,0.9815247,0.000026952208,0.00011091106,0.010777964,0.00037967283,0.00067482516,0.0013655153,0.00018192006,0.002978015,0.000014743782],"about_ca_topic_score_codex":0.0011351996,"about_ca_topic_score_gemma":0.0013223793,"teacher_disagreement_score":0.0011351996,"about_ca_system_score_codex":0.00029842698,"about_ca_system_score_gemma":0.00018839104,"threshold_uncertainty_score":0.0030397177},"labels":[],"label_agreement":null},{"id":"W3090984746","doi":"10.1007/s00262-020-02728-z","title":"Anti-leukemia effect associated with down-regulated CD47 and up-regulated calreticulin by stimulated macrophages in co-culture","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; National Research Council Canada","funders":"","keywords":"CD47; Calreticulin; Lipopolysaccharide; Peripheral blood mononuclear cell; THP1 cell line; Macrophage; Immune system; Myeloid leukemia; Cell culture; Phagocytosis; Cancer research; Leukemia; In vitro; Tumor necrosis factor alpha; Myeloid; Chemistry; Immunology; Biology; Cell biology; Endoplasmic reticulum; Biochemistry","score_opus":0.007789410902745578,"score_gpt":0.2504423766042135,"score_spread":0.2426529657014679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090984746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938453,0.0019011748,0.0016393292,0.00020836426,0.00015583678,0.00003861257,0.00035173696,0.000067817535,0.0017918588],"genre_scores_gemma":[0.9875759,0.0011716991,0.0032726682,0.0001533298,0.0000931044,0.00010763426,0.00087410957,0.00004142245,0.0067101466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995826,0.000086974185,0.00003936801,0.00006514177,0.00007243447,0.00015349506],"domain_scores_gemma":[0.99983907,0.00003753138,0.000021310445,0.000034812027,0.000030275804,0.000036960435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025166984,0.00048663263,0.00063536136,0.00031133686,0.00024761644,0.00038769728,0.00028644496,0.0003390087,0.0018654242],"category_scores_gemma":[0.00013662588,0.0001781712,0.00043253868,0.00032151438,0.00024630985,0.00024820407,0.0003809241,0.0012759379,0.0009329662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073146564,0.000113194415,0.00013692085,0.00003758561,0.0000060663856,0.00007097476,0.000021437929,0.00003136208,0.997872,0.000065031665,0.00006263763,0.0008513268],"study_design_scores_gemma":[0.00006401533,0.0004603545,0.0025865089,0.000006037056,0.000019894653,0.00018570572,0.000029812627,0.0005702214,0.99392974,0.000033545395,0.002109259,0.000004894112],"about_ca_topic_score_codex":0.00053757656,"about_ca_topic_score_gemma":0.00076597516,"teacher_disagreement_score":0.0018654242,"about_ca_system_score_codex":0.00022343277,"about_ca_system_score_gemma":0.00032603115,"threshold_uncertainty_score":0.0062404275},"labels":[],"label_agreement":null},{"id":"W3093736638","doi":"10.1007/s00262-020-02701-w","title":"Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; National Institutes of Health","keywords":"Myeloid-derived Suppressor Cell; Tumor microenvironment; Pancreatic cancer; Cancer research; Immune system; Chemokine; STAT3; Myeloid; Stromal cell; Biology; Medicine; Immunology; Cancer; Suppressor; Signal transduction; Internal medicine; Cell biology","score_opus":0.01571391587852462,"score_gpt":0.2621415783990787,"score_spread":0.2464276625205541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093736638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970413,0.0007907915,0.000541204,0.00009062704,0.00006857394,0.000019947478,0.0001548276,0.0000553237,0.0012373871],"genre_scores_gemma":[0.99666303,0.00056530366,0.00043681782,0.00006491176,0.000021068056,0.0000373047,0.00033334855,0.000011207079,0.001867015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985194,0.000027494088,0.000010977448,0.000020262314,0.000028973898,0.000060339244],"domain_scores_gemma":[0.9999063,0.000027368726,0.000017162654,0.000013778643,0.000006386464,0.00002899007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017439644,0.00025117863,0.00033670603,0.00021635294,0.00011535466,0.00014546838,0.00012974485,0.00026657165,0.0022970724],"category_scores_gemma":[0.00011901336,0.00015425096,0.0003300819,0.00016798702,0.00022912562,0.00010338428,0.0001269049,0.00090744114,0.00036361383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009863772,0.00014526404,0.00019061664,0.000039153627,0.000006527471,0.000040961295,0.000014789471,0.000067485984,0.9972063,0.000040943836,0.00007599493,0.0011855488],"study_design_scores_gemma":[0.00012529283,0.003936079,0.0090211285,0.0000063594252,0.00004347578,0.0003000959,0.000045127883,0.0008210455,0.98374176,0.00004194692,0.0019119824,0.0000056927665],"about_ca_topic_score_codex":0.00034948604,"about_ca_topic_score_gemma":0.00048325377,"teacher_disagreement_score":0.0022970724,"about_ca_system_score_codex":0.00014941109,"about_ca_system_score_gemma":0.00022603857,"threshold_uncertainty_score":0.007684469},"labels":[],"label_agreement":null},{"id":"W311717631","doi":"10.1007/s00262-002-0343-x","title":"A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; Immunoconjugate; Medicine; Ovarian cancer; Internal medicine; Ovarian carcinoma; Gastroenterology; Adverse effect; Oncology; Cytotoxic T cell; Monoclonal antibody; Cancer; Myeloid leukemia; Antibody; Immunology; Chemistry","score_opus":0.01381652151134338,"score_gpt":0.2800756681982798,"score_spread":0.2662591466869364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W311717631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974685,0.0005003272,0.00027103294,0.00021763783,0.000047811835,0.0006895539,0.00014742723,0.000031470416,0.00062631955],"genre_scores_gemma":[0.99651897,0.0005476094,0.0005919079,0.00027950457,0.00007083622,0.00058450975,0.0004571788,0.000013919975,0.00093567016],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995604,0.0002139549,0.000018031016,0.000064665954,0.00004066221,0.00010229625],"domain_scores_gemma":[0.9994854,0.00010898598,0.000057990364,0.00006519578,0.000027264743,0.00025516446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012253813,0.0009587548,0.0020171343,0.0003762132,0.0005850019,0.00077401305,0.0005749325,0.0013040042,0.0018216287],"category_scores_gemma":[0.0009478005,0.0005302777,0.0008606255,0.0003703751,0.0008852299,0.00066488,0.00034548878,0.0024988437,0.00054947886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5033233,0.12083926,0.022803929,0.0006512915,0.0012165447,0.0018911901,0.0012098089,0.007099854,0.14553978,0.0006543487,0.0031285048,0.19164218],"study_design_scores_gemma":[0.2628774,0.69865173,0.02163905,0.000020256362,0.00038964237,0.001118748,0.00013859157,0.0022027155,0.009829536,0.00020399752,0.0028927668,0.000035582976],"about_ca_topic_score_codex":0.0018894667,"about_ca_topic_score_gemma":0.003048174,"teacher_disagreement_score":0.0020171343,"about_ca_system_score_codex":0.0010577509,"about_ca_system_score_gemma":0.001274773,"threshold_uncertainty_score":0.0076745152},"labels":[],"label_agreement":null},{"id":"W3120579476","doi":"10.1007/s00262-020-02823-1","title":"Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"CD8; Immunosenescence; Lung cancer; Immunology; Immune system; Medicine; Cytotoxic T cell; Cancer; Internal medicine; Oncology; Biology","score_opus":0.00831132474066344,"score_gpt":0.2774168532262508,"score_spread":0.2691055284855874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120579476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990553,0.00028507345,0.00004324743,0.000035375808,0.000009815005,0.0000026330204,0.00020086786,0.0000027812441,0.00036486477],"genre_scores_gemma":[0.9994747,0.000064433145,0.000028599263,0.000023453314,0.000013876017,0.000003671134,0.00017813804,8.3542676e-7,0.00021246815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998161,0.000036202095,0.00002570491,0.00003670471,0.000034767894,0.00005040857],"domain_scores_gemma":[0.9993462,0.0002353628,0.00019417533,0.000032925782,0.000067715155,0.00012359992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019530488,0.00022038876,0.00037239603,0.0006140443,0.00031822003,0.0006022551,0.00019976209,0.00047058638,0.0013243159],"category_scores_gemma":[0.0012091922,0.00016655859,0.0003049303,0.000719579,0.0001959811,0.000344007,0.00023587683,0.00073230476,0.00018834166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017824503,0.000020345653,0.99879587,0.000003953619,0.000021526377,0.00006844025,0.000016362885,0.000020652142,0.0002490531,0.000005856279,0.000028439734,0.0005912169],"study_design_scores_gemma":[0.000007254784,0.00010845526,0.9989511,0.0000027747787,0.000030286468,0.00028996574,0.00014313446,0.00019183065,0.00010303769,0.000025944133,0.00014350528,0.0000027484944],"about_ca_topic_score_codex":0.0017006949,"about_ca_topic_score_gemma":0.0021461016,"teacher_disagreement_score":0.0017006949,"about_ca_system_score_codex":0.00019981197,"about_ca_system_score_gemma":0.00021589815,"threshold_uncertainty_score":0.004430294},"labels":[],"label_agreement":null},{"id":"W3122051635","doi":"10.1007/s00262-021-02851-5","title":"Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Western University; University of Alberta; University of Toronto; Dalhousie University; University of British Columbia; University of Calgary; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Immunosuppression; Internal medicine; Psoriatic arthritis; Discontinuation; Context (archaeology); Rheumatology; Adverse effect; Cancer; Rheumatoid arthritis; Psoriasis; Polyarthritis; Arthritis; Oncology; Immunology","score_opus":0.03504324545533205,"score_gpt":0.3368035687868914,"score_spread":0.30176032333155933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122051635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982356,0.0028345983,0.00080890616,0.0016014442,0.00013632627,0.00011782537,0.00031646,0.0000438018,0.011784645],"genre_scores_gemma":[0.99651414,0.0010573838,0.00044581335,0.00066946534,0.0003200611,0.000015611204,0.00021025521,0.000015241893,0.0007520662],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9993241,0.00006914447,0.000102232574,0.00014620111,0.000132669,0.00022567625],"domain_scores_gemma":[0.99766505,0.0005747522,0.00051050266,0.00022339633,0.00024217617,0.00078421057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004141566,0.0010156101,0.00074129144,0.0016052948,0.0026276682,0.0012486879,0.0009674283,0.0024288462,0.0032639694],"category_scores_gemma":[0.0030940748,0.0006939651,0.0010985956,0.0012440592,0.0012624225,0.0012252406,0.001075194,0.0017771976,0.00067075534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005135991,0.00009425332,0.13162032,0.00003106592,0.00003468689,0.8639544,0.00029776036,0.00008381465,0.00045258531,0.00015494316,0.0010506014,0.002174139],"study_design_scores_gemma":[0.000009318542,0.00004121151,0.03450933,0.000015869738,0.000027534566,0.96410334,0.00032575664,0.00011505893,0.000120724784,0.000066843604,0.0006529878,0.000012097586],"about_ca_topic_score_codex":0.010316189,"about_ca_topic_score_gemma":0.017935233,"teacher_disagreement_score":0.9896838,"about_ca_system_score_codex":0.0019230419,"about_ca_system_score_gemma":0.0017407236,"threshold_uncertainty_score":0.020512283},"labels":[],"label_agreement":null},{"id":"W3132281503","doi":"10.1007/s00262-021-02884-w","title":"Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien; European Association of Urology; Universität Wien","keywords":"Medicine; Logistic regression; Proportional hazards model; Internal medicine; Oncology; Urothelial carcinoma; Neutrophil to lymphocyte ratio; Urology; Cancer; Gastroenterology; Lymphocyte; Bladder cancer","score_opus":0.006188259279066357,"score_gpt":0.24731278082606012,"score_spread":0.24112452154699376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132281503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989213,0.00044858115,0.00007373306,0.000028290404,0.000004282665,0.000007132927,0.0003739144,0.0000027650306,0.00013999538],"genre_scores_gemma":[0.99919826,0.00009772447,0.00007190525,0.000014720753,0.000011736599,0.0000073802157,0.000573795,0.0000014615342,0.000022991571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991492,0.0003098954,0.00011018187,0.00019710176,0.00017054987,0.000063081556],"domain_scores_gemma":[0.9969273,0.0006068532,0.0015906462,0.00026877606,0.00026094384,0.00034543007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015553677,0.0002576318,0.00046183428,0.0007415479,0.00023929047,0.0005647786,0.00037202524,0.00029492084,0.0005139161],"category_scores_gemma":[0.0033013206,0.00015144849,0.00048512022,0.0011348196,0.00024742764,0.0002856007,0.00052683527,0.00026389645,0.00010182558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010558351,0.000009715781,0.99886996,0.000007371426,0.00007394707,0.0000138828655,0.000019088722,0.00003149036,0.000089135625,0.0000030185324,0.000045576027,0.0007312384],"study_design_scores_gemma":[0.000014982802,0.000060526036,0.99934584,0.0000053157437,0.000054024964,0.0001383002,0.000045982237,0.00015470952,0.00006290695,0.0000047849608,0.0001101505,0.000002484018],"about_ca_topic_score_codex":0.0016366366,"about_ca_topic_score_gemma":0.002299104,"teacher_disagreement_score":0.0016366366,"about_ca_system_score_codex":0.00027759047,"about_ca_system_score_gemma":0.00029842043,"threshold_uncertainty_score":0.008225679},"labels":[],"label_agreement":null},{"id":"W3155027568","doi":"10.1007/s00262-021-02936-1","title":"A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Cancer Institute, University of Pittsburgh; National Cancer Institute; National Institutes of Health; Ovarian Cancer Research Fund; Roswell Park Cancer Institute; Ovarian Cancer Research Alliance","keywords":"Blockade; Medicine; Ovarian cancer; Immune checkpoint; Immunotherapy; Cancer immunotherapy; Context (archaeology); CD8; Cancer research; Oncology; Immunology; Cancer; Internal medicine; Immune system; Biology","score_opus":0.012406338624845248,"score_gpt":0.24840957037000375,"score_spread":0.2360032317451585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155027568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719873,0.0020069042,0.018182458,0.0006814295,0.00015146192,0.0003126525,0.0005161013,0.00047055283,0.005691225],"genre_scores_gemma":[0.98876256,0.00089402066,0.006995499,0.00011606486,0.00002268928,0.00012486319,0.00024821996,0.00003115501,0.0028050595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990284,0.000010890331,0.0000039235756,0.000016267079,0.000024585031,0.000041494386],"domain_scores_gemma":[0.99996793,0.0000047059298,0.000008090478,0.0000046887008,0.0000036426704,0.000010903678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016764236,0.0004265985,0.00028739445,0.00022419267,0.00015769724,0.0004123189,0.00023646656,0.00028575488,0.0021188566],"category_scores_gemma":[0.00009635779,0.00015841612,0.00018570747,0.00011930175,0.00023453799,0.0002905603,0.00032090224,0.0011186593,0.00041227782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064469,0.00055656687,0.0003600773,0.00008512445,0.00001853064,0.000067800625,0.000028312548,0.0020106689,0.964318,0.0026114366,0.0009653709,0.02833348],"study_design_scores_gemma":[0.00026246588,0.002968686,0.0010028646,0.000013531996,0.000050357172,0.00031742686,0.000039782957,0.006233267,0.9797763,0.00075058563,0.008573621,0.000011136522],"about_ca_topic_score_codex":0.00024383518,"about_ca_topic_score_gemma":0.0008928048,"teacher_disagreement_score":0.0021188566,"about_ca_system_score_codex":0.00026444122,"about_ca_system_score_gemma":0.000580708,"threshold_uncertainty_score":0.0070883036},"labels":[],"label_agreement":null},{"id":"W3164391832","doi":"10.1007/s00262-021-02953-0","title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Cystectomy; Biomarker; Lymph node; Bladder cancer; Oncology; Internal medicine; Lymphovascular invasion; Metastasis; Proportional hazards model; Urology; Cancer; Gastroenterology","score_opus":0.02685112807642974,"score_gpt":0.34695266755807463,"score_spread":0.3201015394816449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164391832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956065,0.00017101108,0.00007992343,0.000020746571,0.0000028378504,0.0000035961205,0.00007686118,0.0000027570256,0.000081499085],"genre_scores_gemma":[0.99977976,0.000025947684,0.000062059495,0.0000062642544,0.000005348391,0.0000029651655,0.00009709232,8.694995e-7,0.000019776076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940085,0.00022508357,0.000063259526,0.00011650107,0.0001098229,0.00008449767],"domain_scores_gemma":[0.9958228,0.0017004587,0.0014304647,0.00027958542,0.00025794815,0.00050868554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012571735,0.00022565268,0.0002958874,0.00035316258,0.0001835116,0.00052745856,0.0002508735,0.0002866526,0.0008278219],"category_scores_gemma":[0.004249689,0.00009198653,0.0004065173,0.00035666264,0.0003030147,0.00029833024,0.00036198823,0.00044667354,0.00012018597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009996606,0.000048498146,0.9956814,0.00001162307,0.00006286537,0.000037253678,0.000019975098,0.00023523143,0.00044546628,0.0000075046264,0.000036496527,0.0024140363],"study_design_scores_gemma":[0.000016739566,0.0004975826,0.9978448,0.000004647988,0.000059840277,0.0001872435,0.00003860897,0.00083754206,0.0003992869,0.000028636889,0.000080706865,0.0000044387807],"about_ca_topic_score_codex":0.0005627946,"about_ca_topic_score_gemma":0.00073010183,"teacher_disagreement_score":0.0012571735,"about_ca_system_score_codex":0.00031506992,"about_ca_system_score_gemma":0.00035388602,"threshold_uncertainty_score":0.0066486},"labels":[],"label_agreement":null},{"id":"W3179524201","doi":"10.1007/s00262-021-02975-8","title":"Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors","year":2021,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Cancer research; Lymphokine-activated killer cell; Cancer immunotherapy; Ex vivo; Tumor microenvironment; Natural killer cell; Cell therapy; Biology; Immunology; Interleukin 21; Interleukin 12; Cytotoxic T cell; Stem cell; T cell; In vivo; Immune system; In vitro; Cell biology; Tumor cells; Biotechnology","score_opus":0.053330679132548006,"score_gpt":0.35285999589876776,"score_spread":0.29952931676621974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179524201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009528109,0.9989309,0.00019651708,0.00014286822,0.00018221892,0.0000038177805,0.000012784629,0.000004962344,0.00043075497],"genre_scores_gemma":[0.0004961155,0.9984515,0.00025669325,0.00014188676,0.0001437985,0.000006491011,0.000029346547,0.0000015942109,0.00047257126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998017,0.000032254462,0.000022752662,0.000032680575,0.000089540204,0.000021089983],"domain_scores_gemma":[0.9996414,0.00018933638,0.000040243474,0.000010098183,0.00008622905,0.000032631022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091084157,0.0010084156,0.001285715,0.0015930086,0.0001830045,0.0010615016,0.00093793013,0.0010139173,0.0021836138],"category_scores_gemma":[0.00070217374,0.00025744323,0.00039902682,0.0015630323,0.0005124019,0.0013155349,0.00064784574,0.0024279314,0.0018338846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012966926,0.00009681485,0.00011805992,0.009271307,0.00005505066,0.00010749918,0.00003748694,0.0004153031,0.004295463,0.0038751266,0.019274585,0.96232367],"study_design_scores_gemma":[0.000045957622,0.00018327769,0.00060138904,0.002460724,0.000093577844,0.000866819,0.000039381386,0.00016034287,0.0017606954,0.0023095957,0.991454,0.00002425629],"about_ca_topic_score_codex":0.0006656478,"about_ca_topic_score_gemma":0.0013890979,"teacher_disagreement_score":0.0021836138,"about_ca_system_score_codex":0.00052706077,"about_ca_system_score_gemma":0.000785627,"threshold_uncertainty_score":0.007304907},"labels":[],"label_agreement":null},{"id":"W3186426676","doi":"10.1007/s00262-021-02982-9","title":"Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Ministry of Education, Science and Technology; National Research Foundation of Korea; National Research Foundation","keywords":"K562 cells; Cytotoxic T cell; Lymphokine-activated killer cell; Interleukin 21; Interleukin 12; Immunotherapy; Peripheral blood mononuclear cell; NK-92; Immunology; Cancer research; Biology; Cell culture; Molecular biology; Chemistry; Cell biology; In vitro; Immune system; Leukemia; Biochemistry","score_opus":0.01661279733867771,"score_gpt":0.25216604707919843,"score_spread":0.23555324974052072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186426676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982097,0.00018093934,0.00036226268,0.000042018954,0.000016924976,0.000056916255,0.000061826744,0.000029362169,0.0010399845],"genre_scores_gemma":[0.9986632,0.0001022135,0.0004144893,0.000045200777,0.000015276044,0.000035233974,0.00018622709,0.000007199835,0.000530937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997284,0.00006728354,0.00002723813,0.000051498515,0.00005371867,0.000071730814],"domain_scores_gemma":[0.9997912,0.00009500333,0.000013016604,0.000031639865,0.00002042202,0.000048814665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029743963,0.00030201997,0.000385786,0.00026954082,0.00029624786,0.00046662518,0.00019451746,0.00030184464,0.0019676632],"category_scores_gemma":[0.0004528105,0.00017789874,0.00026403865,0.00022042869,0.0002151555,0.00026983136,0.00028167022,0.0006780099,0.00034759624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026341465,0.00093411223,0.015422712,0.00006030492,0.000028025892,0.0010710355,0.0002984426,0.00039163156,0.96568674,0.0003089419,0.0003712569,0.012792665],"study_design_scores_gemma":[0.0012302736,0.016160253,0.11904335,0.000039857787,0.00027337813,0.013179554,0.0005043085,0.006979414,0.83294886,0.00033429186,0.009276654,0.000029814006],"about_ca_topic_score_codex":0.0004244118,"about_ca_topic_score_gemma":0.00043381154,"teacher_disagreement_score":0.0019676632,"about_ca_system_score_codex":0.00025834094,"about_ca_system_score_gemma":0.0002524995,"threshold_uncertainty_score":0.0065824986},"labels":[],"label_agreement":null},{"id":"W3199514812","doi":"10.1007/s00262-021-03051-x","title":"The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"Drs Martin and Dorothy Spatz Charitable Foundation","keywords":"CD47; Cytotoxic T cell; Cancer research; Mycosis fungoides; Immunotherapy; Immunology; Cutaneous T-cell lymphoma; Lymphoma; Medicine; Antibody; Biology; Immune system; In vitro","score_opus":0.015303673055613896,"score_gpt":0.30924680586576947,"score_spread":0.29394313281015555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199514812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93384147,0.048510518,0.0022371276,0.0010280522,0.00024869756,0.00007283244,0.00007317484,0.000053054126,0.01393509],"genre_scores_gemma":[0.9928731,0.0050131395,0.00047662668,0.00008712693,0.00009275764,0.000028603357,0.000022427128,0.000005127693,0.0014011002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979657,0.00008292042,0.000014947663,0.0000148436775,0.000030461955,0.000060216622],"domain_scores_gemma":[0.99988496,0.000040993884,0.000023635375,0.000015240497,0.000013289106,0.000021944537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000378223,0.00027920853,0.00033722725,0.00020399102,0.00027988444,0.00059893075,0.00014843413,0.00046272483,0.002334647],"category_scores_gemma":[0.0002931486,0.00010627705,0.00017795085,0.00006797335,0.00034267153,0.00056407816,0.00033198335,0.0006168792,0.0003992388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044307373,0.0004141979,0.005957227,0.0009445526,0.000040117593,0.0024947391,0.00026900013,0.0010893861,0.8212089,0.010386899,0.0013730518,0.15139115],"study_design_scores_gemma":[0.0012587716,0.008534375,0.06322734,0.00056188204,0.00038622413,0.019876035,0.0010989761,0.008378381,0.8048502,0.007881632,0.08389525,0.00005087961],"about_ca_topic_score_codex":0.00020597206,"about_ca_topic_score_gemma":0.00020050036,"teacher_disagreement_score":0.002334647,"about_ca_system_score_codex":0.00024087446,"about_ca_system_score_gemma":0.00035131484,"threshold_uncertainty_score":0.0078101754},"labels":[],"label_agreement":null},{"id":"W3200945286","doi":"10.1007/s00262-021-03059-3","title":"Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Cancer research; Radioresistance; Tumor microenvironment; STAT1; Head and neck squamous-cell carcinoma; Immune system; Immunotherapy; Biology; Cancer; Cancer cell; Cell; Immunology; Head and neck cancer; Medicine; Radiation therapy; Interferon; Internal medicine","score_opus":0.018780933229145952,"score_gpt":0.2955135721291337,"score_spread":0.2767326388999878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200945286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759114,0.0011105993,0.00023748602,0.00010531939,0.000039709743,0.000012167652,0.00014265893,0.000043228716,0.0007177526],"genre_scores_gemma":[0.99780244,0.00044782538,0.00017719044,0.000048471666,0.000008126457,0.000012051476,0.00026043615,0.0000069909483,0.0012364831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998691,0.000019155363,0.000008458109,0.000013395856,0.00003816255,0.000051771993],"domain_scores_gemma":[0.99993944,0.000011570701,0.0000132321875,0.0000100013895,0.000006500957,0.000019244751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015355917,0.00021997771,0.00027815983,0.0003027147,0.00018562585,0.00029617106,0.0002144581,0.00022666722,0.0021783009],"category_scores_gemma":[0.00014074988,0.00011528088,0.00025888314,0.00019300473,0.00027857968,0.0001792972,0.00014057498,0.0008220812,0.0004123348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015368246,0.00048577914,0.0015414607,0.00007479292,0.000027096625,0.000052977128,0.00002653138,0.00029046228,0.984511,0.00011408996,0.00041067298,0.010928254],"study_design_scores_gemma":[0.00020253709,0.005278324,0.037816007,0.00001817723,0.00012818091,0.0005312191,0.00016831509,0.0019418885,0.9485195,0.00017044634,0.0052100946,0.000015289956],"about_ca_topic_score_codex":0.0007297418,"about_ca_topic_score_gemma":0.0014699034,"teacher_disagreement_score":0.0021783009,"about_ca_system_score_codex":0.00029967318,"about_ca_system_score_gemma":0.00035521097,"threshold_uncertainty_score":0.0072872043},"labels":[],"label_agreement":null},{"id":"W3206590901","doi":"10.1007/s00262-021-03073-5","title":"Molecular imaging of cellular immunotherapies in experimental and therapeutic settings","year":2021,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Robarts Clinical Trials; Western University","funders":"","keywords":"Immune system; Ex vivo; Medicine; Cancer; Biodistribution; Immunotherapy; Cancer research; Bioinformatics; In vivo; Immunology; Biology; Internal medicine","score_opus":0.03297253149538901,"score_gpt":0.37100936070885276,"score_spread":0.3380368292134638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206590901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019612357,0.806784,0.13041691,0.003794462,0.0014154981,0.00025014588,0.00094650174,0.000865284,0.035914905],"genre_scores_gemma":[0.11759239,0.7515276,0.11015689,0.003705848,0.0011669807,0.0008824047,0.0014902491,0.00030642658,0.01317134],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993493,0.00020933466,0.00003809204,0.000117922464,0.0002163986,0.00006896985],"domain_scores_gemma":[0.99963737,0.0001680376,0.00005370661,0.000032029002,0.000079939855,0.000028801796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014954475,0.00067260116,0.0007680773,0.0012283091,0.00028096698,0.001394539,0.00083116064,0.0016724261,0.0026625644],"category_scores_gemma":[0.00090787275,0.00040879103,0.00055593497,0.000959879,0.0007787926,0.0015494352,0.000675174,0.0020406526,0.0014954366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003451883,0.00014776671,0.000548698,0.008729581,0.00014100576,0.0005681714,0.00024232455,0.0019789303,0.70313776,0.022413427,0.021067722,0.2406795],"study_design_scores_gemma":[0.000045579392,0.0005991266,0.002108218,0.0011562597,0.0001694218,0.003361516,0.00015247506,0.004256848,0.45430052,0.0054566218,0.52827215,0.00012126312],"about_ca_topic_score_codex":0.0006781165,"about_ca_topic_score_gemma":0.000622836,"teacher_disagreement_score":0.0026625644,"about_ca_system_score_codex":0.0009908727,"about_ca_system_score_gemma":0.0006011337,"threshold_uncertainty_score":0.008907199},"labels":[],"label_agreement":null},{"id":"W3214261499","doi":"10.1007/s00262-021-03072-6","title":"Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Higher Committee for Education Development in Iraq; KWF Kankerbestrijding","keywords":"Calreticulin; Endoplasmic reticulum; Unfolded protein response; Thapsigargin; Apoptosis; Cell biology; Extracellular; Flow cytometry; Programmed cell death; Biology; Cancer research; Chemistry; Molecular biology; Biochemistry","score_opus":0.010970727874084906,"score_gpt":0.27020247783225904,"score_spread":0.2592317499581741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214261499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421567,0.0025274942,0.0008519887,0.00008393655,0.000029819153,0.00005522076,0.0006233234,0.000023267141,0.0015892807],"genre_scores_gemma":[0.99311674,0.0012890155,0.0013976048,0.00008838067,0.000018229133,0.00008036599,0.0020492848,0.0000104570745,0.0019498436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999027,0.000010380285,0.000009802013,0.000015909432,0.000029922874,0.000031281717],"domain_scores_gemma":[0.9999205,0.00001758962,0.000016155711,0.000013935171,0.0000201889,0.0000115892435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097470554,0.00021754588,0.0003054124,0.00016433926,0.0001628494,0.0002262626,0.000076048935,0.00016755046,0.0011993673],"category_scores_gemma":[0.00011417789,0.00008988096,0.00023393231,0.00026519716,0.00010472088,0.000119171455,0.0001797491,0.0003850108,0.00033387696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037977452,0.000030420955,0.00076751545,0.00008958782,0.000008417983,0.00014002691,0.000051060306,0.000038197388,0.9965237,0.000036263853,0.00009492187,0.001840067],"study_design_scores_gemma":[0.000107177904,0.0008038417,0.05420201,0.000018522062,0.000037791207,0.0011203098,0.00013640113,0.0009827907,0.93504006,0.0000604742,0.0074811326,0.000009527433],"about_ca_topic_score_codex":0.00086374814,"about_ca_topic_score_gemma":0.0010452041,"teacher_disagreement_score":0.0011993673,"about_ca_system_score_codex":0.00029949553,"about_ca_system_score_gemma":0.00016727031,"threshold_uncertainty_score":0.0040122867},"labels":[],"label_agreement":null},{"id":"W3215213683","doi":"10.1007/s00262-021-03118-9","title":"MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lawson Health Research Institute; University of Victoria; Robarts Clinical Trials; University of British Columbia; Western University","funders":"National Health and Medical Research Council; Australian Research Council; Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Cancer Society; Canada Foundation for Innovation","keywords":"Cytotoxic T cell; Biology; CD8; Granzyme B; Tumor necrosis factor alpha; Immunology; Cytokine; Cancer research; Antigen","score_opus":0.02110291212026178,"score_gpt":0.2747592289003097,"score_spread":0.2536563167800479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215213683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849454,0.002038542,0.004117136,0.00018714751,0.00010375095,0.000055335106,0.00091828837,0.0002803061,0.0073540597],"genre_scores_gemma":[0.9859294,0.00045549468,0.002371227,0.00009379386,0.00008726606,0.000046139292,0.00095334527,0.000052483094,0.010010744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999853,0.00001813066,0.00000908993,0.000026047817,0.0000284022,0.00006539234],"domain_scores_gemma":[0.9996902,0.00004386724,0.00004481528,0.00004637592,0.000049085986,0.00012575518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106340005,0.00029293293,0.0002981116,0.0003872027,0.00030812324,0.0005968892,0.00013992118,0.00030991156,0.005639258],"category_scores_gemma":[0.00017900782,0.0001376339,0.0002315718,0.0001599856,0.00018417754,0.00041365647,0.00044519827,0.0010007542,0.002424137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005195166,0.000038608745,0.0011386246,0.00003530118,0.000004825782,0.00031313146,0.00006173844,0.00004566243,0.9947196,0.00028472254,0.00010577288,0.0027324604],"study_design_scores_gemma":[0.00006207292,0.0007246281,0.02895811,0.000018013327,0.000021095071,0.0019753436,0.0002931724,0.0011811998,0.95287883,0.00039898683,0.01347059,0.000017970877],"about_ca_topic_score_codex":0.0002773659,"about_ca_topic_score_gemma":0.00029691774,"teacher_disagreement_score":0.005639258,"about_ca_system_score_codex":0.00015691861,"about_ca_system_score_gemma":0.00015067599,"threshold_uncertainty_score":0.018865168},"labels":[],"label_agreement":null},{"id":"W4205468989","doi":"10.1007/s00262-021-03088-y","title":"Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; National Cancer Institute; Fundação para a Ciência e a Tecnologia; U.S. Food and Drug Administration; Swim Across America","keywords":"Oncolytic virus; Medicine; Cancer research; Melanoma; Immunotherapy; Immune system; FOXP3; Cytotoxic T cell; Immune checkpoint; Tumor microenvironment; Combination therapy; CD8; Immunology; Pharmacology; Biology","score_opus":0.026589077853391038,"score_gpt":0.3032453718668765,"score_spread":0.27665629401348546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205468989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996005,0.0002724044,0.0018377322,0.000087773304,0.00005603334,0.00004492232,0.00019220184,0.000093278926,0.0014106852],"genre_scores_gemma":[0.9957419,0.000119780736,0.0015935703,0.000030026798,0.000018228526,0.000047829773,0.0001554399,0.000024138259,0.0022689598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997824,0.000027172424,0.000013369271,0.000041993902,0.00006721918,0.00006787728],"domain_scores_gemma":[0.9999255,0.000008186451,0.000021639487,0.000007874162,0.0000054767643,0.000031287174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012234725,0.00035502226,0.00023428186,0.00030910567,0.0002035952,0.0002365234,0.00014106618,0.00036390702,0.0014045413],"category_scores_gemma":[0.000065292814,0.00013706824,0.00022912255,0.00012760176,0.00022935204,0.00024786472,0.00017757303,0.00080715393,0.00024396634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002238075,0.00009474464,0.000114178285,0.0000111451955,0.0000027380938,0.000045062217,0.000012305996,0.0000996544,0.9983524,0.0001418111,0.00006346457,0.00083863485],"study_design_scores_gemma":[0.000050804265,0.0009561665,0.0013720408,0.0000026637051,0.00001558469,0.00030760918,0.000032790027,0.0011044416,0.99396634,0.000075135904,0.0021121216,0.000004244966],"about_ca_topic_score_codex":0.0005764408,"about_ca_topic_score_gemma":0.00097140163,"teacher_disagreement_score":0.0014045413,"about_ca_system_score_codex":0.000204909,"about_ca_system_score_gemma":0.00023732008,"threshold_uncertainty_score":0.0046986938},"labels":[],"label_agreement":null},{"id":"W4214496408","doi":"10.1007/s00262-022-03169-6","title":"Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; National Center for Advancing Translational Sciences; Institute for Clinical and Translational Research, University of Wisconsin, Madison; National Cancer Institute; National Institutes of Health; ECOG-ACRIN Cancer Research Group; LUNGevity Foundation; Bristol-Myers Squibb; International Association for the Study of Lung Cancer","keywords":"Biology; Microbiome; Human microbiome; Immune system; Humanized mouse; Feces; Human Microbiome Project; Immunology; Microbiology; Bioinformatics","score_opus":0.020243961806006173,"score_gpt":0.2630004640901598,"score_spread":0.24275650228415363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214496408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926085,0.0008366499,0.0037464416,0.00021662412,0.000108705746,0.00009601679,0.0008043563,0.00014076117,0.0014419155],"genre_scores_gemma":[0.992105,0.0005231783,0.0026256316,0.00017515339,0.000026920345,0.00017428097,0.0006292928,0.00004945331,0.003691022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969804,0.00003952477,0.000012395187,0.00008614368,0.00006348494,0.0001003646],"domain_scores_gemma":[0.9998281,0.000016133281,0.000072184186,0.000020622385,0.000013493481,0.00004940952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001724135,0.00058176747,0.000319294,0.0006478646,0.00021897345,0.0005070572,0.0001612434,0.00043483582,0.0028382353],"category_scores_gemma":[0.00019732062,0.0002438526,0.00048560573,0.0002020435,0.0004263379,0.00026147734,0.00025206173,0.0011993719,0.00056479557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020041615,0.00041838983,0.0010659818,0.000043639273,0.000011417885,0.00006359294,0.00003501916,0.00014724449,0.9931151,0.00015682454,0.00014156733,0.0027970586],"study_design_scores_gemma":[0.00023162083,0.0055293655,0.020074531,0.000036754696,0.00009292658,0.00043765287,0.00039503438,0.0019995098,0.966811,0.00029818804,0.0040771235,0.000016368356],"about_ca_topic_score_codex":0.00030617448,"about_ca_topic_score_gemma":0.0010851258,"teacher_disagreement_score":0.0028382353,"about_ca_system_score_codex":0.00038018034,"about_ca_system_score_gemma":0.00034628116,"threshold_uncertainty_score":0.0094947815},"labels":[],"label_agreement":null},{"id":"W4220919246","doi":"10.1007/s00262-022-03159-8","title":"Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Merck KGaA; Pfizer","keywords":"Medicine; Refractory (planetary science); Cohort; Dosing; Avelumab; Adverse effect; Internal medicine; Open label; Surgery; Gastroenterology; Immunotherapy; Cancer; Nivolumab","score_opus":0.046444493886341906,"score_gpt":0.34590043743839666,"score_spread":0.29945594355205474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220919246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910546,0.0059489273,0.0004050547,0.0003572491,0.000045445406,0.0005299642,0.00064288714,0.00003593567,0.0009799389],"genre_scores_gemma":[0.9882979,0.005245407,0.0020994267,0.00066715595,0.00015038643,0.00065461907,0.00219343,0.00002771925,0.00066413713],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994386,0.00032631887,0.000045281067,0.00007069758,0.00006346192,0.00005562293],"domain_scores_gemma":[0.99870336,0.0003029269,0.0004812542,0.00010996448,0.000078761084,0.00032374312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018780617,0.00059039606,0.0011515844,0.00019114987,0.00019821916,0.0006126883,0.00053864805,0.00057653646,0.001865559],"category_scores_gemma":[0.001425687,0.00020557182,0.001029568,0.0003099922,0.0005542976,0.0005731614,0.00025665798,0.0021495188,0.0003986645],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5270219,0.032300554,0.04060722,0.0029748715,0.0038635477,0.0010675491,0.00089259853,0.0042630974,0.085939296,0.00069687626,0.01040935,0.28996313],"study_design_scores_gemma":[0.4887969,0.40805137,0.06620796,0.0002177131,0.0014710968,0.0031044877,0.00012600531,0.0020797453,0.013894022,0.00036636376,0.015626691,0.000057594174],"about_ca_topic_score_codex":0.00038142808,"about_ca_topic_score_gemma":0.0015440483,"teacher_disagreement_score":0.0018780617,"about_ca_system_score_codex":0.0007953581,"about_ca_system_score_gemma":0.0009261329,"threshold_uncertainty_score":0.00993228},"labels":[],"label_agreement":null},{"id":"W4248464463","doi":"10.1007/s00262-008-0564-8","title":"Progress in Vaccination against Cancer 2007 (PIVAC 7)","year":2008,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Trent University; British Society for Immunology; Nottingham Trent University","keywords":"Vaccination; Cancer; Medicine; Virology; Internal medicine","score_opus":0.02062129178391662,"score_gpt":0.32944676982050436,"score_spread":0.3088254780365877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248464463","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55683523,0.3328939,0.02812206,0.009726522,0.0054196664,0.0008185766,0.0017530755,0.0012014628,0.06322945],"genre_scores_gemma":[0.796557,0.13404992,0.018930694,0.0033567126,0.00087605004,0.0003194832,0.0051447777,0.00016273455,0.040602528],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996649,0.00006205384,0.000020701735,0.000055029323,0.00008905696,0.00010829578],"domain_scores_gemma":[0.9998406,0.000036962076,0.00002257396,0.000015981694,0.00004229886,0.00004159501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011061513,0.00044036756,0.0003895266,0.0006025927,0.00027843923,0.0010275092,0.00046389282,0.0008088933,0.0036485444],"category_scores_gemma":[0.0003167472,0.00023330863,0.00041594854,0.00030052924,0.0003975368,0.00044852763,0.0006010907,0.0014089678,0.0019647577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015342289,0.0008150894,0.0019383673,0.001535993,0.00010787542,0.00019607233,0.00013789872,0.0013730577,0.566309,0.010698356,0.015405235,0.39994884],"study_design_scores_gemma":[0.0002983174,0.0037954175,0.004790713,0.00027338485,0.00018947962,0.0011291703,0.0001077564,0.0015242943,0.5642144,0.001657307,0.42198583,0.000033949735],"about_ca_topic_score_codex":0.0014369902,"about_ca_topic_score_gemma":0.0013103618,"teacher_disagreement_score":0.0036485444,"about_ca_system_score_codex":0.00085403025,"about_ca_system_score_gemma":0.0014667099,"threshold_uncertainty_score":0.012205601},"labels":[],"label_agreement":null},{"id":"W4282977144","doi":"10.1007/s00262-022-03228-y","title":"Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Irish Research Council; Irish Research Council for Science, Engineering and Technology; Irish Research eLibrary","keywords":"Immune checkpoint; Immune system; Cancer research; Acidosis; Adenocarcinoma; Medicine; Internal medicine; Immunology; Cancer; Immunotherapy","score_opus":0.014016184611313641,"score_gpt":0.2539326952524399,"score_spread":0.23991651064112623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282977144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889719,0.0039533637,0.00092120824,0.000273724,0.00012680072,0.000074541735,0.0039644637,0.000038107206,0.0016758459],"genre_scores_gemma":[0.9931611,0.0013294659,0.0004920455,0.00020438421,0.000043534958,0.00008300164,0.0030368837,0.000008927713,0.0016405584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986947,0.0000242072,0.000011959593,0.00003637676,0.000026303267,0.00003166837],"domain_scores_gemma":[0.9999231,0.000013522242,0.000019634746,0.0000051879842,0.000016251173,0.00002233169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013332526,0.0002118187,0.00029173808,0.00030219913,0.00020041628,0.00038078902,0.00012731188,0.00025692486,0.0058049313],"category_scores_gemma":[0.0002467986,0.00010651781,0.00031497923,0.00027147512,0.00011357599,0.00013231297,0.00023637639,0.0005014292,0.00061270816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021471592,0.0004904893,0.15548816,0.0015849111,0.00032778244,0.0018953315,0.0007373421,0.0009218329,0.74575144,0.00031469547,0.0055260938,0.06549032],"study_design_scores_gemma":[0.00077200646,0.008239162,0.7548152,0.00024206267,0.00065843674,0.004759397,0.0022058657,0.0025297042,0.19773845,0.0007562835,0.027198961,0.00008429947],"about_ca_topic_score_codex":0.00071617065,"about_ca_topic_score_gemma":0.0007825322,"teacher_disagreement_score":0.0058049313,"about_ca_system_score_codex":0.00016755222,"about_ca_system_score_gemma":0.00014764363,"threshold_uncertainty_score":0.019419432},"labels":[],"label_agreement":null},{"id":"W4285083671","doi":"10.1007/s00262-022-03245-x","title":"Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Pfizer (Canada)","funders":"","keywords":"Antigen; Priming (agriculture); Immunology; Cancer immunotherapy; Immune system; Immunotherapy; Cytotoxic T cell; Cancer vaccine; Viral vector; DNA vaccination; Antibody; Biology; CD8; T cell; Virology; Medicine; Immunization; Recombinant DNA; In vitro","score_opus":0.024578786222986128,"score_gpt":0.2818643514443684,"score_spread":0.25728556522138224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285083671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97876817,0.0014812037,0.011182808,0.0003699585,0.00019815261,0.0015041577,0.0008191627,0.00025561353,0.005420708],"genre_scores_gemma":[0.982894,0.0012166862,0.009299532,0.00016117081,0.000059809365,0.00080493314,0.0016657127,0.00003864287,0.0038595272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978477,0.000051475297,0.000012007115,0.00003168668,0.000040067673,0.00008000977],"domain_scores_gemma":[0.99984765,0.000027586762,0.000028550268,0.000024065548,0.000022101573,0.000049994396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058886857,0.0004953811,0.00035979014,0.0003361643,0.00028018188,0.00041001514,0.0005764087,0.0004953966,0.002226497],"category_scores_gemma":[0.00028833473,0.00021158032,0.00028529073,0.00016950755,0.00029947696,0.00034540793,0.00018773119,0.0020741187,0.00046829635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004376101,0.010788981,0.0006925701,0.00027053885,0.00005493657,0.00008270647,0.00007462977,0.0049177525,0.9309784,0.0011350184,0.0012931708,0.045335203],"study_design_scores_gemma":[0.002549644,0.12377551,0.0029352217,0.000058970032,0.00014359041,0.0005118368,0.00004868794,0.0052638846,0.85247344,0.0003430162,0.01187802,0.000018245359],"about_ca_topic_score_codex":0.0006867822,"about_ca_topic_score_gemma":0.0009947025,"teacher_disagreement_score":0.002226497,"about_ca_system_score_codex":0.00032735578,"about_ca_system_score_gemma":0.000880665,"threshold_uncertainty_score":0.007448375},"labels":[],"label_agreement":null},{"id":"W4300972003","doi":"10.1007/s00262-022-03297-z","title":"Detecting monocyte trafficking in an animal model of glioblastoma using R2* and quantitative susceptibility mapping","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Innate immune system; CD16; Immune system; Medicine; Cancer research; Immunotherapy; Monocyte; Flow cytometry; Acquired immune system; Tumor microenvironment; Tumor progression; Glioma; Immunology; Cancer; CD8; Internal medicine; CD3","score_opus":0.05395765473774904,"score_gpt":0.31596423342840135,"score_spread":0.2620065786906523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300972003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535059,0.00056188146,0.042374752,0.0003265765,0.000050480074,0.00012553357,0.00035567538,0.0003223746,0.0023768726],"genre_scores_gemma":[0.963671,0.00057125126,0.030536273,0.00012322482,0.000028900973,0.00022773321,0.0002394813,0.00009450362,0.0045075547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996723,0.00006573639,0.0000137610805,0.000081956605,0.000046296696,0.00012013673],"domain_scores_gemma":[0.99969816,0.0000839634,0.000089197885,0.000044533594,0.000027846547,0.000056304863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006413015,0.00046043954,0.00030674625,0.0008072374,0.00030459443,0.00037363352,0.00034060044,0.0006472015,0.0016904355],"category_scores_gemma":[0.00023688175,0.00025554627,0.0002744594,0.00029713692,0.0005173482,0.00039376414,0.00034189897,0.0012079604,0.00036583876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051251636,0.00009707791,0.00037155006,0.000025965264,0.0000039932993,0.0001012729,0.00003742298,0.00019097253,0.99586135,0.00062745315,0.000078363,0.002092078],"study_design_scores_gemma":[0.000077310215,0.0009846848,0.003290538,0.0000092657165,0.000028539245,0.0005670792,0.00011746697,0.008085696,0.98455775,0.00041834736,0.0018386258,0.000024739207],"about_ca_topic_score_codex":0.0013034933,"about_ca_topic_score_gemma":0.0018495172,"teacher_disagreement_score":0.0016904355,"about_ca_system_score_codex":0.0003658109,"about_ca_system_score_gemma":0.00027712798,"threshold_uncertainty_score":0.00565511},"labels":[],"label_agreement":null},{"id":"W4308057718","doi":"10.1007/s00262-022-03313-2","title":"Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canada Research Chairs; Cancer Research Society","keywords":"CCL20; Radioresistance; Cancer research; Head and neck squamous-cell carcinoma; Immune system; Chemokine; Tumor microenvironment; Medicine; Flow cytometry; Immunotherapy; Immunology; Biology; Radiation therapy; Head and neck cancer; Internal medicine; Chemokine receptor","score_opus":0.022720418079313104,"score_gpt":0.2710689946598808,"score_spread":0.24834857658056772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308057718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429697,0.0012303219,0.0008168222,0.00020326972,0.00012605653,0.00006517648,0.0002681316,0.00019109104,0.00280211],"genre_scores_gemma":[0.99527824,0.0005233477,0.0005587667,0.000072832205,0.000020528852,0.000038243154,0.0002822695,0.000021324024,0.003204431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976915,0.000029668441,0.000010852363,0.000024070272,0.000055675617,0.00011059385],"domain_scores_gemma":[0.99992657,0.0000086275895,0.000013329389,0.000014303715,0.000007692991,0.000029404762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016917298,0.000296024,0.00033158038,0.0002463909,0.00020972487,0.00037875507,0.00027745156,0.00029532827,0.0036685995],"category_scores_gemma":[0.00013485627,0.00014057767,0.00029814374,0.00013132875,0.00026557568,0.00020468346,0.00019176105,0.00097021676,0.00075709814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005905766,0.00044356502,0.00042444494,0.000057371504,0.000015558195,0.00006129501,0.000029455981,0.00033327602,0.9912777,0.00036837277,0.00064514606,0.0057531605],"study_design_scores_gemma":[0.00018367577,0.003818315,0.0062017543,0.000010818588,0.00003609234,0.0003682334,0.000075754484,0.002168825,0.9780949,0.00012130598,0.008907646,0.000012765723],"about_ca_topic_score_codex":0.00093293685,"about_ca_topic_score_gemma":0.002606276,"teacher_disagreement_score":0.0036685995,"about_ca_system_score_codex":0.0003308604,"about_ca_system_score_gemma":0.0005047041,"threshold_uncertainty_score":0.012272716},"labels":[],"label_agreement":null},{"id":"W4309260043","doi":"10.1007/s00262-022-03329-8","title":"Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Cancer Society; London Health Sciences Foundation","keywords":"BTLA; Granzyme B; Transplantation; Immunology; T cell; Renal cell carcinoma; CD8; Medicine; Biology; Internal medicine; Immune system","score_opus":0.012756396693555133,"score_gpt":0.2449532232831614,"score_spread":0.23219682658960628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309260043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984463,0.0004388274,0.00034894518,0.00005707946,0.000055217468,0.000012718828,0.000027892982,0.00003128484,0.0005817329],"genre_scores_gemma":[0.9988085,0.00017106092,0.00024787267,0.000044690307,0.000022737431,0.0000124020635,0.000053475,0.0000055021283,0.0006338053],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989116,0.000017246894,0.0000053200906,0.000012424876,0.00002625577,0.000047618654],"domain_scores_gemma":[0.9998878,0.00001465793,0.00001949189,0.000014378285,0.000010173829,0.00005348686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012203544,0.00023818648,0.00038646164,0.00020235835,0.0002103517,0.00030037598,0.00012917367,0.00020973227,0.0010997137],"category_scores_gemma":[0.00023095131,0.00005881092,0.00022158619,0.00013806096,0.00022608574,0.00023024008,0.0001884065,0.0008983981,0.00021689119],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004258116,0.0014118933,0.0027121436,0.00008334454,0.000026232277,0.0005314621,0.00008457633,0.00024934628,0.9577369,0.00016256729,0.00025658097,0.03248675],"study_design_scores_gemma":[0.00047097803,0.026364326,0.0756027,0.00004003095,0.00020531676,0.0037918766,0.00045716867,0.004001985,0.8809554,0.00045721073,0.00762564,0.000027307822],"about_ca_topic_score_codex":0.00026183584,"about_ca_topic_score_gemma":0.00044913555,"teacher_disagreement_score":0.0010997137,"about_ca_system_score_codex":0.00018801098,"about_ca_system_score_gemma":0.00023680432,"threshold_uncertainty_score":0.0036788583},"labels":[],"label_agreement":null},{"id":"W4310154835","doi":"10.1007/s00262-022-03333-y","title":"Pharmacological potentiation of monocyte-derived dendritic cell cancer immunotherapy","year":2022,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Cancer immunotherapy; Dendritic cell; Tumor microenvironment; Cancer research; T cell; Medicine; Cancer; Immune system; Immunology; Internal medicine","score_opus":0.04885717410195012,"score_gpt":0.342480103968901,"score_spread":0.2936229298669509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310154835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018030549,0.9977731,0.00017090251,0.00017950631,0.0004129919,0.000009382218,0.000028496168,0.0000107538945,0.0012344938],"genre_scores_gemma":[0.0013842138,0.99647444,0.00019869505,0.00032851475,0.00032838006,0.000015509615,0.000068719906,0.0000025603451,0.0011989613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986804,0.000021319296,0.000015851938,0.000026137941,0.000047553658,0.000021077592],"domain_scores_gemma":[0.999858,0.00006162954,0.000023104994,0.0000063524985,0.000030942057,0.000019859028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004852934,0.0012505386,0.0016848112,0.0011310229,0.00020184055,0.0009908935,0.0009523429,0.0010919757,0.003266876],"category_scores_gemma":[0.0004984594,0.00031520872,0.00046387664,0.0012284548,0.000451805,0.00083617325,0.0005551401,0.002375835,0.0023591903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038393316,0.00020528444,0.00009699439,0.013712025,0.000112581576,0.00020314295,0.000026405149,0.00050126686,0.00634096,0.003895774,0.045060236,0.9294614],"study_design_scores_gemma":[0.00016516955,0.00035265702,0.0008666191,0.0021098868,0.00016728649,0.00084821106,0.000023447972,0.00018399056,0.0020011808,0.0019476629,0.99130625,0.000027736914],"about_ca_topic_score_codex":0.0007082111,"about_ca_topic_score_gemma":0.0014760147,"teacher_disagreement_score":0.003266876,"about_ca_system_score_codex":0.0005448839,"about_ca_system_score_gemma":0.0006540542,"threshold_uncertainty_score":0.01092875},"labels":[],"label_agreement":null},{"id":"W4328049217","doi":"10.1007/s00262-023-03413-7","title":"Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Institute for Research in Immunology and Cancer; Princess Margaret Cancer Centre","funders":"Scheme for Promotion of Academic and Research Collaboration; Terry Fox Research Institute","keywords":"Epitope; Antigen; Biology; Ovarian cancer; Tumor antigen; Antibody; Immunology; Cancer; Cancer research; Immunotherapy; Immune system; Genetics","score_opus":0.016909549630141064,"score_gpt":0.27719745910523813,"score_spread":0.26028790947509706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328049217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959258,0.00091424875,0.001307288,0.00004500734,0.0000064513238,0.000012999647,0.0014606129,0.0000259665,0.00030167418],"genre_scores_gemma":[0.9950936,0.000451981,0.002069534,0.00007225367,0.000011160125,0.000021887963,0.0018982292,0.000011201368,0.00037023824],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999355,0.0000092740265,0.000006213629,0.000019251027,0.000015391572,0.000014418999],"domain_scores_gemma":[0.9999186,0.00002203789,0.000025969804,0.000006701323,0.000015228268,0.00001145501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012283074,0.0001742525,0.00023904144,0.00067210814,0.00012883305,0.00039817113,0.00007011967,0.00016390468,0.00059313857],"category_scores_gemma":[0.0001923507,0.00007847313,0.00018792317,0.0004950046,0.0001013458,0.00013030662,0.00020354183,0.00020677883,0.00017037512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053730875,0.00003900741,0.08632798,0.00022640103,0.000071758535,0.0003483164,0.0001465841,0.00044534265,0.8991916,0.000050819774,0.00024906895,0.012365783],"study_design_scores_gemma":[0.000024831637,0.00037333716,0.8478239,0.00004458404,0.00018740927,0.0022849005,0.00076027686,0.009129593,0.13451675,0.0004047253,0.004428132,0.00002155715],"about_ca_topic_score_codex":0.000343987,"about_ca_topic_score_gemma":0.00051575486,"teacher_disagreement_score":0.00067210814,"about_ca_system_score_codex":0.00009286019,"about_ca_system_score_gemma":0.00008501996,"threshold_uncertainty_score":0.001984179},"labels":[],"label_agreement":null},{"id":"W4365813711","doi":"10.1007/s00262-023-03442-2","title":"Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L− effector memory cells while suppressing regulatory T cells, leading to long-term survival","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Leukemia; Adoptive cell transfer; Granzyme B; Immunology; Biology; CD8; Immune system; Interleukin 21; Cytotoxic T cell; IL-2 receptor; Granzyme; Cancer research; Molecular biology; T cell; Perforin","score_opus":0.027116800034224724,"score_gpt":0.30158481317946384,"score_spread":0.2744680131452391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365813711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884769,0.0009123934,0.006730734,0.00014152267,0.00013176566,0.000117138035,0.00059488567,0.00039027992,0.0025045134],"genre_scores_gemma":[0.99146956,0.00039801712,0.00280797,0.0000617018,0.000029870918,0.000066607914,0.00072733796,0.000049432,0.004389514],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997234,0.000034186745,0.000039201575,0.00004527315,0.0000766271,0.00008131072],"domain_scores_gemma":[0.9997838,0.000034130535,0.0000709431,0.00003653429,0.000015788957,0.000058843227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016701166,0.0006641482,0.00032749373,0.00043378217,0.00018889,0.00050727086,0.00022088882,0.0004912578,0.0014880798],"category_scores_gemma":[0.000119567114,0.00019616375,0.00042013606,0.00022200386,0.0002353534,0.0002791247,0.00027097578,0.001314841,0.000869437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017946685,0.00009460847,0.00012322125,0.000018293333,0.000006422035,0.0000454882,0.000015902833,0.00018428416,0.9979658,0.00015328801,0.000049836337,0.0011633486],"study_design_scores_gemma":[0.00004358329,0.00030053465,0.00061658584,0.000002774652,0.000013511302,0.00011606494,0.000008516996,0.0008120075,0.9965496,0.000053400894,0.0014803369,0.0000030145231],"about_ca_topic_score_codex":0.00028004326,"about_ca_topic_score_gemma":0.00041681938,"teacher_disagreement_score":0.0014880798,"about_ca_system_score_codex":0.000373809,"about_ca_system_score_gemma":0.0002357882,"threshold_uncertainty_score":0.00497818},"labels":[],"label_agreement":null},{"id":"W4384665022","doi":"10.1007/s00262-023-03486-4","title":"Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"Oncolytic virus; Measles virus; Antigen; CD8; Melanoma; Cancer research; Antigen presentation; Immune system; Biology; Tumor antigen; Cytotoxic T cell; Cell culture; T cell; Virology; Immunotherapy; Immunology; Measles; In vitro; Vaccination","score_opus":0.020831922032300092,"score_gpt":0.30938512561190995,"score_spread":0.28855320357960984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384665022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959971,0.00037388658,0.0015843362,0.000034045097,0.0000357837,0.000029486739,0.00012991301,0.000027098864,0.0017884757],"genre_scores_gemma":[0.9966438,0.0001480618,0.0006173464,0.000022516682,0.000008243838,0.000015737613,0.00018608356,0.000012066307,0.0023462595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998492,0.000020915006,0.000010882169,0.00002561353,0.000028058965,0.00006543451],"domain_scores_gemma":[0.99989533,0.000028279395,0.000020937385,0.000018052991,0.000011757056,0.00002553632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010806853,0.0002674846,0.00019054028,0.0001643413,0.00015043466,0.00034080393,0.00013438748,0.00021598258,0.0011294828],"category_scores_gemma":[0.00012409466,0.00012628501,0.0002440843,0.000111753,0.0001390671,0.00021985002,0.00022085806,0.0007615438,0.00037880288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011712476,0.000023961302,0.00016906418,0.000007774683,0.0000019408421,0.000026289148,0.000014413126,0.000040645467,0.99903166,0.00010940325,0.000014957608,0.00044284257],"study_design_scores_gemma":[0.00001908994,0.0002663665,0.002990819,0.000002969261,0.000009350027,0.00013843407,0.00004604668,0.00082888565,0.99432486,0.00007058043,0.0013005285,0.0000020929808],"about_ca_topic_score_codex":0.00048800875,"about_ca_topic_score_gemma":0.000513814,"teacher_disagreement_score":0.0011294828,"about_ca_system_score_codex":0.00032088146,"about_ca_system_score_gemma":0.0001767465,"threshold_uncertainty_score":0.0037784576},"labels":[],"label_agreement":null},{"id":"W4385442670","doi":"10.1007/s00262-023-03509-0","title":"Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Japan Society for the Promotion of Science; Nagoya City University","keywords":"Oncolytic virus; Interferon; Sting; Innate immune system; Immune system; Stimulator of interferon genes; Biology; Immunity; Tumor microenvironment; Cancer research; Immunotherapy; Immunology","score_opus":0.02208788827978729,"score_gpt":0.2857743054169383,"score_spread":0.263686417137151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381256,0.0013963252,0.0016078847,0.00035135425,0.0002632566,0.00010519549,0.0005189996,0.0002545487,0.0016898386],"genre_scores_gemma":[0.991285,0.0010916474,0.0017148812,0.00014457235,0.00007933826,0.00012276202,0.0004720531,0.00004801698,0.00504159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995566,0.000084088926,0.00003162692,0.00007298099,0.00008810159,0.00016669706],"domain_scores_gemma":[0.9996088,0.00006575655,0.00009679017,0.00005392489,0.000019657367,0.00015515661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003659136,0.0011142816,0.0006385433,0.0010825972,0.0002545847,0.00051523204,0.00044494538,0.00095438247,0.0016953358],"category_scores_gemma":[0.00019071823,0.00037335046,0.00070172956,0.00032608243,0.0005491742,0.0005296352,0.00017781123,0.0027239681,0.0005136937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018800478,0.0008714424,0.0001328794,0.000067574816,0.000014856836,0.00011228264,0.000023038714,0.00022056597,0.99466115,0.00018426587,0.00014738023,0.0016845394],"study_design_scores_gemma":[0.00034722357,0.007760942,0.0020186603,0.00002521639,0.00007695785,0.00028863692,0.00005840491,0.002054043,0.9852969,0.00011478382,0.0019417432,0.000016594471],"about_ca_topic_score_codex":0.0008382781,"about_ca_topic_score_gemma":0.001482047,"teacher_disagreement_score":0.0016953358,"about_ca_system_score_codex":0.0005203474,"about_ca_system_score_gemma":0.00042291384,"threshold_uncertainty_score":0.0056714416},"labels":[],"label_agreement":null},{"id":"W4387597413","doi":"10.1007/s00262-023-03520-5","title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","year":2023,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Toronto; Western University","funders":"Canadian Institutes of Health Research","keywords":"Colorectal cancer; Medicine; Immunotherapy; Oncology; Cancer; Internal medicine; Cancer research","score_opus":0.06282607383926041,"score_gpt":0.3628216248640533,"score_spread":0.29999555102479286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387597413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001313309,0.99812824,0.00013328322,0.0006376926,0.00020836211,0.000007858518,0.000015262563,0.0000085485335,0.0007294728],"genre_scores_gemma":[0.000838974,0.99749255,0.00023770363,0.0005158337,0.00024976567,0.000015783915,0.000034414996,0.0000019316083,0.0006130247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998313,0.00004347683,0.00002331992,0.000025032681,0.000058451984,0.000018395453],"domain_scores_gemma":[0.9997391,0.00012608548,0.0000344878,0.0000069435014,0.00006680396,0.000026528012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008187528,0.0006820139,0.0011036409,0.001358522,0.00021343346,0.00096782146,0.00079167145,0.0010644114,0.0029528558],"category_scores_gemma":[0.0007153054,0.00026588605,0.00051997724,0.001103548,0.00033210745,0.0015928654,0.0006675495,0.0025403572,0.001708243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105453575,0.0001067067,0.00012418277,0.009044084,0.00008222043,0.00013726129,0.000040490402,0.00042691798,0.00097219157,0.0039825044,0.033318415,0.95165956],"study_design_scores_gemma":[0.000052190975,0.00021336533,0.0004156405,0.0031768868,0.00011577086,0.0007806976,0.000042196225,0.00021037618,0.00041073252,0.0020655126,0.99249953,0.000017050508],"about_ca_topic_score_codex":0.0006351265,"about_ca_topic_score_gemma":0.0015907979,"teacher_disagreement_score":0.0029528558,"about_ca_system_score_codex":0.00048477424,"about_ca_system_score_gemma":0.00085027923,"threshold_uncertainty_score":0.009878218},"labels":[],"label_agreement":null},{"id":"W4390963940","doi":"10.1007/s00262-023-03593-2","title":"Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Cancer Institute; Sanofi","keywords":"Pembrolizumab; Medicine; Melanoma; Aflibercept; Oncology; Internal medicine; Adverse effect; Immune system; Combination therapy; Immunology; Gastroenterology; Immunotherapy; Cancer research; Bevacizumab; Chemotherapy","score_opus":0.009877809274415455,"score_gpt":0.2785006858800478,"score_spread":0.26862287660563233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390963940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974573,0.0017988893,0.0001145094,0.00007920353,0.000010795224,0.000070806294,0.000049048333,0.000006736821,0.00041261793],"genre_scores_gemma":[0.99889,0.00048046195,0.00025919089,0.000096216136,0.000027275019,0.000030314812,0.00010548145,0.0000016437979,0.00010951831],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978215,0.00008744454,0.000017656324,0.000045305354,0.00003168076,0.000035828518],"domain_scores_gemma":[0.9997129,0.00007453206,0.00007663265,0.000012284304,0.000015962472,0.00010763828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006247247,0.00036074562,0.00087406824,0.00023506432,0.00026604757,0.0003250492,0.000208211,0.0003293448,0.0006859027],"category_scores_gemma":[0.0006926899,0.0001939844,0.00036458086,0.00022212835,0.00018574996,0.00021924295,0.0001228196,0.00056629005,0.00016745256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08905684,0.005800748,0.6264181,0.0007099596,0.0011500979,0.004047308,0.0007248559,0.0017650322,0.1085073,0.00018963075,0.0019827895,0.15964738],"study_design_scores_gemma":[0.015509833,0.11585981,0.83912647,0.00009889002,0.0012660857,0.011000122,0.0002799818,0.0044829096,0.006634271,0.00017027209,0.0055315513,0.0000398045],"about_ca_topic_score_codex":0.00049621874,"about_ca_topic_score_gemma":0.00093202974,"teacher_disagreement_score":0.00087406824,"about_ca_system_score_codex":0.0003004648,"about_ca_system_score_gemma":0.00028884568,"threshold_uncertainty_score":0.003303945},"labels":[],"label_agreement":null},{"id":"W4391786157","doi":"10.1007/s00262-023-03623-z","title":"INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"MacroGenics; AstraZeneca; Eli Lilly and Company; Astellas Pharma; Bristol-Myers Squibb","keywords":"Tremelimumab; Medicine; Tolerability; Discontinuation; Adverse effect; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cancer; Phases of clinical research; Clinical trial; Immunotherapy; Ipilimumab","score_opus":0.023970639687783277,"score_gpt":0.34388055676956547,"score_spread":0.3199099170817822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391786157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866215,0.0013490513,0.00095387705,0.00045189966,0.00013293,0.0073631294,0.0013874257,0.00013672338,0.001603422],"genre_scores_gemma":[0.9754995,0.0016777249,0.003967202,0.0012408815,0.00036614854,0.009512063,0.002541004,0.000062324514,0.005133081],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995059,0.00023977878,0.000023328144,0.00007252078,0.00005312087,0.00010535742],"domain_scores_gemma":[0.9995111,0.000069829635,0.00010527732,0.000050895047,0.000035010526,0.00022778797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020201355,0.0020668723,0.0020389645,0.000663488,0.00049233646,0.000996406,0.0008219833,0.001280073,0.0045719454],"category_scores_gemma":[0.00080468226,0.00076869794,0.00122941,0.00039959254,0.0008585553,0.0011400187,0.0004398943,0.0029355492,0.0010415725],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58755034,0.23300351,0.004957959,0.0012189118,0.00093233585,0.00036726444,0.00040619334,0.0029594062,0.0835363,0.000466564,0.0038579516,0.080743335],"study_design_scores_gemma":[0.45838302,0.5264146,0.0056326417,0.000022316462,0.00023655895,0.00023408797,0.000047085712,0.0008845322,0.005059732,0.00014804985,0.0029093088,0.00002808454],"about_ca_topic_score_codex":0.00051764457,"about_ca_topic_score_gemma":0.0014402192,"teacher_disagreement_score":0.0045719454,"about_ca_system_score_codex":0.000915835,"about_ca_system_score_gemma":0.0016546714,"threshold_uncertainty_score":0.015294671},"labels":[],"label_agreement":null},{"id":"W4393343265","doi":"10.1007/s00262-024-03654-0","title":"Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"National Institute for Health and Care Research; Boehringer Ingelheim","keywords":"Medicine; Adverse effect; Pharmacokinetics; Internal medicine; Maximum tolerated dose; Gastroenterology","score_opus":0.009003923693406368,"score_gpt":0.3100422142431986,"score_spread":0.30103829054979225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393343265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855881,0.0122577185,0.00029719886,0.00026352465,0.00002299892,0.00013506676,0.00020598716,0.000020862219,0.0012084943],"genre_scores_gemma":[0.99530584,0.0032547228,0.00043792865,0.00019014727,0.000031339987,0.000057444777,0.00044573547,0.0000030042615,0.00027383532],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998216,0.00006447999,0.00001940321,0.000029483694,0.000038331,0.0000266366],"domain_scores_gemma":[0.999728,0.00008538413,0.00008123561,0.000009250235,0.000026788379,0.00006924886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007225206,0.00024665275,0.0004859415,0.00016440195,0.00017298292,0.00028760606,0.00018732887,0.00020201769,0.0006283006],"category_scores_gemma":[0.00053672644,0.00009023495,0.00023678895,0.0002900801,0.00020197858,0.00021997665,0.00017334668,0.00045677656,0.00017432412],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057123434,0.0034807462,0.25465164,0.0024813563,0.00062358513,0.0016218271,0.0005235414,0.0052769114,0.059957214,0.0002522576,0.006833782,0.60717374],"study_design_scores_gemma":[0.037622064,0.17138542,0.70296997,0.0004682733,0.0011351835,0.009786043,0.00037492404,0.0067517357,0.025798649,0.00055497146,0.04309272,0.00005996991],"about_ca_topic_score_codex":0.00068954355,"about_ca_topic_score_gemma":0.0017568944,"teacher_disagreement_score":0.0007225206,"about_ca_system_score_codex":0.00048036498,"about_ca_system_score_gemma":0.00056382956,"threshold_uncertainty_score":0.0038211346},"labels":[],"label_agreement":null},{"id":"W4400242698","doi":"10.1007/s00262-024-03746-x","title":"Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Colorectal cancer; Correlation; Chemokine; Receptor; Oncology; Internal medicine; Outcome (game theory); Medicine; Cancer research; Cancer; Immunology; Mathematics","score_opus":0.011248347935053846,"score_gpt":0.2606225179786767,"score_spread":0.24937417004362283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400242698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998587,0.0007578378,0.00011810748,0.000026221924,0.000005320432,0.0000045460697,0.0001554381,0.000006769692,0.00033869338],"genre_scores_gemma":[0.9994585,0.00013931637,0.00007251629,0.000014629519,0.000008525807,0.000004775152,0.00019543416,0.0000011756948,0.00010507519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997805,0.00004311084,0.000026651134,0.000061971055,0.000049097252,0.000038680584],"domain_scores_gemma":[0.9994281,0.00011186743,0.00029454066,0.000029081126,0.00006143512,0.000074909614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002570432,0.0001839164,0.00032260007,0.00052511663,0.00015027322,0.00037618255,0.00009342944,0.00028494495,0.00045882782],"category_scores_gemma":[0.0010182259,0.000081695434,0.00021271771,0.00051009207,0.0001543669,0.00020415855,0.00017070798,0.00024753762,0.00010366978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007010017,0.000026730339,0.99367756,0.0000170747,0.000047684025,0.00010128034,0.000025072086,0.000081055114,0.0017297966,0.000009442045,0.000048096303,0.0035352556],"study_design_scores_gemma":[0.000005789397,0.00018732039,0.99872786,0.000003008106,0.000033301923,0.0003408543,0.000038990183,0.00021117211,0.00026453592,0.000017200216,0.00016716961,0.000002846535],"about_ca_topic_score_codex":0.0006348953,"about_ca_topic_score_gemma":0.00080193154,"teacher_disagreement_score":0.0006348953,"about_ca_system_score_codex":0.00020730829,"about_ca_system_score_gemma":0.00013388455,"threshold_uncertainty_score":0.0015349388},"labels":[],"label_agreement":null},{"id":"W4400266836","doi":"10.1007/s00262-024-03740-3","title":"Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Karolinska Institutet; Cancerfonden; Memorial Sloan-Kettering Cancer Center","keywords":"Treosulfan; Mesothelin; Fludarabine; Cancer research; Ovarian cancer; Medicine; Immunology; Antigen; Cancer; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.017341642191132958,"score_gpt":0.33033527995686185,"score_spread":0.3129936377657289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400266836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977488,0.0007407733,0.00046708848,0.00002869835,0.0000145828935,0.000023458946,0.00015386521,0.0000146101775,0.0008080338],"genre_scores_gemma":[0.99759823,0.00032447968,0.00058032153,0.00003462378,0.000006796429,0.000023293615,0.00029855064,0.0000052596924,0.0011284916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989295,0.000028575509,0.000009653579,0.000018733359,0.000023120128,0.000026980977],"domain_scores_gemma":[0.99993956,0.0000140568745,0.000012732786,0.0000086462915,0.000009299625,0.00001565689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079122125,0.00025944973,0.00021030738,0.00008062831,0.000074208096,0.00014148094,0.000113274335,0.00015871081,0.00092946505],"category_scores_gemma":[0.00009224583,0.000051037332,0.00017269287,0.000067260014,0.00007645009,0.00010859288,0.00009421666,0.00021116213,0.00016395439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043473166,0.000051987292,0.00034460725,0.000033245542,0.000007834713,0.00006105333,0.00001800959,0.00019942682,0.99676114,0.000054934142,0.00004092353,0.0019921404],"study_design_scores_gemma":[0.000026053182,0.0014771152,0.0036421944,0.0000037382313,0.000018493474,0.00018001176,0.000021768206,0.00046355033,0.99236816,0.000015503892,0.0017807956,0.0000026698078],"about_ca_topic_score_codex":0.0010010712,"about_ca_topic_score_gemma":0.0013852154,"teacher_disagreement_score":0.0010010712,"about_ca_system_score_codex":0.00012275345,"about_ca_system_score_gemma":0.00016542344,"threshold_uncertainty_score":0.0031093955},"labels":[],"label_agreement":null},{"id":"W4402279313","doi":"10.1007/s00262-024-03813-3","title":"Correction to: Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells","year":2024,"lang":"en","type":"erratum","venue":"Cancer Immunology Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mesothelin; Treosulfan; Fludarabine; Olaparib; Chimeric antigen receptor; Ovarian cancer; Cancer research; Medicine; Oncology; Antigen; Immunology; Internal medicine; Biology; Immunotherapy; Chemotherapy; Cancer; Gene; Immune system; Poly ADP ribose polymerase; Genetics; Cyclophosphamide","score_opus":0.014802131076722286,"score_gpt":0.3236933696166772,"score_spread":0.3088912385399549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402279313","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012453414,0.0010295514,0.00030290423,0.029439522,0.9672295,0.000013070266,0.00023402921,0.00008811898,0.0015387802],"genre_scores_gemma":[0.01251976,0.010308787,0.003463512,0.09758103,0.6496062,0.00013485861,0.0010645414,0.00086536945,0.22445598],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748635,0.00037526968,0.0003948567,0.00033007373,0.0011462227,0.0002671757],"domain_scores_gemma":[0.98665327,0.0036803754,0.0006458696,0.00067860936,0.007296462,0.0010454535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028083099,0.0018082552,0.0014529639,0.002604331,0.0020207884,0.0027638227,0.0026863639,0.006367965,0.028336482],"category_scores_gemma":[0.025315246,0.0008623748,0.0014720864,0.0011620075,0.0017689016,0.0013054127,0.0012655514,0.008748067,0.0149357375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056925313,0.00000777563,0.000055001798,0.0001087956,0.000014341372,0.0004921444,0.000014390558,0.000044672754,0.00008909828,0.00038771352,0.993067,0.005662014],"study_design_scores_gemma":[0.000051732506,0.000021098287,0.00038656004,0.00014485858,0.000046328732,0.0008697187,0.000031376247,0.00018462891,0.00046757466,0.0005636849,0.99721503,0.000017339293],"about_ca_topic_score_codex":0.011723478,"about_ca_topic_score_gemma":0.014008876,"teacher_disagreement_score":0.028336482,"about_ca_system_score_codex":0.0035503763,"about_ca_system_score_gemma":0.0037660308,"threshold_uncertainty_score":0.09479505},"labels":[],"label_agreement":null},{"id":"W4404148479","doi":"10.1007/s00262-024-03862-8","title":"Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Japan Society for the Promotion of Science; Osaka University","keywords":"Wilms' tumor; Cytotoxic T cell; Cancer research; Gene; Solid tumor; Biology; Medicine; Pathology; Cancer; Genetics; In vitro","score_opus":0.004829506386005347,"score_gpt":0.22181714913101552,"score_spread":0.21698764274501017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404148479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997676,0.000041647105,0.000046369383,0.0000041221356,0.0000017813348,0.0000028923766,0.00001637404,0.00000316957,0.000116098105],"genre_scores_gemma":[0.99985826,0.000013394215,0.000018261897,0.000006095492,0.0000037016434,0.000001489007,0.000029038094,9.785507e-7,0.0000687587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999876,0.000020867014,0.000011014373,0.000042561922,0.000025146164,0.000024386263],"domain_scores_gemma":[0.9997193,0.000072357594,0.00007792015,0.00002072955,0.000029899644,0.000079703714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010849838,0.00017879989,0.0002423816,0.0003494489,0.00027876755,0.00025204034,0.00008921533,0.00023531994,0.0012512607],"category_scores_gemma":[0.0004963557,0.00011658636,0.000117419884,0.00015185845,0.00016951142,0.00017428075,0.00015360063,0.000251714,0.00016207856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00112265,0.0001869633,0.89579636,0.00004095223,0.00004486657,0.0068558906,0.0005903882,0.00019006227,0.08531108,0.000078449004,0.00019705796,0.009585369],"study_design_scores_gemma":[0.000038995575,0.0013737075,0.9711227,0.000006631919,0.000045798875,0.01749358,0.00025882773,0.0006817635,0.008284426,0.000063568645,0.00062064675,0.000009375008],"about_ca_topic_score_codex":0.00030559502,"about_ca_topic_score_gemma":0.00023343434,"teacher_disagreement_score":0.0012512607,"about_ca_system_score_codex":0.00014074157,"about_ca_system_score_gemma":0.0000694726,"threshold_uncertainty_score":0.0041858554},"labels":[],"label_agreement":null},{"id":"W4410897048","doi":"10.1007/s00262-025-04084-2","title":"Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Daiichi-Sankyo; Kagoshima University","keywords":"Medicine; Sarcopenia; Internal medicine; Osteoporosis; Cancer; Body mass index; Pathological; Rheumatology; Gastroenterology; Immune system; Stage (stratigraphy); Oncology; Immunology","score_opus":0.012672301445357,"score_gpt":0.3108486347569695,"score_spread":0.2981763333116125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410897048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941385,0.0002794067,0.000036542864,0.000011247768,0.0000022730337,0.0000039739734,0.000060396553,0.0000013892869,0.00019086762],"genre_scores_gemma":[0.99977726,0.00005587927,0.00003850479,0.000006282127,0.000005195723,0.0000028773743,0.000082304774,2.983694e-7,0.00003136313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990475,0.00002059311,0.000014794432,0.000018720848,0.000020610518,0.000020493508],"domain_scores_gemma":[0.999493,0.0000795057,0.00024300869,0.000017989161,0.00005667031,0.00010973053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025308662,0.0001773292,0.0001668937,0.0004977033,0.00019319807,0.00020198013,0.00011026533,0.00018998497,0.001017949],"category_scores_gemma":[0.0006856704,0.00008163056,0.0001701011,0.00043032406,0.00019910584,0.00015107363,0.00018969028,0.00019817532,0.00010802031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008075819,0.000005615398,0.99894315,0.0000034723878,0.000006843581,0.000051812567,0.0000072855096,0.000017924722,0.00027665208,0.000002225883,0.000016816732,0.0005874396],"study_design_scores_gemma":[0.000004593654,0.0000799112,0.9992829,0.0000022093795,0.000010373137,0.00034826476,0.000041212592,0.00009902569,0.00006944482,0.0000060304415,0.00005501501,0.0000010309766],"about_ca_topic_score_codex":0.00069648516,"about_ca_topic_score_gemma":0.001330066,"teacher_disagreement_score":0.001017949,"about_ca_system_score_codex":0.00012144839,"about_ca_system_score_gemma":0.00013008142,"threshold_uncertainty_score":0.0034053922},"labels":[],"label_agreement":null},{"id":"W4411121742","doi":"10.1007/s00262-025-04088-y","title":"NLRP3 activation promotes cGAS/STING signaling and antitumor immunity by colorectal cancer cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; University Hospital Foundation; University of Alberta","keywords":"Sting; Cancer research; Immunity; Colorectal cancer; Signal transduction; Medicine; Immunology; Cancer; Biology; Immune system; Internal medicine; Cell biology","score_opus":0.009776076470840942,"score_gpt":0.2748164852944155,"score_spread":0.26504040882357455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411121742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928197,0.0022548216,0.0024595752,0.00015245205,0.00004747853,0.00007219851,0.0004912686,0.00017775972,0.0015247199],"genre_scores_gemma":[0.9967193,0.00050727464,0.0014427336,0.000060432856,0.000014287768,0.00006059086,0.00043088433,0.000009933006,0.00075457373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978656,0.00004379255,0.000023603274,0.00003786959,0.000049912738,0.00005822677],"domain_scores_gemma":[0.9998901,0.000021209082,0.00003130702,0.00001791767,0.0000109851135,0.00002848637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020600407,0.00040741873,0.00035115276,0.00023212643,0.00015207825,0.0003487869,0.00012421256,0.00028537505,0.0017919306],"category_scores_gemma":[0.00013227374,0.00010494811,0.00046289735,0.00023247638,0.0002618461,0.00021766394,0.0002518782,0.00086812075,0.00055692776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042344126,0.00006552938,0.00028608058,0.0000800595,0.000005971262,0.000060618408,0.00002836114,0.00008284558,0.9972904,0.00004689502,0.000085586646,0.0015442164],"study_design_scores_gemma":[0.00007325262,0.0011493143,0.009402051,0.000016534412,0.000022504777,0.00041547394,0.000050911705,0.0016018933,0.98414755,0.00007667457,0.0030362261,0.000007643361],"about_ca_topic_score_codex":0.00034400175,"about_ca_topic_score_gemma":0.00048141883,"teacher_disagreement_score":0.0017919306,"about_ca_system_score_codex":0.00031868485,"about_ca_system_score_gemma":0.00024935658,"threshold_uncertainty_score":0.0059945583},"labels":[],"label_agreement":null},{"id":"W4411621161","doi":"10.1007/s00262-025-04105-0","title":"Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor-resistant tumors resulting in complete responses","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Tumor microenvironment; Immune system; Cancer research; Melanoma; Immunotherapy; Cytotoxic T cell; Chemokine; Acquired immune system; Interleukin 12; Cancer; Immunology; Cancer immunotherapy; Biology; Medicine; Internal medicine; In vitro","score_opus":0.030743658589663967,"score_gpt":0.30224594091405105,"score_spread":0.27150228232438706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411621161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722505,0.0005465079,0.0008208657,0.00006618516,0.00005073692,0.00005856783,0.0002553234,0.00009513781,0.0008816355],"genre_scores_gemma":[0.995654,0.00036996693,0.0011489182,0.000043692962,0.000016010817,0.00007852494,0.00034042378,0.000017484028,0.002331007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998925,0.000015344904,0.000011360706,0.000022770966,0.000026237407,0.000031890213],"domain_scores_gemma":[0.9999274,0.0000130236795,0.000017340059,0.000009364533,0.0000072918056,0.000025667667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010638483,0.0003238725,0.00031924498,0.00018647665,0.00009753685,0.00018128305,0.00012460095,0.00021478963,0.0015930026],"category_scores_gemma":[0.00007899072,0.000095640455,0.00018728153,0.00009517474,0.00017870989,0.00015483037,0.00008258335,0.0008403083,0.0003182789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003954719,0.00020019992,0.000074966,0.000037383386,0.000004376807,0.000022202004,0.000017935701,0.00009957311,0.9973603,0.00004047879,0.000082725855,0.0016643599],"study_design_scores_gemma":[0.00005331931,0.004063368,0.0009678673,0.0000038409125,0.000014340764,0.00008473741,0.000021482692,0.0006897393,0.99295104,0.000013642213,0.0011335325,0.0000032049572],"about_ca_topic_score_codex":0.00037186584,"about_ca_topic_score_gemma":0.0005217432,"teacher_disagreement_score":0.0015930026,"about_ca_system_score_codex":0.00017063328,"about_ca_system_score_gemma":0.00017501178,"threshold_uncertainty_score":0.0053290725},"labels":[],"label_agreement":null},{"id":"W4416344138","doi":"10.1007/s00262-025-04217-7","title":"CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8+CD103+ cDC1 and TRM cell responses","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Science and Technology Program of Suzhou; Saskatchewan Cancer Agency; Cancer Research Society","keywords":"Metastatic melanoma; Irreversible electroporation; Agonist; Electroporation; Melanoma; Immunotherapy; Cancer; Cell","score_opus":0.013943632009932443,"score_gpt":0.31594044235290675,"score_spread":0.3019968103429743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416344138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967925,0.0010256473,0.0010102196,0.000054954,0.000020240404,0.000026788135,0.000055359975,0.00004624185,0.00096811965],"genre_scores_gemma":[0.9975957,0.0004872108,0.0007106499,0.00003249209,0.000009896335,0.000019118117,0.00007961007,0.0000074451527,0.001057937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999948,0.000008664426,0.0000030728122,0.0000091907805,0.000013487469,0.000017507531],"domain_scores_gemma":[0.9999758,0.0000036166996,0.0000059819076,0.0000021251667,0.0000023520201,0.000010147668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006039019,0.00020272874,0.00022852301,0.000088266046,0.00005309062,0.00011203702,0.00009101123,0.00013471258,0.000778261],"category_scores_gemma":[0.00005116242,0.000058634585,0.00012835275,0.00004282614,0.00008218308,0.00009706809,0.00008437633,0.00044159524,0.00012522103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001240796,0.00009168901,0.000060063154,0.000029395223,0.0000020628434,0.000017193846,0.000008147593,0.000078929916,0.9971048,0.000025223906,0.000045520614,0.002412921],"study_design_scores_gemma":[0.00006579286,0.0030937325,0.0028802482,0.000007674266,0.000022608878,0.00021119052,0.000014030062,0.001159402,0.98976606,0.000029595752,0.0027451697,0.0000044298786],"about_ca_topic_score_codex":0.0001966229,"about_ca_topic_score_gemma":0.00037263698,"teacher_disagreement_score":0.000778261,"about_ca_system_score_codex":0.000072496456,"about_ca_system_score_gemma":0.00009826156,"threshold_uncertainty_score":0.002603531},"labels":[],"label_agreement":null},{"id":"W48985345","doi":"10.1007/s00262-002-0365-4","title":"Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Granulocyte colony-stimulating factor; Epirubicin; Medicine; Cyclophosphamide; CD34; Breast cancer; CD19; Leukapheresis; Dendritic cell; Immunology; Chemotherapy; Internal medicine; Cancer; Antigen; Stem cell; Biology","score_opus":0.0168381012225429,"score_gpt":0.29297891319408265,"score_spread":0.2761408119715397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48985345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918026,0.0001468771,0.000086773936,0.000033799806,0.000007252228,0.000007936626,0.00008041994,0.0000054240586,0.0004511404],"genre_scores_gemma":[0.99928766,0.000053300006,0.000049347127,0.00004453446,0.000007197374,0.0000068074255,0.00018713837,0.000002412879,0.0003616588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990106,0.00002280202,0.0000097951,0.000019631392,0.000016872265,0.00002974568],"domain_scores_gemma":[0.99963903,0.00011640155,0.000063650135,0.000043289623,0.000027281603,0.00011028353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012135127,0.00009365503,0.00031079532,0.00017254901,0.0001782448,0.00027781448,0.00010657592,0.0002464172,0.0019041807],"category_scores_gemma":[0.00061977137,0.00009576996,0.00011736749,0.00012765724,0.00019495064,0.00018208478,0.00014450216,0.00037895096,0.00031775952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020054474,0.0013247925,0.23311216,0.00015378154,0.00008717723,0.004284361,0.00035954147,0.00028892036,0.69186264,0.00040824077,0.0011989517,0.046864953],"study_design_scores_gemma":[0.00083124853,0.01809501,0.8378965,0.000034868677,0.00022727129,0.023626326,0.0005438334,0.0019398421,0.109383516,0.00057139265,0.006815793,0.000034381686],"about_ca_topic_score_codex":0.00031789983,"about_ca_topic_score_gemma":0.00020491563,"teacher_disagreement_score":0.0019041807,"about_ca_system_score_codex":0.0001281798,"about_ca_system_score_gemma":0.00017756541,"threshold_uncertainty_score":0.006370127},"labels":[],"label_agreement":null}]}